Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AC007325.2 ENSG00000277196 Unmapped 138082-161852 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 12.8;skin 1: 12.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 5.1;Distal tubular cells: 6.6" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.4" "Lineage enhanced" "Detected in single" "T-cells: 1.4" "Group enriched" "Detected in some" 13 "OE19: 84.6;RPTEC TERT1: 44.7" HPA020361 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" 0.0 0.0 0.0 0.0 0.6 6.4 0.0 0.0 11.1 0.0 0.0 2.1 0.0 0.0 2.8 4.5 1.6 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 12.6 12.8 0.0 0.0 0.0 0.0 1.1 1.8 0.5 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 2.0 0.0 0.6 1.2 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.4 0.0 0.1 0.0 0.0 2.4 4.5 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.1 4.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 84.6 0.0 0.0 0.0 0.0 44.7 0.1 0.1 0.1 0.0 1.7 0.3 4.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 AC011455.2 ENSG00000269547 19 38915404-38949855 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.6;ovary: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.7;A549: 5.2;AN3-CA: 2.8;T-47d: 4.4;U-251 MG: 6.4" "HPA052730, HPA056957" Uncertain Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (6.10e-2)" "unprognostic (3.79e-2)" 1.3 2.6 0.3 1.7 0.3 0.0 0.1 0.4 1.1 0.3 0.1 0.0 1.2 0.5 0.1 0.4 0.8 1.1 0.1 0.1 1.6 1.1 0.2 0.0 0.2 3.0 0.6 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.2 0.2 0.2 0.0 0.3 0.1 0.1 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.2 0.0 2.8 0.9 0.0 0.5 0.0 0.3 0.4 0.0 0.0 0.0 0.0 1.8 0.0 0.3 1.3 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.1 0.0 0.5 0.3 1.2 0.5 0.5 0.0 1.2 0.3 2.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.2 0.0 1.4 1.4 0.0 6.4 0.0 0.6 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACADS "ACAD3, SCAD" ENSG00000122971 "Acyl-CoA dehydrogenase short chain" P16219 12 120725735-120740008 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 58.4;skeletal muscle: 50.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 23.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004799, CAB019284, HPA022271" Enhanced Enhanced Nucleoplasm,Centrosome,Mitochondria NA NA 15000 Mitochondria "Nucleoplasm, Centrosome" "CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472" "unprognostic (7.14e-2)" "unprognostic (3.03e-3)" "unprognostic (8.15e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.11e-3)" "unprognostic (5.75e-2)" "prognostic favorable (2.43e-4)" "unprognostic (5.65e-2)" "unprognostic (1.22e-1)" "unprognostic (2.14e-1)" "unprognostic (2.69e-2)" "unprognostic (4.04e-2)" "prognostic favorable (3.33e-6)" "unprognostic (1.23e-2)" "unprognostic (1.81e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.34e-5)" 19.5 14.5 5.7 10.0 5.2 5.3 18.0 2.3 4.6 2.9 26.2 4.7 4.5 35.8 2.8 5.3 5.0 2.9 9.1 32.6 3.7 3.3 13.2 58.4 5.6 7.8 5.0 4.1 2.3 14.4 3.0 2.4 4.3 3.8 4.1 9.0 5.6 8.9 4.6 50.7 3.4 35.3 6.5 3.8 8.6 9.5 10.7 5.4 4.0 8.1 16.8 4.3 5.0 3.2 6.8 11.4 7.2 14.0 15.3 14.7 10.0 2.0 7.2 0.4 6.3 8.6 3.4 7.2 3.0 3.0 3.9 2.9 5.6 5.1 0.2 7.8 2.5 1.8 3.3 4.2 1.3 0.5 10.5 5.3 5.2 2.2 11.9 6.2 0.4 23.6 10.3 2.0 1.7 0.1 1.2 3.9 13.3 4.2 0.0 1.7 4.2 7.2 12.0 1.3 6.6 3.0 5.3 2.7 1.4 7.3 11.5 0.7 4.0 6.2 0.0 9.8 0.6 5.0 8.2 4.4 0.1 3.1 3.0 0.5 10.0 5.6 2.5 6.7 4.4 2.6 7.2 13.0 6.4 12.4 14.0 8.8 5.9 11.3 13.0 11.4 6.8 14.7 13.2 1.3 15.3 8.7 9.5 11.9 10.0 5.7 5.2 2.3 4.6 3.7 3.3 5.0 4.1 3.8 5.4 11.9 10.7 10.2 10.2 6.0 1.1 32.5 30.6 2.7 5.7 17.4 0.0 60.7 43.1 26.8 15.8 14.2 312.7 23.3 28.4 26.2 16.9 7.1 19.5 154.5 47.4 1.6 43.8 12.9 27.2 26.3 19.8 11.1 16.9 32.5 94.5 13.0 25.9 154.3 17.0 74.9 0.7 6.5 13.0 29.1 8.3 4.0 63.2 20.3 144.6 9.0 ACADVL "ACAD6, LCACD, VLCAD" ENSG00000072778 "Acyl-CoA dehydrogenase very long chain" P49748 17 7217125-7225273 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019006, HPA020595" Enhanced Supported Nucleoplasm,Nucleoli,Mitochondria NA NA 19000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA019006: AB_1844478, HPA020595: AB_1844479" "unprognostic (4.81e-2)" "unprognostic (2.86e-1)" "unprognostic (2.21e-2)" "unprognostic (1.09e-2)" "unprognostic (6.63e-3)" "unprognostic (1.51e-1)" "unprognostic (1.89e-2)" "unprognostic (1.39e-1)" "unprognostic (1.07e-1)" "unprognostic (3.21e-1)" "prognostic favorable (6.87e-4)" "unprognostic (3.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (4.01e-1)" "unprognostic (2.84e-3)" 32.7 69.2 22.8 18.2 21.1 15.1 24.1 19.8 18.4 21.1 44.0 16.5 26.7 51.7 17.4 19.7 31.5 14.2 24.4 118.2 20.2 12.2 35.2 90.0 17.3 9.8 18.5 16.8 15.5 67.8 31.5 32.3 40.2 20.9 22.1 24.2 20.0 27.4 29.0 132.3 20.3 51.2 25.0 15.7 21.9 28.7 11.5 18.6 14.6 29.6 36.9 21.2 22.4 31.8 8.3 32.0 37.9 29.0 11.6 14.9 20.0 33.5 32.1 13.2 18.1 57.0 21.0 25.0 24.7 34.4 28.1 17.5 12.9 30.3 18.0 20.6 51.7 10.1 25.9 8.8 27.0 24.9 56.9 9.1 9.6 22.8 19.7 27.4 9.1 25.0 23.3 24.7 23.5 37.1 43.6 25.3 22.1 12.3 21.9 45.1 12.7 9.4 11.0 6.2 35.2 12.7 13.2 14.6 42.6 62.6 30.6 3.5 8.7 34.8 44.3 20.2 12.9 20.3 14.0 25.1 24.9 18.7 12.6 24.1 20.6 9.6 0.9 45.9 16.1 18.1 6.8 29.0 37.9 13.5 18.0 12.4 8.3 10.9 14.9 32.0 7.6 8.3 10.2 6.3 11.6 12.0 26.0 9.7 20.0 22.8 21.1 19.8 18.4 20.2 12.2 18.5 16.8 20.9 18.6 56.6 73.4 64.0 249.7 77.5 39.6 397.7 150.3 17.4 43.3 191.9 58.9 369.3 157.5 241.9 107.0 71.4 453.8 23.3 66.5 164.5 100.7 311.9 89.7 297.9 171.6 31.8 172.2 51.5 68.0 184.1 115.3 93.1 77.6 423.8 144.6 37.1 129.2 196.4 124.8 276.8 38.8 103.5 102.3 100.5 34.7 76.5 554.7 68.2 215.2 275.4 ACSL1 "ACS1, FACL1, FACL2, LACS, LACS1, LACS2" ENSG00000151726 "Acyl-CoA synthetase long chain family member 1" P33121 4 184755595-184826818 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 105.0;liver: 190.9" "Group enriched" "Detected in many" 4 "Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "neutrophil: 80.2" "Lineage enriched" "Detected in many" 9 "granulocytes: 80.2" "Cell line enhanced" "Detected in many" "ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011316, HPA011964" Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA011316: AB_1844536, HPA011964: AB_1844537" "unprognostic (1.10e-2)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.21e-2)" "unprognostic (1.82e-3)" "unprognostic (2.75e-2)" "unprognostic (1.79e-1)" "unprognostic (5.89e-2)" "unprognostic (9.83e-2)" "unprognostic (3.15e-1)" "prognostic favorable (1.25e-5)" "unprognostic (2.77e-1)" "unprognostic (4.38e-2)" "unprognostic (6.25e-3)" "unprognostic (3.13e-2)" 105.0 6.7 4.2 14.1 13.5 46.0 54.4 3.2 9.6 7.2 12.2 16.4 5.5 4.9 5.7 12.7 8.8 6.4 5.7 24.3 6.4 4.1 32.8 190.9 20.7 18.9 24.0 3.8 4.2 7.3 5.9 8.7 4.4 11.6 14.2 2.6 9.1 17.9 4.8 89.1 20.4 4.5 6.4 18.2 16.9 6.5 6.4 15.9 2.1 8.3 10.1 5.8 7.6 11.0 0.5 2.2 80.2 8.9 0.7 0.7 2.9 6.1 1.9 1.2 3.1 151.2 36.7 1.0 3.4 1.7 2.0 1.4 0.4 1.7 2.5 0.3 4.0 4.9 3.8 5.4 2.2 1.7 12.4 1.9 1.8 1.7 5.0 24.3 4.9 4.6 80.3 18.6 1.7 8.7 3.6 2.6 0.4 0.8 7.8 9.8 3.2 0.3 6.8 0.2 4.1 2.7 0.9 1.0 3.2 47.8 17.5 4.6 4.3 3.1 9.4 10.5 0.5 3.4 5.0 2.8 1.8 2.1 4.3 1.0 3.0 1.5 1.1 5.8 6.9 2.8 2.3 8.9 2.8 0.5 5.2 0.5 0.5 0.4 0.2 2.2 0.5 0.4 0.3 80.2 0.7 3.6 0.4 0.7 2.9 4.2 13.5 3.2 9.6 6.4 4.1 24.0 3.8 11.6 15.9 23.8 107.2 14.5 16.5 18.7 5.8 89.7 28.1 13.4 21.6 29.6 17.7 8.6 79.6 3.9 359.4 5.6 2.6 0.0 11.0 1.9 9.1 56.1 23.1 1018.8 39.4 3.2 0.0 19.0 136.2 335.5 17.8 64.1 30.4 24.4 4.2 3.3 9.0 0.9 15.6 75.0 10.3 12.9 12.0 8.1 16.7 35.9 2.9 10.0 1.7 21.4 AIM2 PYHIN4 ENSG00000163568 "Absent in melanoma 2" O14862 1 159062484-159147096 "Predicted intracellular proteins" "Apoptosis, Immunity, Inflammatory response, Innate immunity" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 44.7;lymphoid tissue: 43.8" "Group enriched" "Detected in some" 6 "B-cells: 18.9;Early spermatids: 19.7;Late spermatids: 24.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "memory B-cell: 44.7;naive B-cell: 14.3" "Lineage enriched" "Detected in many" 9 "B-cells: 44.7" "Cell line enhanced" "Detected in some" "Daudi: 31.8;HDLM-2: 44.3;Karpas-707: 17.6;U-266/70: 14.8;U-266/84: 11.1;U-87 MG: 13.7" "Low region specificity" "Detected in all" "HPA031365, HPA040309" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA031365: AB_10601332, HPA040309: AB_2676925" "unprognostic (6.05e-2)" "unprognostic (7.68e-2)" "unprognostic (4.24e-3)" "unprognostic (2.08e-2)" "unprognostic (6.94e-2)" "unprognostic (3.44e-1)" "unprognostic (3.20e-1)" "unprognostic (1.35e-1)" "unprognostic (4.27e-2)" "unprognostic (1.28e-3)" "unprognostic (7.10e-3)" "unprognostic (1.13e-1)" "unprognostic (1.23e-12)" "unprognostic (1.01e-1)" "unprognostic (3.91e-2)" "unprognostic (2.28e-1)" "unprognostic (2.32e-3)" 0.7 0.3 1.3 28.2 0.9 0.4 0.6 0.5 0.6 0.4 1.9 0.1 0.0 0.7 0.2 0.2 4.1 0.5 1.1 0.5 1.2 0.6 0.9 0.8 2.0 24.1 0.5 0.2 0.6 0.3 0.0 8.8 0.4 0.5 0.7 1.0 0.5 1.9 0.0 0.2 0.3 12.8 0.2 2.6 43.8 1.3 1.4 1.4 1.4 0.7 0.6 25.9 4.0 0.5 44.7 1.2 4.7 2.4 0.0 3.3 1.4 5.3 0.0 0.3 0.0 0.0 4.4 0.0 0.0 0.5 0.4 0.3 0.0 0.0 31.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 44.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 2.9 0.0 2.8 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 0.1 14.8 11.1 0.3 13.7 1.2 2.3 4.2 2.4 0.0 0.6 2.1 1.7 44.7 1.6 1.1 1.2 14.3 0.1 0.4 4.7 0.0 2.2 0.0 3.3 1.4 1.3 0.9 0.5 0.6 1.2 0.6 0.5 0.2 0.5 1.4 0.0 0.0 18.9 0.1 0.0 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 19.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.9 24.1 0.3 1.0 3.3 1.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 2.1 0.0 0.4 AL139011.2 ENSG00000258465 1 160217464-160285130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 14 "Alveolar cells type 2: 1.6;Club cells: 3.4;granulocytes: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 6.7;BJ hTERT+: 5.9;EFO-21: 6.6;HDLM-2: 6.0" "HPA027218, HPA027381, HPA044837" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA027218: AB_10602586, HPA027381: AB_1858808, HPA044837: AB_10962496" "unprognostic (4.71e-2)" "unprognostic (1.75e-1)" "unprognostic (2.21e-2)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (8.04e-4)" "unprognostic (4.70e-2)" "unprognostic (1.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.18e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.87e-3)" "unprognostic (2.92e-1)" "unprognostic (5.29e-1)" "unprognostic (1.06e-1)" "unprognostic (5.18e-3)" 8.6 4.0 3.7 3.0 10.2 2.0 4.4 15.4 11.4 4.8 4.7 8.6 2.5 3.5 6.3 4.2 5.3 6.4 4.6 16.7 3.8 3.9 6.2 10.8 4.1 3.2 3.6 5.9 7.6 4.0 6.7 4.1 5.0 9.1 5.5 3.5 6.1 5.5 3.0 14.6 4.0 4.2 7.8 4.1 3.7 4.3 4.8 4.1 2.5 7.9 3.8 3.4 5.8 4.7 5.8 8.9 6.7 6.5 8.0 5.0 8.0 0.1 2.1 0.3 0.5 6.7 1.9 0.6 0.9 5.9 3.3 0.8 0.0 0.8 0.2 6.6 1.0 5.2 0.8 1.1 0.2 0.0 6.0 0.0 0.3 0.7 0.2 3.4 0.0 0.3 3.2 0.2 3.0 3.4 3.5 0.5 0.8 1.0 4.7 0.5 0.3 1.1 0.0 0.3 0.6 0.6 0.5 0.0 0.3 0.3 0.8 0.6 0.8 0.2 1.4 0.0 1.0 2.8 5.6 0.0 0.8 0.8 0.0 0.2 0.8 3.4 0.5 0.4 0.3 0.3 6.4 6.3 6.2 3.6 6.5 5.0 5.8 4.4 4.7 8.9 3.9 2.5 3.2 6.7 8.0 6.3 2.5 4.9 8.0 3.7 10.2 15.4 11.4 3.8 3.9 3.6 5.9 9.1 4.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 ANGEL2 "Ccr4d, FLJ12793, KIAA0759L" ENSG00000174606 "Angel homolog 2" Q5VTE6 1 212992182-213015826 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030795, HPA030796" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" NA NA Nucleoplasm "Nuclear bodies, Mitochondria" "HPA030795: , HPA030796: AB_10600979" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (8.73e-2)" "unprognostic (2.76e-1)" "unprognostic (2.04e-2)" "unprognostic (1.93e-2)" "unprognostic (1.50e-1)" "unprognostic (4.98e-2)" "unprognostic (1.33e-2)" "unprognostic (2.92e-1)" "unprognostic (2.70e-3)" "unprognostic (6.46e-2)" "prognostic unfavorable (8.39e-6)" "unprognostic (9.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.20e-4)" 11.4 11.7 18.0 10.8 32.6 9.5 17.8 21.6 22.7 14.5 9.3 16.9 8.6 8.6 14.8 14.2 10.2 12.2 10.4 9.2 17.4 13.8 13.3 13.0 11.0 15.8 17.0 13.9 19.1 10.5 15.5 14.8 10.8 13.8 14.5 11.0 12.3 9.8 11.2 11.0 15.1 10.7 12.2 14.9 15.5 10.5 9.0 15.9 19.5 14.0 7.9 14.9 10.8 9.7 7.8 7.2 7.6 5.9 14.1 11.3 6.7 8.7 7.0 11.4 9.7 8.7 12.9 10.2 7.2 12.0 11.5 11.5 4.7 6.5 8.5 6.6 7.1 6.4 6.9 13.1 6.9 11.7 15.9 7.9 8.5 5.6 4.6 9.6 8.4 10.2 7.9 8.9 9.0 9.3 9.8 9.7 7.7 9.8 8.8 13.2 2.9 9.6 5.7 26.9 4.8 5.1 4.9 20.5 8.9 9.0 5.9 5.6 16.3 8.6 11.7 13.3 12.7 9.0 6.2 7.2 9.5 5.1 11.7 10.9 6.5 6.2 5.7 10.7 6.3 8.7 7.4 5.9 7.6 7.4 5.5 9.1 7.8 9.2 7.6 7.2 5.3 9.8 8.1 4.0 14.1 4.4 4.4 11.3 6.7 18.0 32.6 21.6 22.7 17.4 13.8 17.0 13.9 13.8 15.9 44.7 9.8 14.6 7.5 6.2 21.3 12.6 17.8 28.1 15.9 12.2 9.8 12.8 10.0 8.7 1.2 11.3 6.7 0.0 9.2 12.6 10.6 8.8 16.2 11.5 10.5 27.0 6.4 11.6 19.2 1.5 14.4 11.3 3.3 10.8 9.2 13.4 8.4 7.0 13.1 13.5 17.6 19.4 9.0 7.4 16.2 6.0 9.2 18.1 8.8 6.2 ANKRD34B DP58 ENSG00000189127 "Ankyrin repeat domain 34B" A5PLL1 5 80556755-80570488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 31.0" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 2.0;Collecting duct cells: 3.5;Intestinal endocrine cells: 1.7;Kupffer cells: 3.2" "Cancer enhanced" "Detected in some" "prostate cancer: 2.3" "Region enriched" "Detected in many" 6 "basal ganglia: 31.0" "Cell type enriched" "Detected in some" 5 "neutrophil: 7.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 7.2" "Cell line enriched" "Detected in some" 29 "RPTEC TERT1: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA043327 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA043327: AB_10794180" "unprognostic (1.05e-1)" "unprognostic (4.16e-6)" "unprognostic (2.07e-4)" "unprognostic (1.05e-1)" "unprognostic (3.03e-1)" "unprognostic (8.25e-4)" "unprognostic (6.44e-2)" "unprognostic (1.80e-1)" "unprognostic (9.41e-2)" "unprognostic (6.52e-3)" "unprognostic (1.93e-1)" "unprognostic (4.28e-2)" "unprognostic (1.02e-1)" "unprognostic (2.33e-1)" "unprognostic (2.94e-2)" 0.1 0.3 0.9 1.5 31.0 5.7 0.3 0.0 0.9 0.5 0.1 0.4 0.3 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.0 4.1 2.8 0.1 0.2 3.0 1.2 0.2 0.0 0.0 0.0 0.0 0.4 0.7 0.5 0.2 0.0 0.3 0.2 0.0 0.1 0.1 0.2 0.4 1.0 0.1 1.0 5.1 0.0 0.1 0.0 4.6 0.1 0.0 0.0 0.0 7.2 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 46.9 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.3 0.9 31.0 0.0 0.9 1.0 4.1 1.2 0.2 0.7 5.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 1.7 0.0 3.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 ANKRD37 Lrp2bp ENSG00000186352 "Ankyrin repeat domain 37" Q7Z713 4 185396021-185400628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 135.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036626, HPA058127" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA036626: AB_10671963, HPA058127: AB_2683614" "unprognostic (9.08e-2)" "unprognostic (2.85e-3)" "unprognostic (3.89e-2)" "unprognostic (2.36e-3)" "unprognostic (1.19e-1)" "unprognostic (2.27e-1)" "unprognostic (7.51e-2)" "unprognostic (9.12e-2)" "unprognostic (1.74e-1)" "unprognostic (1.09e-1)" "unprognostic (7.36e-2)" "unprognostic (9.69e-3)" "unprognostic (2.81e-2)" "unprognostic (1.38e-1)" "unprognostic (1.41e-1)" "unprognostic (6.45e-3)" "unprognostic (1.08e-1)" 7.7 8.9 11.0 3.9 15.2 3.3 10.9 9.9 20.9 17.2 7.5 6.0 5.4 4.8 4.9 4.1 35.8 8.0 4.8 13.6 12.0 9.6 6.4 14.2 12.4 3.0 12.3 5.8 14.8 13.5 1.7 11.7 10.7 16.8 24.1 7.0 8.4 35.4 21.9 22.1 7.3 4.9 5.0 16.1 4.6 5.2 8.7 14.2 1.5 14.2 18.6 12.2 14.3 22.8 7.7 4.2 10.2 3.9 3.2 8.1 3.0 6.2 0.9 0.7 3.6 4.9 3.1 3.4 2.9 2.2 2.1 4.7 1.5 1.8 3.0 1.2 5.3 4.4 2.4 3.4 3.7 2.7 8.5 0.9 2.0 3.2 4.5 2.1 1.9 4.7 0.6 4.0 2.0 2.8 15.7 2.7 2.0 3.1 5.1 5.9 1.6 1.6 7.5 1.0 0.6 5.0 0.5 1.0 8.2 2.6 0.5 5.0 8.9 2.0 2.0 8.6 2.7 1.8 1.2 3.5 4.6 3.7 2.6 3.3 9.6 2.8 1.3 13.1 1.4 5.3 0.4 3.8 10.2 5.5 3.5 4.7 7.6 4.3 8.1 2.6 7.7 3.3 4.7 2.0 3.2 3.9 4.2 5.1 3.0 11.0 15.2 9.9 20.9 12.0 9.6 12.3 5.8 16.8 14.2 20.8 23.7 16.6 23.8 52.8 24.8 1.2 0.0 101.7 22.7 8.7 27.5 15.7 21.6 17.9 3.7 11.7 61.7 23.3 20.0 36.6 28.6 40.4 63.2 20.4 13.8 9.5 115.1 10.4 6.7 2.0 8.6 24.5 135.0 28.9 93.8 89.4 40.5 35.1 11.0 15.7 103.2 6.5 35.0 13.3 15.1 42.0 70.6 11.7 31.3 16.2 ARGLU1 FLJ10154 ENSG00000134884 "Arginine and glutamate rich 1" Q9NWB6 13 106541673-106568164 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HeLa: 91.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034962, HPA056792" Supported Enhanced Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA034962: AB_10611676, HPA056792: AB_2683236" "unprognostic (1.66e-2)" "unprognostic (3.10e-2)" "unprognostic (2.24e-1)" "unprognostic (2.82e-1)" "unprognostic (3.97e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-3)" "unprognostic (3.21e-2)" "unprognostic (9.00e-2)" "unprognostic (1.52e-1)" "prognostic favorable (3.92e-5)" "unprognostic (1.43e-3)" "prognostic unfavorable (1.09e-4)" "unprognostic (2.91e-3)" "unprognostic (2.65e-1)" "unprognostic (2.87e-1)" "prognostic favorable (7.34e-5)" 43.5 31.8 59.1 46.5 63.6 67.5 46.1 82.1 72.8 37.9 41.7 44.9 33.5 35.2 62.2 50.9 38.1 50.2 55.0 40.4 55.7 20.6 30.5 24.4 65.3 75.7 62.5 44.5 65.2 34.1 24.0 61.1 48.3 44.0 38.9 48.6 35.5 46.8 48.2 34.1 53.0 54.3 43.3 51.8 50.4 42.8 25.9 67.2 40.2 45.5 22.0 61.0 44.0 44.9 23.7 23.2 34.7 18.0 16.5 18.6 10.9 26.6 14.8 67.4 15.1 10.7 18.6 15.0 29.7 9.0 10.0 15.2 30.2 38.8 32.4 10.2 11.6 11.7 30.2 14.2 12.2 18.8 42.1 15.1 37.2 91.5 15.5 9.5 60.0 24.8 16.6 16.1 9.1 12.3 25.0 12.7 22.5 13.4 25.2 12.8 9.4 23.7 31.9 17.8 19.6 5.6 40.9 16.9 15.4 11.2 31.1 17.6 25.3 14.0 22.5 6.7 27.9 17.7 31.1 23.0 13.4 13.4 14.9 16.6 28.3 23.3 38.8 27.7 38.5 15.3 34.7 18.0 16.7 18.6 14.6 17.2 20.7 13.8 11.6 14.4 23.7 15.8 13.8 30.3 16.5 13.4 23.2 15.5 10.9 59.1 63.6 82.1 72.8 55.7 20.6 62.5 44.5 44.0 67.2 131.0 200.7 147.3 175.2 232.4 221.8 78.3 101.9 224.9 215.0 108.2 127.6 118.5 84.6 100.9 28.5 282.9 157.6 93.5 97.9 120.4 173.1 219.9 158.9 69.6 87.5 287.6 180.1 188.4 85.6 18.1 236.2 133.0 121.4 162.3 134.2 304.1 112.4 133.3 204.7 39.4 283.1 213.4 189.5 194.6 112.8 229.2 154.9 147.4 126.3 268.6 ARID4B "BCAA, BRCAA1, RBP1L1, SAP180" ENSG00000054267 "AT-rich interaction domain 4B" Q4LE39 1 235131634-235328219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027205, HPA027333" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027205: , HPA027333: AB_1845013" "unprognostic (2.62e-1)" "unprognostic (2.38e-1)" "unprognostic (1.67e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-3)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-2)" "unprognostic (1.30e-2)" "unprognostic (1.03e-1)" "unprognostic (5.69e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (2.23e-4)" "unprognostic (1.42e-2)" "unprognostic (1.25e-1)" "unprognostic (3.52e-2)" "unprognostic (8.84e-3)" 15.3 13.8 14.9 19.0 22.5 34.1 15.9 32.8 17.6 19.7 13.4 19.2 18.2 9.1 18.7 18.1 12.0 15.0 15.2 10.6 15.2 14.5 13.1 14.0 15.5 22.3 26.9 13.9 21.8 16.8 23.8 25.7 14.7 20.3 17.9 10.7 12.0 16.7 17.0 12.3 12.3 14.2 14.6 19.8 19.8 14.7 19.5 23.4 33.7 20.2 8.2 18.9 18.2 18.6 17.1 11.7 35.9 11.8 16.6 17.0 6.0 12.2 9.2 16.2 12.5 11.9 12.5 13.3 14.0 12.3 9.7 9.5 9.5 13.1 14.4 16.3 10.5 6.9 10.9 13.1 5.9 14.1 18.5 14.2 11.6 11.1 7.9 9.1 12.4 17.1 8.4 8.0 11.9 10.2 12.7 13.1 9.2 15.0 20.7 9.1 5.5 18.5 11.3 14.8 8.8 6.1 6.9 11.5 12.0 10.6 10.3 13.2 18.3 17.8 14.8 13.8 4.9 15.6 20.1 18.0 12.0 9.1 14.6 13.6 20.2 16.0 14.4 8.2 9.1 16.0 24.6 7.1 19.5 16.1 7.6 14.7 15.6 17.0 13.7 6.8 17.1 16.9 14.4 35.9 16.6 11.8 11.7 13.6 6.0 14.9 22.5 32.8 17.6 15.2 14.5 26.9 13.9 20.3 23.4 95.3 99.9 54.7 68.9 110.4 111.2 62.2 35.7 91.0 101.2 29.6 113.9 55.7 16.6 62.0 329.6 108.9 41.9 46.7 41.8 58.1 114.7 81.5 105.3 23.1 39.4 106.5 86.4 65.7 52.4 349.2 93.7 99.4 79.2 108.2 45.8 77.7 57.3 49.9 72.9 15.0 150.5 45.3 129.6 212.6 167.8 93.1 131.0 129.6 39.6 111.5 ARMCX1 "ALEX1, GASP7" ENSG00000126947 "Armadillo repeat containing, X-linked 1" Q9P291 X 101550531-101554700 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 9.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 26.9;ASC TERT1: 24.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;LHCN-M2: 24.4;RH-30: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000268, HPA005685, CAB020695" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "CAB020695: , HPA000268: , HPA005685: AB_10600781" "unprognostic (2.31e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.25e-2)" "unprognostic (2.39e-1)" "unprognostic (2.18e-3)" "unprognostic (2.13e-1)" "unprognostic (1.23e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.32e-5)" "unprognostic (1.02e-1)" "unprognostic (2.85e-2)" "unprognostic (2.20e-3)" "unprognostic (8.77e-2)" "unprognostic (2.12e-2)" "unprognostic (1.09e-2)" 17.5 29.8 13.6 7.4 16.5 2.7 18.9 13.4 21.5 24.4 18.7 9.6 15.9 6.2 27.3 19.0 12.3 16.3 14.8 26.6 13.3 18.4 12.1 3.8 11.6 4.4 13.7 14.6 42.6 10.2 20.1 18.0 12.5 16.4 25.8 7.0 13.0 12.0 21.1 22.7 8.1 7.6 26.3 9.1 11.4 10.0 8.1 10.5 3.5 14.0 11.6 3.3 26.8 29.7 0.2 9.9 0.5 4.3 2.1 3.7 2.1 0.7 0.2 5.6 0.0 26.9 24.2 0.0 8.7 17.2 11.0 27.8 0.0 0.1 0.0 7.5 13.4 12.1 0.7 0.0 1.2 6.2 0.0 0.0 5.0 1.7 0.0 14.2 0.0 0.0 20.2 1.7 8.3 0.0 9.1 6.6 0.0 0.1 0.1 24.4 0.3 0.0 0.0 8.0 0.0 0.0 0.0 30.8 0.0 7.5 0.0 5.5 4.6 0.0 0.1 15.0 1.6 0.9 3.7 8.7 6.7 3.5 19.4 0.1 0.0 0.1 0.0 6.5 0.0 4.1 0.0 4.3 0.5 0.0 3.9 0.7 0.0 0.6 0.3 9.9 0.2 1.5 3.7 0.1 2.1 1.1 5.1 0.9 2.1 13.6 16.5 13.4 19.9 13.3 18.4 13.7 14.6 16.4 10.5 23.8 6.1 0.0 23.8 29.5 26.3 54.8 7.6 5.3 5.7 22.7 5.9 1.4 11.6 14.6 0.3 23.2 0.5 0.0 6.0 2.1 52.1 21.0 24.2 0.4 23.6 20.6 5.2 17.8 9.4 0.9 43.7 11.0 55.6 6.4 1.0 31.1 7.5 0.0 41.8 11.4 13.3 45.3 48.4 1.7 0.7 19.1 2.2 1.0 0.6 7.4 ATOH1 "bHLHa14, HATH1, MATH-1, Math1" ENSG00000172238 "Atonal bHLH transcription factor 1" Q92858 4 93828753-93830964 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "intestine: 29.5" "Cell type enriched" "Detected in some" 36 "Mucus-secreting cells: 198.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 3.7;HL-60: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA049400 Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA049400: " "prognostic favorable (3.26e-5)" "unprognostic (5.20e-1)" "unprognostic (2.69e-1)" "unprognostic (1.26e-1)" "unprognostic (2.70e-1)" 0.0 0.0 0.1 6.4 0.1 0.0 0.1 0.1 0.1 0.1 22.5 0.0 0.0 8.8 0.1 0.0 0.1 0.1 2.7 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 15.0 0.0 0.1 0.0 0.0 0.1 29.5 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.8 0.2 0.5 0.0 0.2 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 198.8 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 BOLA3 ENSG00000163170 "BolA family member 3" Q53S33 2 74135398-74147994 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cardiomyocytes: 267.6;Distal tubular cells: 298.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046393, HPA053162" Uncertain Supported "Nuclear bodies,Mitochondria,Cytosol" NA NA "Nuclear bodies, Mitochondria" Cytosol "HPA046393: , HPA053162: AB_2682063" "unprognostic (1.38e-2)" "unprognostic (1.84e-1)" "unprognostic (1.83e-2)" "unprognostic (4.23e-2)" "unprognostic (9.35e-2)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.86e-3)" "unprognostic (8.03e-2)" "unprognostic (1.60e-2)" "unprognostic (4.03e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (9.90e-5)" "unprognostic (1.19e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (4.40e-1)" 18.5 16.1 23.2 11.7 26.0 18.0 20.4 15.6 29.8 11.0 24.0 7.5 12.1 18.4 10.0 13.8 12.6 11.2 12.5 56.8 18.9 21.0 22.0 15.7 14.1 14.7 24.1 18.1 6.9 27.8 12.8 12.3 7.7 17.6 11.5 19.7 11.9 21.5 14.2 57.2 5.9 15.3 14.4 15.8 8.8 16.8 8.2 10.6 7.7 12.1 27.9 11.1 8.9 9.1 14.3 20.7 3.4 9.7 15.2 32.0 13.9 23.4 30.5 11.1 10.9 20.5 19.5 27.5 21.9 12.9 24.4 16.7 39.6 10.9 15.5 20.0 18.9 24.6 12.4 25.5 31.2 21.9 30.4 42.0 19.7 21.2 60.4 18.4 38.6 9.7 15.5 23.9 23.6 29.4 11.2 18.0 34.7 41.2 18.4 26.3 36.1 32.2 28.8 16.3 45.3 46.9 21.2 28.9 31.8 32.2 23.7 16.8 10.0 15.5 25.6 27.0 15.4 14.6 24.5 9.9 20.2 34.5 22.5 43.4 16.9 29.7 21.2 21.3 31.0 18.1 3.4 4.8 1.1 23.2 9.1 25.3 14.3 32.0 24.5 12.1 12.4 28.0 24.1 0.9 15.2 9.7 20.7 27.8 13.9 23.2 26.0 15.6 29.8 18.9 21.0 24.1 18.1 17.6 10.6 8.9 28.0 16.4 39.3 20.1 27.8 267.6 56.0 46.8 30.7 80.3 15.7 50.8 298.4 83.8 13.0 34.9 78.6 186.9 96.3 140.3 38.4 51.5 25.3 87.3 98.4 25.4 73.1 36.2 31.6 5.4 30.5 28.8 94.5 91.0 107.7 29.9 82.6 51.8 43.5 165.7 37.6 19.4 43.8 63.5 96.7 14.8 18.7 29.9 160.6 37.4 C10orf67 "bA215C7.4, C10orf115, LINC01552, MGC46732" ENSG00000179133 "Chromosome 10 open reading frame 67" Q8IYJ2 10 23201916-23344845 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 1: 35.7;Ciliated cells: 49.5;Late spermatids: 23.1;Spermatocytes: 63.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 4.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 5.3;SiHa: 8.5" HPA038131 Approved Approved Vesicles,Microtubules,Mitochondria NA No "Vesicles, Microtubules, Mitochondria" "HPA038131: AB_10670658" "unprognostic (4.76e-4)" "unprognostic (2.38e-1)" "unprognostic (3.75e-2)" "unprognostic (2.92e-2)" "unprognostic (9.67e-3)" "unprognostic (1.91e-1)" "unprognostic (1.54e-1)" "unprognostic (1.78e-2)" "unprognostic (8.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.24e-2)" "unprognostic (2.46e-3)" "unprognostic (3.98e-1)" "unprognostic (3.59e-2)" "unprognostic (3.84e-3)" "unprognostic (9.58e-2)" 0.1 0.1 1.3 1.7 2.6 0.2 0.0 0.1 1.9 0.3 0.5 0.4 1.3 0.5 0.2 4.6 0.1 7.3 0.2 3.2 1.6 1.4 5.0 0.5 4.0 0.3 0.9 0.5 1.8 0.3 0.4 9.0 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.6 1.9 0.4 0.0 0.7 0.2 0.1 13.8 0.6 0.0 0.6 0.7 0.1 0.1 0.1 1.1 1.1 1.0 0.5 1.1 4.2 0.0 1.5 0.1 1.9 0.2 0.0 0.5 0.4 0.2 0.1 2.0 1.7 0.1 2.4 0.2 0.2 1.6 0.2 5.3 0.2 0.7 1.7 0.5 0.4 0.1 0.7 0.4 1.0 0.1 0.0 0.6 1.7 0.7 1.0 0.2 0.0 0.2 0.2 0.8 0.0 0.3 0.1 0.5 0.9 0.1 0.1 0.1 0.2 0.4 1.7 0.4 0.9 0.4 8.5 0.4 0.1 0.3 0.3 0.3 0.2 0.4 1.5 0.4 0.1 1.1 0.2 0.1 2.5 0.2 0.1 1.0 0.5 0.6 0.7 0.3 0.6 1.1 1.5 0.8 0.1 1.0 1.1 1.0 0.8 1.1 0.3 1.1 4.2 0.0 1.3 2.6 0.1 1.9 1.6 1.4 0.9 0.5 1.2 0.6 35.7 3.7 0.0 0.0 2.5 0.1 1.1 0.0 49.5 3.4 0.0 0.0 0.0 1.7 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 12.2 0.8 6.5 0.0 63.7 2.1 1.1 0.0 0.0 0.0 0.0 C12orf65 "FLJ38663, SPG55" ENSG00000130921 "Chromosome 12 open reading frame 65" Q9H3J6 12 123232916-123257959 "Disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 80.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057595 Approved Approved Nucleoplasm,Mitochondria,Cytosol No Yes "Nucleoplasm, Cytosol" Mitochondria "HPA057595: " "unprognostic (9.07e-3)" "unprognostic (1.51e-2)" "unprognostic (5.30e-2)" "unprognostic (8.19e-3)" "unprognostic (1.23e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (4.29e-9)" "unprognostic (9.33e-3)" "unprognostic (2.39e-1)" "unprognostic (2.50e-2)" "unprognostic (6.33e-3)" "unprognostic (1.20e-2)" "unprognostic (2.01e-2)" "unprognostic (3.89e-2)" "unprognostic (3.19e-2)" "unprognostic (9.83e-3)" "prognostic favorable (7.82e-5)" 7.8 15.7 13.2 11.3 15.1 9.6 9.0 21.6 18.2 14.1 10.8 12.3 11.6 13.8 14.9 16.5 10.7 11.7 11.1 17.4 13.2 15.2 12.1 15.6 10.6 18.8 11.5 13.2 21.3 12.4 8.8 24.6 9.2 15.0 15.1 9.7 13.1 21.2 10.8 14.3 17.7 12.6 10.5 14.2 14.7 11.7 17.3 12.2 80.9 15.3 7.9 15.5 14.3 13.7 23.6 10.0 22.6 4.6 17.1 28.9 10.0 14.2 9.9 11.2 21.9 5.6 6.0 6.8 11.9 7.6 12.1 8.9 10.6 8.5 17.8 10.3 3.8 12.3 10.5 12.1 6.5 11.6 13.3 10.8 21.0 9.7 9.2 12.6 9.7 10.6 6.3 15.8 8.8 18.2 18.7 7.8 25.5 22.1 7.4 8.0 6.2 23.3 18.0 8.5 12.1 15.2 17.4 13.3 16.5 11.3 8.2 23.8 10.3 13.3 6.8 12.4 8.4 10.8 11.4 8.8 13.2 15.8 11.9 12.0 12.2 14.0 16.3 8.6 12.9 17.2 22.6 3.5 14.0 15.9 3.8 19.8 23.6 22.0 21.1 6.0 20.2 28.9 24.7 3.7 17.1 4.6 10.0 18.5 10.0 13.2 15.1 21.6 18.2 13.2 15.2 11.5 13.2 15.0 12.2 38.7 45.0 27.9 34.0 40.3 32.8 41.3 15.3 17.4 20.5 24.4 13.7 36.6 51.4 17.6 17.3 20.3 14.7 23.3 9.4 19.4 29.7 17.7 14.0 27.0 12.6 42.9 9.2 16.5 7.5 5.0 35.1 13.2 23.6 37.9 16.9 33.9 12.4 13.3 39.6 23.9 34.3 12.9 33.9 63.0 26.2 31.6 9.0 44.9 20.0 7.1 C12orf73 "DKFZp547P055, FLJ13975" ENSG00000204954 "Chromosome 12 open reading frame 73" Q69YU5 12 103950202-103965708 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 43.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038883 Uncertain Approved "Plasma membrane,Centrosome,Mitochondria" "Secreted - unknown location" NA NA "Centrosome, Mitochondria" "Plasma membrane" "HPA038883: AB_10794735" "unprognostic (9.24e-2)" "unprognostic (3.26e-3)" "unprognostic (3.66e-3)" "unprognostic (7.20e-2)" "unprognostic (3.28e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (6.98e-4)" "unprognostic (8.96e-2)" "unprognostic (1.86e-2)" "unprognostic (3.79e-2)" "unprognostic (3.03e-3)" "unprognostic (2.07e-1)" "unprognostic (1.33e-2)" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (6.27e-2)" "prognostic favorable (1.61e-4)" 6.7 11.4 14.3 8.3 14.5 4.4 9.7 15.5 17.5 7.2 7.4 11.4 7.2 7.7 9.5 13.2 7.0 8.9 5.5 11.1 13.0 14.6 9.4 8.3 5.8 10.0 13.3 13.3 11.5 9.7 9.4 21.0 7.3 13.6 10.7 9.5 8.3 8.3 11.1 43.8 9.0 7.7 7.9 14.1 7.0 9.9 10.1 13.8 11.4 11.5 12.9 10.2 6.6 6.9 11.7 11.3 8.6 5.1 12.0 14.5 3.9 5.9 11.1 16.9 10.3 4.9 6.4 11.0 6.4 3.9 7.2 5.9 11.8 5.2 7.0 8.6 3.9 6.3 9.6 10.0 8.2 5.5 10.1 20.3 10.6 16.3 14.8 7.2 15.6 9.7 5.7 9.4 3.6 6.4 17.6 6.6 20.6 13.6 4.8 6.6 6.8 17.3 23.6 8.2 5.7 19.0 10.0 6.3 6.9 9.4 8.0 27.7 9.5 6.5 11.3 14.9 7.6 19.3 8.5 3.3 8.8 4.9 6.5 6.5 13.1 20.1 14.7 10.0 8.9 7.7 7.3 5.1 8.6 10.5 4.2 10.4 11.7 9.8 10.0 7.2 10.7 14.5 13.5 1.4 12.0 3.8 11.3 13.8 3.9 14.3 14.5 15.5 17.5 13.0 14.6 13.3 13.3 13.6 13.8 6.0 5.0 6.7 8.5 5.4 16.5 14.9 7.6 13.4 5.7 8.7 0.0 9.7 23.2 20.3 59.5 6.7 9.2 0.0 10.6 10.4 7.6 8.0 9.2 11.6 14.8 7.9 10.9 6.2 8.3 25.4 8.1 7.1 1.7 11.8 10.9 12.3 16.5 3.5 8.1 17.7 13.1 6.5 7.2 23.1 21.2 4.5 7.4 4.9 11.5 7.0 C21orf2 "A2, LRRC76, YF5" ENSG00000160226 "Chromosome 21 open reading frame 2" O43822 21 44328944-44339402 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 196.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 18.8 13.4 19.8 11.3 21.6 19.7 9.2 10.3 23.4 13.8 14.7 18.2 14.3 13.4 12.6 19.1 6.9 14.7 13.2 11.3 19.5 16.6 18.0 11.6 12.8 12.4 16.4 19.1 15.2 14.5 7.4 17.6 12.4 13.2 12.3 3.9 14.3 16.1 17.2 21.0 22.3 15.4 5.8 12.6 16.1 21.1 16.7 11.2 10.9 16.4 8.1 13.0 8.1 7.0 10.8 21.7 1.2 8.5 12.1 9.7 4.9 8.0 3.4 3.2 4.2 2.1 1.4 12.9 4.2 2.5 1.7 0.9 6.1 2.4 5.8 8.4 1.4 3.4 3.8 0.6 0.8 0.4 8.8 8.4 6.0 2.7 7.1 2.8 6.5 6.5 2.0 1.5 0.7 1.5 2.9 1.0 4.4 7.3 10.0 1.0 9.9 7.1 15.9 8.1 4.1 5.2 18.1 4.2 12.9 1.9 11.8 8.6 7.9 5.8 1.4 6.9 2.0 6.2 14.3 4.7 3.6 4.7 3.9 3.1 16.3 8.6 4.0 8.9 13.1 6.5 1.2 7.1 1.0 7.1 8.5 8.5 10.8 7.3 9.7 7.3 8.6 8.5 8.2 0.9 12.1 6.2 21.7 4.0 4.9 19.8 21.6 10.3 22.4 19.5 16.6 16.4 19.1 13.2 11.2 3.0 16.5 25.0 18.4 14.4 43.7 2.2 35.7 32.1 9.1 12.2 35.3 25.4 66.3 24.9 73.3 10.0 27.6 0.0 51.4 12.3 38.1 21.2 19.5 18.1 31.3 35.0 31.6 9.2 14.5 196.9 24.5 17.6 40.5 31.5 29.6 34.1 20.6 31.1 29.7 36.0 24.8 12.9 18.9 40.3 10.9 13.6 27.3 20.8 31.8 18.6 C7orf31 ENSG00000153790 "Chromosome 7 open reading frame 31" Q8N865 7 25134697-25180356 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 60.9" "Group enriched" "Detected in many" 17 "Early spermatids: 399.0;Late spermatids: 665.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 18.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA020346 Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA020346: AB_1845758" "unprognostic (3.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (6.90e-3)" "prognostic unfavorable (1.81e-4)" "unprognostic (1.19e-1)" "unprognostic (3.40e-2)" "unprognostic (1.95e-1)" "unprognostic (2.90e-1)" "unprognostic (1.06e-1)" "unprognostic (3.12e-3)" "unprognostic (8.26e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (1.10e-1)" "unprognostic (1.15e-2)" 2.4 6.2 1.5 4.8 3.1 1.3 2.3 4.0 1.6 3.3 5.1 2.9 2.0 3.3 3.3 2.9 2.4 2.6 3.7 3.1 1.9 1.5 2.6 1.2 2.8 7.0 2.0 2.2 4.6 1.8 4.3 2.1 1.1 2.3 3.2 3.6 4.1 6.0 2.3 0.9 1.8 3.9 2.4 2.9 3.7 3.4 60.9 2.4 5.9 4.6 0.9 3.3 3.5 5.1 3.0 5.9 2.3 1.3 2.8 2.8 0.9 2.8 2.0 4.5 5.2 1.8 1.0 2.5 1.2 4.9 3.7 5.6 3.9 2.7 7.2 1.9 2.2 14.6 1.1 5.0 1.4 4.0 3.4 4.9 3.4 0.2 5.2 4.3 5.5 8.3 3.1 3.9 3.0 0.7 2.6 0.7 6.2 5.1 4.0 0.9 0.0 5.6 7.0 1.8 6.6 1.8 7.0 5.2 1.1 2.5 3.6 1.3 3.8 1.2 4.9 4.6 6.6 0.8 9.2 1.0 2.3 6.2 0.0 1.8 18.0 5.7 10.3 0.7 5.3 10.6 1.4 1.3 2.3 1.7 0.6 2.3 3.0 1.1 1.5 1.7 2.1 2.8 2.2 0.1 2.8 0.8 5.9 2.8 0.9 1.5 3.1 4.0 1.6 1.9 1.5 2.0 2.2 2.3 2.4 0.0 5.3 2.9 2.3 1.0 0.9 1.0 2.5 5.3 0.0 0.0 0.0 2.8 3.3 1.0 399.0 2.2 2.5 0.0 3.4 2.1 2.5 0.9 0.0 1.0 2.4 0.0 4.1 1.8 5.0 665.4 6.6 2.9 3.3 4.6 2.8 7.7 3.2 6.5 4.9 0.6 0.5 0.0 2.1 31.4 12.4 0.5 1.9 4.3 6.0 0.9 CALHM2 FAM26B ENSG00000138172 "Calcium homeostasis modulator family member 2" Q9HA72 10 103446786-103452402 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA014706 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA014706: AB_2243916" "unprognostic (2.45e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-1)" "unprognostic (2.48e-1)" "unprognostic (3.92e-2)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (1.63e-1)" "unprognostic (8.85e-2)" "unprognostic (5.78e-2)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (8.59e-2)" "unprognostic (2.47e-1)" "unprognostic (3.56e-1)" "unprognostic (4.74e-1)" 24.2 10.5 3.7 10.2 3.8 1.8 28.7 1.9 7.1 34.1 9.2 3.9 8.0 5.6 36.0 18.4 13.4 19.7 18.2 17.0 3.9 2.2 5.7 3.7 11.1 15.9 4.8 5.4 32.5 4.5 1.9 4.0 23.6 4.8 18.2 4.0 10.7 7.6 10.0 8.9 8.9 9.0 19.8 5.5 24.4 7.2 14.1 3.1 3.0 11.0 9.2 10.8 19.9 24.1 7.1 36.6 11.2 47.9 14.0 21.5 17.1 5.3 3.8 0.9 1.2 14.3 23.8 4.6 18.8 19.1 5.8 8.2 1.6 2.6 1.6 2.1 21.5 0.3 2.5 1.9 0.0 1.1 0.2 10.8 3.8 1.1 0.3 6.5 0.6 0.3 8.1 0.0 1.7 0.0 10.8 6.8 4.1 0.8 10.0 3.7 12.3 1.4 1.7 2.4 1.1 3.4 4.5 1.5 3.6 0.5 0.4 2.7 1.2 0.7 3.1 1.0 0.4 0.6 1.2 12.1 1.8 2.3 6.4 1.3 1.5 3.5 1.9 15.9 11.8 0.3 11.2 22.7 0.4 21.5 42.2 17.5 7.1 14.8 17.6 36.6 1.5 2.9 11.2 0.9 14.0 47.9 4.2 18.9 17.1 3.7 3.8 1.9 7.1 3.9 2.2 4.8 5.4 4.8 3.1 3.0 1.1 3.4 2.8 4.7 0.0 2.8 2.5 0.0 0.0 3.5 0.0 2.0 0.0 3.1 0.8 20.4 0.0 0.0 0.2 63.7 23.4 0.8 8.1 0.0 47.4 0.0 1.2 28.3 27.5 0.8 42.3 14.7 8.5 1.8 0.0 0.3 0.2 0.0 15.2 0.3 0.0 19.4 29.8 0.7 0.2 3.3 16.0 17.3 0.0 1.0 CASP14 "MGC119078, MGC119079, MICE" ENSG00000105141 "Caspase 14" P31944 19 15049384-15058293 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Hydrolase, Protease, Thiol protease" Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skin 1: 109.4" "Cell type enriched" "Detected in some" 5 "Suprabasal keratinocytes: 83.9" "Cancer enhanced" "Detected in many" "cervical cancer: 62.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "hTCEpi: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" "CAB010059, HPA027062" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA 2200000 "Nucleoplasm, Cytosol" Mitochondria "CAB010059: AB_626800, HPA027062: AB_2672101" "unprognostic (1.17e-2)" "unprognostic (6.44e-3)" "unprognostic (6.22e-2)" "unprognostic (2.77e-1)" "prognostic unfavorable (7.59e-4)" "unprognostic (9.42e-2)" "unprognostic (2.19e-2)" "prognostic unfavorable (5.96e-4)" "unprognostic (2.68e-1)" "unprognostic (4.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.97e-1)" 0.2 0.2 0.2 0.0 0.3 0.0 1.9 0.2 0.3 17.9 0.2 0.0 0.8 0.0 1.1 0.3 1.2 0.1 0.0 0.2 0.3 0.2 0.4 0.3 0.2 0.0 0.2 0.0 0.1 0.3 0.0 0.2 0.5 0.0 7.7 0.0 0.0 0.8 2.7 0.3 109.4 0.2 0.0 0.2 0.1 0.2 1.6 0.0 2.3 0.2 0.9 0.0 0.6 4.0 0.8 0.5 2.3 0.6 0.1 0.6 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.6 0.4 0.4 0.2 0.4 0.3 0.6 0.4 0.1 0.8 0.5 0.4 2.3 0.1 0.2 0.5 0.6 0.0 0.2 0.3 0.2 0.3 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 16.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 83.9 0.6 0.0 0.0 0.1 CCDC51 FLJ12436 ENSG00000164051 "Coiled-coil domain containing 51" Q96ER9 3 48432164-48440456 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010980, HPA011408" Supported Supported Nucleoplasm,Centrosome,Mitochondria NA NA "Nucleoplasm, Mitochondria" Centrosome "HPA010980: AB_1846155, HPA011408: AB_2072212" "unprognostic (1.24e-2)" "unprognostic (5.23e-2)" "unprognostic (5.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.50e-1)" "unprognostic (2.75e-3)" "unprognostic (4.71e-3)" "unprognostic (1.26e-2)" "unprognostic (3.04e-1)" "unprognostic (3.26e-2)" "unprognostic (7.70e-2)" "unprognostic (1.47e-3)" "unprognostic (6.46e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (1.77e-1)" 9.9 14.9 10.1 7.1 12.7 4.5 9.6 10.4 15.9 8.9 12.8 7.5 12.4 11.6 8.2 11.4 15.9 9.7 8.4 12.3 9.2 8.2 15.2 17.8 7.1 9.0 9.9 15.4 8.7 8.5 9.4 7.4 8.5 10.6 7.7 15.1 9.9 11.0 11.2 16.3 10.9 8.8 11.6 8.8 14.7 7.9 10.7 8.9 10.4 11.3 16.1 12.0 8.8 9.7 19.2 18.2 4.8 10.4 10.6 14.8 9.7 9.7 11.9 7.2 8.4 10.6 11.3 19.7 6.5 6.0 13.1 10.7 18.8 16.4 21.2 9.3 5.1 9.8 14.3 17.6 21.2 8.0 9.9 11.6 18.1 18.9 14.1 16.4 8.8 8.3 8.5 48.2 16.1 17.7 7.1 7.4 12.5 10.0 6.2 12.3 9.3 10.2 11.4 15.7 21.0 19.3 7.1 8.4 16.3 17.7 12.2 5.9 12.5 10.7 11.7 17.4 7.0 12.6 13.7 5.6 7.6 10.3 18.8 12.4 10.0 14.6 11.1 10.1 19.1 7.1 2.0 10.4 4.8 12.0 10.2 12.1 19.2 11.2 14.8 18.2 15.4 11.7 13.4 4.5 10.6 6.1 15.2 13.4 9.7 10.1 12.7 10.4 15.9 9.2 8.2 9.9 15.4 10.6 8.9 11.9 1.6 8.9 3.0 4.1 6.8 7.3 22.9 5.3 5.7 8.7 0.0 35.3 19.9 13.2 2.5 5.3 12.6 0.0 10.8 15.3 10.7 3.7 3.5 11.9 14.1 7.9 5.2 3.1 3.8 2.2 11.2 4.1 13.5 13.6 6.3 10.1 12.4 5.8 12.4 27.0 9.5 6.5 3.1 4.8 17.3 4.1 5.6 4.3 12.4 3.1 CD300C "CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR" ENSG00000167850 "CD300c molecule" Q08708 17 74541108-74546143 "CD markers, Predicted membrane proteins" Immunity Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 46.8" "Group enriched" "Detected in some" 12 "granulocytes: 15.0;Hofbauer cells: 29.5;Kupffer cells: 28.1;Macrophages: 33.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4" "Group enriched" "Detected in many" 5 "dendritic cells: 32.5;monocytes: 46.8" "Cell line enhanced" "Detected in some" "HEL: 5.3;HMC-1: 26.2;THP-1: 4.9;U-937: 12.4" "HPA014523, HPA060349" Approved Uncertain "Golgi apparatus,Vesicles,Mitochondria" NA NA "Golgi apparatus" "Vesicles, Mitochondria" "HPA014523: AB_1846293, HPA060349: " "unprognostic (1.55e-2)" "unprognostic (2.60e-1)" "unprognostic (9.99e-3)" "unprognostic (3.79e-1)" "unprognostic (1.21e-1)" "unprognostic (3.47e-2)" "unprognostic (3.81e-2)" "unprognostic (2.19e-1)" "unprognostic (1.68e-2)" "unprognostic (7.51e-2)" "unprognostic (6.51e-2)" "unprognostic (1.50e-2)" "unprognostic (1.37e-3)" "unprognostic (6.27e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (1.16e-2)" "unprognostic (1.09e-1)" 9.8 2.8 3.6 9.0 4.6 10.9 1.8 0.4 2.9 1.2 1.7 2.9 0.0 1.5 1.4 1.9 1.0 1.9 2.8 3.4 2.0 1.7 1.9 2.1 11.2 12.3 5.3 1.3 1.1 1.3 0.5 1.2 3.8 3.9 1.9 1.8 1.8 1.8 0.7 1.1 0.9 2.3 4.1 7.1 14.2 1.6 0.9 2.7 0.1 1.6 0.1 1.4 3.5 1.1 0.4 32.5 8.4 46.8 8.6 0.1 10.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 2.4 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 12.4 0.0 8.4 28.6 1.4 0.1 46.8 0.1 0.4 0.0 0.0 32.5 0.3 0.0 0.0 1.0 8.6 46.4 2.1 0.0 10.7 3.6 4.6 0.4 2.9 2.0 1.7 5.3 1.3 3.9 2.7 0.0 2.2 0.0 0.0 0.3 0.0 0.0 0.0 1.4 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 15.0 0.0 29.5 0.0 0.0 0.0 28.1 0.0 0.0 33.8 1.7 1.8 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 CD3EAP "ASE-1, CAST, PAF49" ENSG00000117877 "CD3e molecule associated protein" O15446 19 45406209-45410766 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Basal keratinocytes: 109.3;Suprabasal keratinocytes: 96.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-251 MG: 65.8" "Low region specificity" "Detected in all" "HPA041664, HPA041734" Supported Enhanced "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA041664: AB_10795693, HPA041734: AB_10794489" "unprognostic (1.03e-1)" "unprognostic (8.98e-2)" "unprognostic (9.28e-2)" "unprognostic (1.37e-3)" "unprognostic (2.46e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (4.79e-9)" "unprognostic (1.62e-3)" "unprognostic (3.21e-1)" "unprognostic (5.01e-2)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (6.29e-9)" "unprognostic (1.02e-1)" "unprognostic (2.81e-1)" "unprognostic (1.38e-2)" "unprognostic (4.53e-2)" 7.3 5.9 7.7 8.4 9.7 4.0 7.1 14.9 9.0 5.6 5.5 6.5 2.9 4.9 6.4 3.0 9.9 7.1 6.4 6.7 7.1 6.4 5.2 6.8 4.5 7.2 8.1 6.0 8.7 18.3 6.6 7.3 5.1 8.0 5.2 4.9 3.1 7.2 4.6 14.2 8.4 4.3 6.6 5.6 5.8 4.3 5.2 9.3 3.6 6.1 7.8 8.5 5.5 5.8 3.5 15.9 1.3 3.7 3.2 4.1 2.1 10.4 10.8 1.7 7.9 2.6 2.1 7.0 5.0 1.7 8.9 5.2 10.6 7.5 16.3 5.3 3.7 7.2 10.1 15.6 14.3 6.3 8.0 10.1 9.0 4.1 7.8 4.4 9.1 3.2 3.2 9.2 12.9 7.1 2.2 6.4 6.0 20.5 3.3 8.6 12.3 6.9 2.6 12.7 11.6 9.1 9.4 6.9 10.7 3.5 7.8 10.8 4.0 10.7 14.3 2.3 3.8 7.2 5.5 6.2 12.7 13.3 7.3 65.8 5.9 23.4 17.3 6.3 13.0 9.1 0.9 2.8 0.3 1.7 3.7 3.4 2.8 2.2 2.4 5.0 3.5 3.1 4.1 1.3 3.2 3.3 15.9 1.2 2.1 7.7 9.7 14.9 9.0 7.1 6.4 8.1 6.0 8.0 9.3 6.0 12.8 10.0 23.3 109.3 4.5 1.2 7.6 6.7 12.5 1.8 9.8 13.7 1.7 15.9 0.2 9.0 1.7 0.0 5.8 19.4 6.6 7.7 5.7 4.2 10.0 11.1 4.6 4.9 2.6 0.5 8.9 7.0 11.8 2.8 4.3 3.5 11.0 0.0 10.6 6.1 5.8 0.0 8.9 0.5 18.9 96.7 6.4 0.0 9.5 11.5 CEACAM19 CEAL1 ENSG00000186567 "Carcinoembryonic antigen related cell adhesion molecule 19" Q7Z692 19 44662278-44684359 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA014462, HPA052865" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA014462: AB_2669006, HPA052865: AB_2681976" "unprognostic (2.91e-1)" "unprognostic (5.29e-3)" "unprognostic (6.96e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-2)" "unprognostic (8.43e-2)" "unprognostic (5.22e-2)" "unprognostic (1.15e-2)" "unprognostic (9.98e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.77e-1)" "unprognostic (3.26e-9)" "unprognostic (8.01e-3)" "unprognostic (9.62e-2)" "unprognostic (1.31e-1)" "unprognostic (2.70e-1)" 1.6 2.9 1.1 0.8 1.9 1.0 2.4 4.3 1.7 3.1 2.4 2.7 2.7 1.4 2.4 4.3 2.1 4.1 1.2 1.8 3.3 4.3 3.8 0.6 0.6 4.0 4.7 1.2 3.9 1.8 4.1 3.3 2.9 3.0 12.5 10.8 2.9 3.0 0.9 1.8 2.0 3.0 3.4 1.7 1.0 4.4 1.7 0.5 1.7 1.0 1.0 0.7 0.6 4.2 8.8 1.3 0.9 3.1 3.6 3.3 2.4 3.6 0.8 1.6 0.3 1.0 0.1 0.8 3.2 0.9 5.3 2.2 0.9 0.7 1.2 5.0 0.1 4.6 1.4 3.2 0.2 0.8 1.1 8.7 2.2 5.4 10.7 2.0 0.6 0.3 0.2 1.2 1.0 0.0 0.5 0.8 1.1 1.0 0.0 1.6 0.2 13.7 1.0 1.7 0.4 0.9 0.9 0.8 1.3 1.2 0.3 17.7 0.3 6.1 1.3 0.7 0.1 0.3 0.0 0.4 1.7 1.4 1.7 1.0 0.6 0.6 0.4 0.3 0.5 0.3 0.6 0.2 1.7 0.4 0.7 1.6 1.0 0.5 0.5 0.3 0.6 3.0 2.1 0.0 0.9 1.8 2.6 4.1 2.5 1.4 2.3 0.0 0.0 0.0 0.0 1.6 0.7 3.1 1.7 0.0 2.9 0.1 0.9 1.3 0.0 1.9 0.2 0.0 1.7 4.9 1.2 0.2 2.8 0.5 0.0 0.0 2.6 0.1 3.5 3.5 2.5 0.2 0.5 0.0 2.8 3.2 0.4 5.3 0.0 0.0 2.2 0.9 CHCHD1 "C10orf34, FLJ25854" ENSG00000172586 "Coiled-coil-helix-coiled-coil-helix domain containing 1" Q96BP2 10 73782047-73783652 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 114.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039046 Approved Supported "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Nucleoli fibrillar center" "HPA039046: AB_10673234" "unprognostic (4.97e-2)" "unprognostic (1.90e-3)" "unprognostic (2.96e-1)" "unprognostic (1.31e-3)" "unprognostic (1.80e-1)" "unprognostic (9.85e-2)" "unprognostic (1.75e-2)" "unprognostic (3.33e-1)" "unprognostic (1.35e-1)" "unprognostic (2.24e-2)" "unprognostic (4.53e-1)" "unprognostic (1.91e-2)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (1.54e-1)" "unprognostic (5.58e-2)" "prognostic favorable (5.42e-4)" 16.4 33.6 22.6 21.7 21.5 16.5 32.0 21.3 29.4 16.4 24.7 9.2 25.9 28.0 16.8 38.6 29.5 17.8 25.3 36.1 19.3 18.4 32.9 37.8 28.9 23.8 19.4 20.9 15.6 47.2 16.3 19.7 25.3 21.2 21.5 20.8 12.7 31.9 28.7 45.1 16.6 24.3 22.0 15.3 24.8 23.4 24.8 15.6 21.0 29.5 31.6 20.6 17.0 18.1 30.7 38.2 22.2 27.3 17.9 32.1 18.2 22.5 17.2 14.5 20.5 12.0 11.7 14.6 11.8 13.8 11.9 16.1 15.4 20.6 11.2 13.1 10.4 12.2 16.0 14.1 15.3 9.9 17.1 26.9 8.6 14.4 23.7 14.1 13.1 13.8 10.9 19.1 10.1 6.9 18.1 16.5 15.6 13.0 12.8 15.7 22.8 16.1 29.0 13.8 21.5 114.1 15.4 11.2 14.6 19.4 12.7 7.2 14.1 7.3 51.5 24.1 12.4 28.8 18.3 9.7 7.6 16.6 12.5 20.2 12.8 13.3 17.7 17.7 26.6 5.9 22.2 27.0 15.9 19.7 27.3 23.7 30.7 24.2 23.5 26.6 26.1 20.3 20.5 11.1 17.9 21.5 38.2 32.1 18.2 22.6 21.5 21.3 29.4 19.3 18.4 19.4 20.9 21.2 15.6 38.7 36.6 58.1 32.1 31.1 26.0 66.9 33.1 77.6 54.6 57.6 21.6 127.4 169.1 72.5 37.4 31.2 94.4 46.7 76.3 142.6 26.2 45.5 28.9 109.7 118.2 19.1 59.4 50.3 55.3 7.6 52.3 50.1 38.8 82.0 88.4 53.2 83.5 89.6 51.9 145.7 27.7 51.8 26.8 44.5 49.1 38.0 107.1 39.9 89.5 42.2 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit" O76031 15 65148219-65185342 "Predicted intracellular proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 50.9" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 189.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: AB_2680312" "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 10.4 12.8 11.3 8.9 12.7 7.7 10.2 10.9 10.7 11.7 13.4 11.2 4.7 9.3 9.8 10.3 15.5 8.9 9.6 15.9 10.7 9.2 16.8 50.9 9.4 8.8 12.8 8.1 10.8 10.6 11.0 6.3 10.6 9.8 9.7 8.9 7.4 8.9 7.1 25.8 15.6 12.6 10.8 9.7 9.7 9.9 9.3 12.6 17.8 12.9 14.7 10.2 12.5 9.5 7.7 9.8 11.4 7.1 8.2 9.2 4.4 5.3 9.1 8.0 10.1 8.5 11.0 8.6 6.1 6.9 6.8 7.1 9.1 7.5 16.6 5.2 8.2 5.0 11.5 29.3 8.1 7.3 6.5 5.3 12.5 8.9 11.5 12.2 15.9 7.3 13.1 11.2 6.2 11.9 7.8 8.6 9.0 11.4 5.9 7.9 6.8 7.5 14.1 9.0 10.6 4.1 14.8 9.5 17.1 12.7 12.4 7.0 5.7 8.3 13.3 9.0 11.0 6.1 13.5 7.5 6.9 6.0 5.5 5.7 6.3 9.6 8.7 6.7 20.2 5.3 3.5 7.1 10.3 7.6 5.7 7.0 7.7 6.7 5.6 6.4 7.2 9.2 7.3 11.4 8.2 5.1 9.8 5.7 4.4 11.3 12.7 10.9 10.7 10.7 9.2 12.8 8.1 9.8 12.6 32.8 28.6 14.9 17.9 17.1 27.3 62.7 28.1 33.5 33.0 31.4 13.7 35.1 18.3 32.5 87.1 17.9 15.6 0.0 27.4 27.2 19.7 20.0 15.1 79.9 19.8 30.2 9.9 22.1 23.9 189.0 26.7 16.0 16.9 26.2 22.4 24.3 27.3 17.5 28.0 28.4 24.1 25.8 16.0 33.9 29.6 26.3 74.6 19.1 23.3 18.4 COA4 "CHCHD8, CMC3, E2IG2" ENSG00000181924 "Cytochrome c oxidase assembly factor 4 homolog" Q9NYJ1 11 73872667-73876988 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040126 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoplasm, Nucleoli fibrillar center" Mitochondria "HPA040126: AB_10795415" "unprognostic (7.30e-2)" "unprognostic (8.69e-2)" "unprognostic (2.09e-1)" "unprognostic (2.60e-2)" "unprognostic (1.87e-1)" "unprognostic (1.40e-2)" "unprognostic (3.64e-3)" "unprognostic (1.49e-1)" "unprognostic (2.22e-2)" "prognostic favorable (3.87e-4)" "unprognostic (1.31e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (1.25e-1)" "unprognostic (8.17e-2)" 19.0 46.2 18.9 17.0 17.3 10.8 18.1 12.2 20.2 17.5 23.9 25.7 27.0 24.7 18.0 22.4 24.9 20.1 31.5 35.3 17.7 17.0 33.2 74.7 14.7 20.2 20.5 16.3 23.2 37.1 17.6 17.2 18.3 19.4 21.5 21.1 17.6 21.2 28.0 33.2 14.4 31.2 16.2 21.5 20.1 19.2 13.5 19.4 16.3 38.7 27.6 18.2 21.5 18.9 23.4 32.3 5.3 20.6 16.7 21.2 15.0 20.9 39.1 16.1 23.5 14.3 17.8 16.3 21.4 14.9 25.4 21.5 28.5 26.1 17.8 43.4 17.6 20.5 21.1 24.6 28.6 19.8 23.3 22.4 29.9 24.3 26.7 27.2 20.3 23.5 22.6 27.4 42.4 27.7 14.5 23.3 17.7 25.7 17.6 22.7 39.9 16.0 31.8 21.2 82.8 40.5 18.7 34.7 47.1 26.9 19.4 14.6 24.5 19.8 22.7 57.5 16.5 31.8 20.6 15.9 21.0 18.7 42.2 27.9 21.8 23.6 60.5 11.5 25.4 23.7 5.3 20.5 4.7 15.9 20.6 20.2 23.4 18.7 16.5 24.6 20.4 20.1 21.2 1.4 16.7 19.1 32.3 19.0 15.0 18.9 17.3 12.2 20.2 17.7 17.0 20.5 16.3 19.4 19.4 32.8 29.0 44.7 53.9 47.6 19.8 62.1 89.2 49.5 36.4 52.4 21.6 140.3 109.5 72.0 22.0 43.6 113.7 46.7 82.4 84.7 46.3 77.6 61.1 154.9 85.2 17.5 69.7 28.8 37.8 8.2 50.9 50.0 27.0 51.3 90.6 41.3 87.3 73.7 36.0 190.6 16.4 6.5 34.3 51.0 36.1 44.8 102.3 34.8 108.4 86.3 CORO7-PAM16 ENSG00000103426 "CORO7-PAM16 readthrough" 16 4340251-4420494 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Ciliated cells: 1.4;Club cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;HDLM-2: 2.4;THP-1: 1.9;TIME: 1.5" "HPA041657, HPA053586, HPA062721" Uncertain Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA041657: AB_10796351, HPA053586: AB_2682201, HPA062721: AB_2684849" "unprognostic (2.95e-2)" "unprognostic (2.46e-1)" "unprognostic (1.44e-1)" "unprognostic (2.46e-1)" "unprognostic (2.11e-1)" "unprognostic (1.24e-2)" "unprognostic (2.11e-4)" "unprognostic (4.39e-2)" "unprognostic (9.83e-3)" "unprognostic (1.20e-1)" "unprognostic (8.75e-3)" "unprognostic (1.05e-1)" "unprognostic (1.38e-1)" "unprognostic (1.79e-2)" "unprognostic (2.59e-2)" "unprognostic (2.19e-1)" "unprognostic (3.85e-1)" 2.4 3.4 5.4 5.2 7.4 6.7 2.0 3.0 6.0 2.0 2.5 10.0 0.6 3.2 2.2 2.4 2.2 2.9 3.1 2.2 4.8 4.1 2.0 2.9 3.4 11.2 10.9 3.2 2.0 2.0 2.0 1.7 2.4 4.1 2.2 2.0 1.1 2.0 3.0 2.4 3.1 2.5 2.2 10.1 4.5 2.5 4.3 9.9 4.7 2.0 1.2 4.1 2.8 1.8 0.4 0.6 2.7 1.3 0.5 0.8 1.3 0.0 0.0 0.0 0.4 0.0 0.3 0.8 0.2 0.4 0.0 0.0 1.7 0.3 0.0 0.2 0.0 0.3 0.9 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.7 0.0 0.5 0.0 0.2 1.4 0.2 0.7 0.7 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.2 0.0 1.9 1.5 0.0 0.0 0.6 0.1 0.6 1.2 0.1 0.0 0.1 0.0 0.0 1.3 0.9 0.8 0.7 0.7 0.3 0.4 0.3 0.6 0.4 0.3 0.3 2.7 0.5 0.4 0.3 0.3 1.3 5.4 7.4 3.0 6.0 4.8 4.1 10.9 3.2 4.1 9.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 COX10 ENSG00000006695 "COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor" Q12887 17 14069496-14208677 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Heme biosynthesis" Transferase "Disease mutation, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 89.2;Late spermatids: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032005, HPA032006" Supported Supported Nucleoli,Mitochondria,Cytosol NA NA Mitochondria "Nucleoli, Cytosol" "HPA032005: AB_10603560, HPA032006: AB_10670554" "unprognostic (6.17e-2)" "unprognostic (3.14e-1)" "unprognostic (1.41e-2)" "unprognostic (4.35e-2)" "unprognostic (1.86e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.40e-2)" "unprognostic (6.27e-3)" "unprognostic (1.07e-1)" "unprognostic (9.46e-3)" "unprognostic (6.46e-2)" "prognostic favorable (4.32e-6)" "prognostic favorable (8.73e-4)" "unprognostic (8.82e-2)" "unprognostic (1.02e-2)" "unprognostic (8.71e-2)" 5.5 6.9 5.3 5.7 6.5 7.0 5.4 6.5 7.2 4.4 11.8 4.1 2.9 9.7 5.1 3.6 9.4 4.8 3.5 18.9 5.8 3.8 10.0 9.3 5.2 8.4 4.5 2.8 4.9 9.6 7.2 6.4 6.6 5.7 5.2 10.1 5.5 6.7 4.8 34.9 6.0 10.9 7.2 4.0 4.6 7.7 15.5 4.9 5.9 5.2 9.6 7.4 7.2 5.8 11.9 13.6 4.0 14.1 8.8 17.5 9.8 7.3 14.1 5.9 8.4 5.9 5.4 13.3 8.9 6.2 16.3 11.3 12.3 5.4 17.3 7.1 9.0 5.6 14.1 11.9 11.5 13.1 9.3 12.0 10.3 11.3 13.6 10.3 10.6 9.7 7.7 14.5 10.2 13.0 6.5 8.6 12.3 13.9 5.9 7.2 9.1 9.0 7.0 8.9 27.6 7.3 7.6 19.9 12.2 10.2 13.8 4.4 7.4 9.2 12.3 11.0 29.1 6.9 6.0 7.0 7.1 6.0 7.2 11.2 7.2 10.1 7.8 10.7 11.0 8.8 3.0 10.6 4.0 9.9 14.1 10.4 11.9 11.6 10.3 13.6 8.2 12.6 11.9 1.2 8.8 11.9 4.6 17.5 9.8 5.3 6.5 6.5 7.2 5.8 3.8 4.5 2.8 5.7 4.9 0.0 14.3 5.2 7.2 8.7 8.0 89.2 7.6 5.3 4.5 10.4 9.8 16.5 34.9 8.0 33.1 4.9 19.0 0.0 7.5 14.8 5.1 7.4 4.7 8.9 9.4 0.0 12.1 4.9 3.8 61.2 2.0 5.4 5.0 4.6 14.2 2.8 8.6 11.0 6.3 11.4 11.6 0.0 5.1 14.6 15.9 9.2 13.5 5.3 15.1 11.8 CPNE2 CPN2 ENSG00000140848 "Copine 2" Q96FN4 16 57092537-57148367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.6" "Cell type enhanced" "Detected in many" 8 "Ito cells: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041132 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA041132: AB_2677316" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (4.93e-3)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (2.10e-2)" "unprognostic (9.14e-2)" "unprognostic (2.10e-3)" "unprognostic (8.78e-3)" "unprognostic (2.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.53e-3)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (7.44e-3)" "unprognostic (1.33e-1)" 14.1 3.9 8.4 4.6 15.1 22.8 11.4 7.9 15.4 16.4 12.0 40.6 1.1 2.0 8.8 3.1 6.4 12.0 5.6 5.9 10.6 11.6 4.8 4.3 15.5 8.2 20.8 9.8 5.1 3.3 3.7 4.9 11.5 12.9 5.1 11.9 4.6 3.7 7.4 4.9 4.0 6.6 10.5 13.5 6.0 3.7 15.3 20.1 0.2 5.8 2.2 3.2 6.4 8.3 0.0 2.1 4.0 4.2 0.5 1.2 0.9 8.4 16.3 25.2 13.9 4.5 4.4 4.2 9.2 14.6 21.1 14.8 4.5 9.8 5.0 8.5 13.9 11.7 13.3 9.9 5.5 11.5 6.2 5.8 2.1 6.5 3.8 8.2 1.7 0.2 4.2 6.2 8.2 4.0 15.8 31.0 2.8 5.6 0.1 5.3 3.9 2.5 24.7 5.7 4.1 3.5 31.5 7.9 4.2 14.0 3.2 0.5 10.2 11.7 2.5 7.0 11.9 2.7 33.7 21.8 19.3 10.5 4.8 11.9 1.2 1.0 11.3 12.5 7.4 13.5 0.0 4.2 1.9 0.7 1.2 0.7 0.0 0.4 1.2 2.1 0.0 0.3 0.6 4.0 0.5 0.4 0.1 0.5 0.9 8.4 15.1 7.9 15.4 10.6 11.6 20.8 9.8 12.9 20.1 17.9 6.1 2.9 13.5 2.1 0.0 2.2 2.5 1.4 2.3 5.2 0.0 0.6 5.0 3.9 14.0 20.4 28.0 0.0 3.4 2.1 10.4 9.0 0.0 1.6 20.0 0.0 3.5 72.4 21.2 4.7 6.4 6.9 6.8 3.6 15.7 3.3 5.9 21.0 7.1 1.6 0.0 32.3 14.4 0.5 1.7 3.8 0.7 4.4 15.9 9.9 CPT2 "CPT1, CPTASE" ENSG00000157184 "Carnitine palmitoyltransferase 2" P23786 1 53196429-53214197 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 69.0" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 64.6;Hepatocytes: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028201, HPA028202, HPA028214" Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoplasm, Mitochondria" Nucleoli "HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958" "unprognostic (2.43e-1)" "unprognostic (2.27e-1)" "prognostic favorable (5.27e-4)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (9.34e-2)" "unprognostic (6.48e-2)" "unprognostic (1.75e-2)" "unprognostic (2.86e-1)" "unprognostic (1.67e-1)" "unprognostic (3.00e-2)" "unprognostic (8.97e-2)" "prognostic favorable (1.46e-12)" "unprognostic (4.00e-2)" "unprognostic (2.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.95e-2)" 7.5 15.5 5.3 6.8 6.1 2.3 6.5 4.0 7.2 5.1 15.4 9.4 10.7 16.6 5.1 7.6 10.5 5.4 11.3 21.4 4.3 4.5 19.8 69.0 6.9 8.3 5.7 3.7 5.3 15.9 10.7 11.5 18.1 6.4 6.0 15.6 13.8 11.8 12.2 13.6 6.0 18.9 5.5 5.2 10.3 10.1 11.2 4.7 9.7 8.3 7.2 10.3 8.0 4.9 5.9 12.4 10.0 13.1 4.8 8.0 6.5 7.7 3.2 7.5 7.3 6.5 3.8 8.5 4.8 4.9 6.9 6.4 1.6 6.5 13.2 7.3 2.2 7.8 7.7 14.0 11.0 5.9 7.3 8.2 7.5 4.3 1.3 9.5 7.1 7.3 8.2 9.4 5.0 4.2 7.7 4.7 11.7 9.6 4.7 4.2 4.5 5.5 5.8 14.0 14.4 8.6 6.4 7.2 13.9 8.6 7.2 11.2 7.6 9.6 12.2 18.1 18.1 14.2 15.2 4.5 3.9 3.1 6.8 3.9 14.5 8.9 8.1 5.0 8.2 5.7 4.1 8.4 10.0 5.1 12.6 6.2 4.5 4.9 5.9 12.4 5.9 8.0 5.5 5.1 4.8 13.1 6.4 7.0 6.5 5.3 6.1 4.0 7.2 4.3 4.5 5.7 3.7 6.4 4.7 11.9 20.8 8.9 5.1 1.5 3.1 12.4 15.3 4.0 3.4 10.4 13.7 64.6 21.6 10.7 1.1 3.6 39.8 0.0 9.3 16.0 2.8 4.8 2.3 80.0 23.6 14.3 13.9 6.7 13.5 2.1 6.4 8.2 6.8 26.2 26.9 10.5 9.8 21.0 4.9 28.3 9.9 6.5 3.2 29.8 16.3 2.3 45.7 7.1 25.3 4.6 CREB3L4 "AIbZIP, ATCE1, CREB3, CREB4, hJAL" ENSG00000143578 "CAMP responsive element binding protein 3 like 4" Q8TEY5 1 153967534-153974363 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 49.9" "Cell type enhanced" "Detected in many" 7 "Glandular cells: 54.0;Mucus-secreting cells: 48.0" "Group enriched" "Detected in all" 5 "breast cancer: 47.8;endometrial cancer: 28.7;prostate cancer: 109.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.9;OE19: 25.3;SK-BR-3: 55.0;T-47d: 44.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA038122 Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" No No "Nucleoplasm, Nuclear membrane" Mitochondria "HPA038122: AB_10669516" "unprognostic (1.35e-1)" "unprognostic (4.71e-2)" "unprognostic (8.13e-3)" "prognostic favorable (7.21e-4)" "unprognostic (2.04e-1)" "unprognostic (1.40e-2)" "unprognostic (5.51e-3)" "unprognostic (5.02e-2)" "unprognostic (1.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.62e-1)" "unprognostic (1.70e-1)" "unprognostic (7.12e-3)" "unprognostic (2.13e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-2)" "unprognostic (9.34e-3)" 4.3 5.0 3.2 5.4 4.0 2.9 22.6 5.7 3.5 14.6 5.1 4.3 18.3 5.0 8.5 12.1 5.1 8.8 7.9 3.2 2.5 1.4 4.5 8.4 4.7 5.5 3.2 3.0 9.3 7.9 3.7 3.4 6.6 4.0 49.9 6.9 4.7 24.7 11.4 6.1 5.9 5.3 3.4 3.3 4.5 13.2 4.3 3.0 12.9 12.5 6.6 8.3 4.5 15.1 6.6 7.3 2.6 3.5 10.9 6.0 3.1 2.3 3.3 3.1 3.4 2.2 3.3 7.8 1.9 2.2 2.6 2.3 1.5 9.7 4.2 10.1 0.8 2.0 3.7 4.6 3.0 1.4 3.4 1.8 3.1 3.6 2.7 1.8 1.4 2.7 3.5 2.9 2.5 5.7 2.4 2.3 5.1 2.4 5.3 1.2 24.9 2.7 1.1 2.1 25.3 4.0 6.2 3.2 7.8 2.8 1.6 5.9 6.3 2.0 55.0 5.2 4.2 44.1 4.5 1.4 0.8 2.4 1.6 1.5 10.0 5.1 3.1 1.7 2.6 2.5 2.2 3.5 2.6 4.5 1.5 6.0 6.3 2.6 3.3 6.4 6.6 2.5 4.8 0.1 10.9 2.1 7.3 2.1 3.1 3.2 4.0 5.7 3.5 2.5 1.4 3.2 3.0 4.0 3.0 6.0 12.5 2.0 15.5 2.6 4.7 1.7 10.2 18.7 12.5 1.8 2.0 11.1 8.3 11.1 0.0 4.9 3.2 0.0 11.8 13.3 3.3 54.0 5.7 12.3 4.8 0.0 8.6 3.1 7.9 0.0 6.6 2.2 5.0 1.8 48.0 6.0 7.4 3.5 2.1 3.6 7.5 19.4 3.3 3.6 8.7 2.6 3.5 4.4 11.8 3.5 CREBL2 ENSG00000111269 "CAMP responsive element binding protein like 2" O60519 12 12611827-12645108 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 77.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043738 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA043738: AB_10795041" "unprognostic (2.87e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" "unprognostic (7.51e-2)" "unprognostic (7.38e-2)" "unprognostic (4.51e-1)" "unprognostic (1.44e-1)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (5.82e-3)" "unprognostic (6.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (6.31e-2)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.53e-1)" 21.9 77.6 24.3 16.5 31.9 3.0 18.9 21.4 24.6 16.4 13.4 14.6 13.5 13.2 11.4 17.5 10.4 14.9 16.4 14.3 19.8 23.0 28.7 28.2 18.5 18.8 20.2 19.8 22.6 14.2 31.7 31.5 13.8 19.7 17.1 14.2 20.5 15.4 14.4 6.6 14.1 13.3 12.0 20.0 20.2 14.1 17.1 18.3 8.6 25.9 6.7 16.6 17.7 14.0 2.0 4.2 3.6 8.7 1.6 8.1 2.2 5.5 7.2 6.3 7.1 22.3 22.6 12.2 10.9 18.4 8.0 11.1 5.2 8.1 4.8 4.2 13.2 12.2 4.7 9.5 8.3 13.7 26.8 5.7 3.8 7.2 6.3 14.6 5.3 7.1 14.6 15.0 9.4 15.5 27.5 11.7 3.8 3.8 7.6 13.5 8.9 2.8 4.4 18.9 5.3 6.6 3.8 10.9 3.0 15.4 16.1 7.4 8.5 11.0 5.4 19.0 28.5 3.0 6.1 9.4 11.1 7.1 10.9 10.7 6.4 8.5 1.2 13.2 4.6 11.4 1.7 3.8 3.6 2.8 8.7 5.0 1.5 5.5 4.4 4.2 2.0 5.5 4.5 0.7 1.6 3.6 2.1 8.1 2.2 24.3 31.9 21.4 24.6 19.8 23.0 20.2 19.8 19.7 18.3 23.8 21.6 14.3 16.0 19.7 16.9 12.3 22.9 16.0 12.5 31.4 2.0 14.7 34.9 16.6 23.6 20.4 18.6 0.0 19.2 14.9 18.4 35.5 10.3 38.9 36.4 35.0 28.8 22.7 83.1 5.0 33.4 54.7 32.1 45.9 18.1 28.7 18.7 10.5 33.2 48.0 11.0 38.8 9.1 30.0 17.4 25.5 23.0 15.3 15.1 19.2 CTNNBIP1 "ICAT, MGC15093" ENSG00000178585 "Catenin beta interacting protein 1" Q9NSA3 1 9848276-9910336 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 116.5" "Cell type enhanced" "Detected in many" 7 "Suprabasal keratinocytes: 254.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042617, HPA067089" Enhanced Approved "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane, Cell Junctions, Mitochondria" "HPA042617: AB_2678081, HPA067089: " "unprognostic (2.71e-1)" "unprognostic (4.46e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.68e-6)" "unprognostic (3.08e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (1.19e-1)" "unprognostic (2.23e-2)" "unprognostic (2.62e-1)" "unprognostic (2.17e-2)" "unprognostic (1.77e-1)" "unprognostic (1.24e-3)" "unprognostic (3.62e-2)" "unprognostic (3.22e-2)" "unprognostic (8.63e-2)" "unprognostic (4.37e-2)" 12.6 4.0 10.1 4.3 8.1 7.7 18.3 21.4 14.8 16.6 5.8 10.1 10.9 7.4 4.8 31.3 49.0 5.2 4.8 13.7 10.1 9.5 5.6 4.8 15.2 4.0 8.4 11.3 5.5 14.1 4.0 6.6 11.0 13.7 9.9 4.2 13.3 15.5 16.5 13.1 116.5 5.8 4.5 9.2 3.3 8.8 11.8 6.5 4.8 7.9 33.9 13.5 5.6 21.7 1.9 6.8 12.9 5.4 8.8 2.9 2.3 26.2 3.9 24.2 18.4 3.6 6.1 7.7 5.2 9.2 7.7 4.9 1.9 33.5 8.1 15.1 6.7 7.9 13.4 2.8 30.9 3.5 20.4 4.3 5.2 1.2 24.4 7.6 3.9 3.1 6.8 30.6 9.8 10.0 6.6 20.7 15.3 9.2 3.8 4.7 16.1 8.7 14.6 12.8 21.2 6.8 10.0 7.1 5.2 3.9 9.0 26.6 16.8 11.8 10.8 15.7 8.6 13.2 9.7 13.5 5.0 6.1 7.5 11.4 8.4 10.9 9.5 1.8 20.0 19.7 2.7 5.4 12.9 2.9 1.9 1.7 1.9 1.5 2.4 6.8 1.6 1.4 1.4 4.0 8.8 1.2 2.1 1.2 2.3 10.1 8.1 21.4 14.8 10.1 9.5 8.4 11.3 13.7 6.5 26.8 11.5 11.8 34.8 91.7 8.4 11.6 22.9 1.4 7.9 17.4 7.9 61.2 28.2 16.0 101.0 18.1 20.6 23.3 16.2 34.6 26.7 52.4 0.0 22.9 49.6 15.9 47.1 16.0 32.6 19.5 13.8 30.5 45.5 5.4 34.9 106.1 27.9 25.8 21.5 23.0 12.2 45.3 22.1 72.3 36.2 254.8 40.5 18.1 24.3 54.7 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153449-54173973 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2" "Cell type enhanced" "Detected in some" 11 "Basal glandular cells: 21.1;Basal keratinocytes: 20.3;Club cells: 29.6;Proximal tubular cells: 33.5;Suprabasal keratinocytes: 17.1;Urothelial cells: 39.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 20 "T-cells: 2.0" "Group enriched" "Detected in some" 16 "A549: 95.1;Hep G2: 27.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022261, HPA063771" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.1 0.1 0.4 0.2 0.7 0.0 2.5 0.1 0.4 2.5 0.1 0.0 0.3 0.0 11.2 0.4 4.4 0.3 0.0 0.1 0.4 0.8 38.8 0.3 1.6 0.1 0.2 0.0 0.1 0.1 0.0 0.7 7.0 0.3 7.0 0.0 0.1 0.3 1.5 0.1 1.0 0.1 0.6 0.2 0.1 0.1 0.3 0.0 0.4 1.4 5.9 25.8 31.2 14.4 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.1 95.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.7 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 1.6 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.1 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.7 0.1 0.4 0.4 0.8 0.2 0.0 0.3 0.0 0.0 0.0 1.5 21.1 20.3 0.0 0.3 0.0 8.1 29.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 17.1 0.1 0.0 0.0 39.9 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761272 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 178.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 17.4 36.6 13.7 17.9 12.7 10.6 23.1 3.9 11.6 23.5 25.4 11.4 63.4 26.5 21.1 34.7 14.3 18.6 44.0 22.9 13.4 9.1 40.1 78.2 21.6 22.6 10.2 10.1 26.1 178.8 30.0 28.4 26.4 21.8 24.8 20.2 22.7 71.1 76.0 5.9 15.2 42.6 18.3 10.8 23.8 31.6 23.2 9.8 15.5 31.2 12.8 18.6 25.9 16.9 18.1 32.8 27.3 33.2 13.1 17.6 22.5 19.2 14.1 17.5 16.1 32.8 39.7 19.4 47.4 73.7 35.9 41.7 10.0 16.5 8.4 31.2 58.5 22.7 3.8 10.8 28.1 40.0 44.3 7.9 11.3 27.3 24.6 31.0 21.1 8.4 20.4 9.8 23.5 42.7 20.8 66.9 9.5 13.1 28.6 35.1 15.3 11.3 13.5 6.3 26.2 32.3 15.5 7.7 13.9 47.3 35.9 11.9 16.0 48.3 19.7 12.6 14.0 15.6 31.0 32.7 22.3 24.2 14.7 25.1 16.1 20.8 12.4 22.0 41.2 33.4 14.9 33.2 18.6 14.8 29.4 17.6 18.1 15.3 13.0 32.8 12.0 11.3 11.2 27.3 13.1 28.5 26.9 16.1 22.5 13.7 12.7 3.9 11.6 13.4 9.1 10.2 10.1 21.8 9.8 14.9 40.1 32.0 53.6 17.1 8.1 11.0 56.0 12.0 30.7 50.6 5.9 59.1 112.7 83.0 10.9 31.6 98.3 0.0 168.9 84.1 36.6 77.8 35.6 106.2 46.0 4.8 42.5 36.2 35.6 22.8 27.6 32.0 27.0 38.7 87.4 19.0 105.6 63.3 32.2 50.2 7.2 0.0 21.7 33.1 6.1 15.8 84.4 24.1 65.2 69.2 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68021274-68023442 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol No No "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: AB_2682200" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favorable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 9.8 12.7 6.2 6.7 8.3 19.7 7.1 6.0 12.9 8.3 7.2 6.4 6.8 5.2 7.5 7.3 9.7 7.1 7.0 9.2 5.2 5.9 8.9 12.4 5.8 18.4 6.4 5.1 8.6 13.3 6.8 4.6 17.1 6.6 6.1 6.0 7.8 6.3 5.2 16.2 9.9 7.9 5.3 3.0 11.1 7.0 11.5 2.7 14.6 10.2 7.3 10.6 8.0 4.8 17.8 18.0 22.9 19.1 17.0 22.9 16.6 6.1 9.2 4.5 5.4 6.3 3.5 10.6 4.2 6.3 10.7 7.6 8.9 9.8 23.2 6.5 5.2 5.8 11.2 6.4 10.2 6.3 3.1 10.6 8.4 4.8 9.2 8.5 13.1 9.0 6.9 11.2 8.8 8.1 3.7 5.9 15.7 14.9 3.6 4.7 13.8 13.7 18.5 11.1 6.3 6.8 13.5 4.2 24.8 7.5 7.2 9.5 6.4 17.2 4.9 9.3 5.4 9.5 14.4 4.2 4.7 4.0 6.7 6.9 8.2 9.9 22.3 5.8 10.1 6.4 17.7 19.1 22.9 15.7 18.8 17.3 12.6 14.6 16.9 18.0 17.8 22.9 16.9 6.3 17.0 18.5 9.0 13.8 16.6 6.2 8.3 6.0 12.9 5.2 5.9 6.4 5.1 6.6 2.7 6.0 5.0 7.5 13.5 8.1 4.8 3.1 2.5 2.7 5.7 3.5 0.0 24.0 11.6 9.5 5.9 6.0 1.7 0.0 8.5 9.4 4.2 3.1 3.5 9.7 15.4 3.2 4.6 4.3 10.3 3.1 4.6 6.6 6.8 11.8 2.8 7.2 7.2 4.5 3.2 14.6 3.4 12.9 4.1 20.6 15.1 9.4 83.5 10.1 5.8 10.3 DGKA "DAGK, DAGK1, DGK-alpha" ENSG00000065357 "Diacylglycerol kinase alpha" P23743 12 55927319-55954027 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.1" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 38.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 42.2;hTERT-HME1: 44.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041645, HPA045462" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Vesicles "Nucleoplasm, Mitochondria" "HPA041645: AB_2677595, HPA045462: AB_2679335" "unprognostic (1.12e-3)" "unprognostic (1.43e-2)" "unprognostic (1.62e-2)" "unprognostic (2.63e-2)" "unprognostic (5.23e-2)" "unprognostic (2.04e-1)" "unprognostic (3.62e-1)" "unprognostic (3.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (1.66e-5)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (1.47e-1)" "unprognostic (7.02e-2)" 4.9 4.7 7.1 31.8 8.2 9.7 4.8 6.0 10.8 8.4 13.4 3.6 3.1 20.5 6.9 4.1 42.0 4.9 7.9 3.8 4.6 2.4 3.9 1.5 7.6 28.6 2.1 4.1 4.9 6.4 6.2 3.1 10.2 3.3 10.6 11.0 4.1 16.2 5.3 1.0 33.0 27.2 5.7 3.7 23.1 4.8 4.4 2.6 117.1 4.5 9.6 57.0 13.0 15.1 7.6 4.0 5.4 2.8 5.2 30.2 10.9 6.7 4.3 3.0 4.0 7.5 9.8 0.9 15.2 15.6 6.0 4.4 2.0 11.5 3.8 3.6 10.1 2.0 12.4 3.2 42.2 7.2 3.2 0.7 6.1 9.1 1.1 6.5 1.9 6.0 8.4 22.8 8.3 44.8 20.0 12.2 22.7 0.7 5.9 16.1 0.7 12.5 2.4 0.6 5.6 5.1 5.8 1.0 0.6 14.2 19.5 0.5 1.7 5.0 0.2 0.5 8.2 2.7 2.0 10.9 3.9 2.8 0.8 0.5 0.7 0.3 9.2 4.7 5.2 1.1 5.2 2.8 5.4 6.5 2.0 11.7 7.6 24.3 11.7 4.0 6.4 30.2 18.1 5.2 5.2 1.2 4.0 26.7 10.9 7.1 8.2 6.0 10.8 4.6 2.4 2.1 4.1 3.3 2.6 3.0 6.2 15.6 8.5 13.4 0.8 2.0 0.0 0.0 11.4 5.2 0.0 13.4 0.0 4.1 6.5 3.3 38.4 0.0 8.4 4.0 3.8 8.2 6.9 0.0 3.7 0.0 2.4 4.9 4.1 4.7 3.4 10.2 0.0 16.2 7.5 4.9 15.8 6.2 2.8 0.1 0.4 6.5 3.1 3.8 2.7 12.2 22.1 20.6 5.2 18.0 DHODH ENSG00000102967 "Dihydroorotate dehydrogenase (quinone)" Q02127 16 72008588-72027664 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Pyrimidine biosynthesis" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 72.4" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010123, HPA011942" Approved Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA010123: AB_1847648, HPA011942: AB_1847649" "unprognostic (4.88e-2)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-2)" "unprognostic (1.41e-3)" "unprognostic (2.10e-1)" "unprognostic (4.27e-2)" "unprognostic (1.31e-2)" "unprognostic (1.26e-1)" "unprognostic (2.68e-1)" "unprognostic (2.14e-1)" "unprognostic (6.40e-2)" "unprognostic (9.26e-3)" "unprognostic (1.98e-1)" "unprognostic (1.97e-1)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" 5.9 4.2 4.7 8.8 5.1 2.9 5.0 2.7 5.0 5.9 4.4 6.1 1.4 3.4 6.6 2.3 5.1 5.2 2.3 11.5 4.3 3.0 6.6 72.4 3.4 5.5 4.8 2.7 6.2 9.9 7.1 4.0 2.6 5.2 3.9 4.8 5.9 6.0 4.4 11.7 4.0 3.0 7.5 4.0 3.5 3.4 4.3 5.4 4.0 3.6 7.1 5.1 3.5 3.3 11.2 13.4 3.9 8.1 9.3 12.9 6.8 7.4 15.5 4.5 7.5 2.4 3.2 8.6 6.4 2.6 9.7 7.5 12.2 6.8 16.8 8.7 3.5 5.4 7.9 8.9 6.9 11.5 3.8 8.4 9.2 7.5 12.0 6.8 12.7 6.8 3.1 7.1 11.7 12.3 3.1 7.0 11.4 14.0 3.1 5.9 19.8 12.0 12.2 10.2 12.7 6.1 15.2 5.9 17.7 5.8 4.9 5.4 6.3 8.6 9.2 4.2 5.8 8.2 6.4 3.0 8.9 5.5 8.4 9.3 5.9 10.9 28.4 4.6 14.0 8.1 3.9 8.1 0.9 9.3 7.7 12.7 11.2 8.9 9.0 13.3 10.6 12.4 12.9 2.1 9.3 5.6 13.4 7.1 6.8 4.7 5.1 2.7 5.0 4.3 3.0 4.8 2.7 5.2 5.4 3.0 9.6 9.5 6.4 4.9 5.7 12.1 7.6 9.4 1.2 7.0 3.9 12.0 5.0 6.6 2.1 6.7 0.7 0.0 4.4 9.6 6.0 5.0 8.1 106.1 6.9 3.2 1.2 2.5 5.3 2.3 2.6 3.4 11.8 3.6 4.4 4.8 5.2 2.9 2.1 20.1 4.2 0.0 9.9 7.9 8.0 3.3 2.4 5.0 6.2 4.1 DPF1 "BAF45b, NEUD4, neuro-d4" ENSG00000011332 "Double PHD fingers 1" Q92782 19 38211006-38229714 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 31.6" "Cell type enhanced" "Detected in many" 16 "Bipolar cells: 18.4;Early spermatids: 23.8;Horizontal cells: 42.9;Late spermatids: 17.6" "Cancer enhanced" "Detected in some" "glioma: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 15.7;SCLC-21H: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049148 Enhanced Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA049148: AB_2680653" "unprognostic (7.72e-2)" "unprognostic (2.33e-1)" "unprognostic (5.38e-2)" "unprognostic (4.11e-3)" "unprognostic (8.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-4)" "unprognostic (1.40e-2)" "unprognostic (2.72e-1)" "unprognostic (5.49e-2)" "unprognostic (4.30e-3)" "unprognostic (2.87e-2)" "unprognostic (1.11e-16)" "unprognostic (2.56e-1)" "unprognostic (3.75e-1)" "unprognostic (6.96e-2)" "unprognostic (8.20e-4)" 1.1 1.5 11.8 1.5 15.7 1.0 0.9 6.4 31.6 0.8 1.0 0.9 0.0 0.9 1.0 0.8 0.8 1.0 1.0 1.0 12.4 7.7 0.8 0.8 1.0 1.1 4.5 11.3 0.9 0.9 0.9 1.3 1.1 2.0 0.9 0.9 0.0 1.2 0.8 1.1 1.2 1.0 1.3 2.1 1.1 0.8 2.5 1.2 0.0 0.8 0.0 1.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.5 3.0 12.8 9.3 0.9 0.6 1.3 3.8 2.2 6.5 5.5 2.1 0.3 5.8 2.6 2.9 2.6 2.3 15.7 2.1 2.9 5.5 3.0 1.9 1.4 0.8 0.3 1.4 1.6 0.7 0.0 3.8 1.2 0.8 1.2 4.4 4.3 0.3 6.1 4.9 3.1 0.3 2.3 1.0 3.5 5.8 6.5 1.2 0.6 1.1 18.5 6.4 4.2 0.4 0.8 1.6 1.9 0.3 1.4 9.4 3.0 2.2 3.4 2.3 7.7 7.7 4.9 2.0 3.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 11.8 15.7 6.4 19.6 12.4 7.7 4.5 11.3 2.0 1.2 0.0 0.0 0.0 0.0 2.1 18.4 1.1 0.0 1.4 0.0 0.0 7.9 0.1 0.0 0.0 23.8 0.3 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 0.2 42.9 0.0 0.0 0.0 17.6 0.6 0.0 0.0 0.0 0.0 2.6 0.1 0.0 2.5 0.0 2.9 0.0 1.3 4.9 6.8 1.0 0.1 0.0 0.0 0.0 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109431-103479863 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 35.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 167.3;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 86.1;Spermatocytes: 64.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.9" "Group enriched" "Detected in many" 5 "NK-cells: 2.9;T-cells: 2.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.0" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 7.3 5.7 6.3 3.8 8.9 1.4 8.4 13.2 9.3 11.5 4.8 5.5 11.0 4.1 11.3 9.6 3.9 14.6 7.8 3.7 7.1 7.1 8.5 2.6 10.2 2.6 4.8 7.9 11.4 5.1 24.2 35.7 3.9 11.2 7.6 2.6 6.2 4.5 10.7 1.6 5.7 3.4 7.8 5.1 4.8 4.2 14.3 5.2 1.1 10.7 3.0 2.4 6.1 6.6 0.5 0.4 0.4 0.2 2.9 2.2 0.0 1.0 2.2 5.7 2.8 8.0 18.0 0.3 3.2 5.2 5.4 5.8 1.2 1.1 0.0 4.5 6.2 2.5 4.3 4.4 6.0 4.3 0.0 4.1 0.8 3.7 0.1 7.7 1.7 1.0 11.2 2.3 12.1 13.9 8.4 2.1 1.1 0.1 0.0 6.9 4.1 0.5 0.4 1.5 0.0 6.1 0.0 4.7 0.1 5.8 0.7 4.1 2.9 5.1 1.4 2.4 1.4 5.3 1.1 5.1 6.5 2.6 6.1 2.1 0.0 0.0 0.0 1.9 5.2 1.9 0.4 0.2 0.0 0.9 0.1 2.2 0.5 0.7 1.1 0.4 0.3 0.8 1.1 0.0 2.9 0.1 0.2 0.0 0.0 6.3 8.9 13.2 9.3 7.1 7.1 4.8 7.9 11.2 5.2 0.0 12.5 0.0 11.5 6.0 22.2 9.4 2.5 167.3 23.9 26.2 106.0 0.3 1.7 5.6 13.4 9.0 0.0 0.0 3.1 0.4 14.8 5.9 3.5 0.8 2.0 30.2 16.6 6.7 1.5 6.5 19.2 3.8 8.5 0.0 0.8 17.7 6.8 1.1 17.3 14.8 86.1 19.4 11.3 64.2 10.4 4.8 0.5 2.5 0.9 5.7 FAM210A "C18orf19, HsT2329, MGC24180" ENSG00000177150 "Family with sequence similarity 210 member A" Q96ND0 18 13663347-13726663 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014324, HPA051564" Uncertain Approved "Nucleoplasm,Golgi apparatus,Mitochondria" NA NA "Nucleoplasm, Golgi apparatus, Mitochondria" "HPA014324: AB_2668972, HPA051564: AB_2681536" "unprognostic (1.32e-1)" "unprognostic (6.98e-2)" "unprognostic (5.78e-2)" "unprognostic (9.18e-3)" "unprognostic (4.13e-2)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.23e-3)" "unprognostic (1.11e-2)" "unprognostic (2.26e-1)" "unprognostic (5.53e-3)" "unprognostic (6.79e-3)" "unprognostic (2.98e-2)" "unprognostic (3.27e-3)" "unprognostic (7.67e-2)" "unprognostic (2.86e-1)" "unprognostic (1.78e-1)" "unprognostic (4.82e-2)" 10.5 8.1 7.5 8.9 7.1 4.0 9.4 8.3 8.8 5.8 9.9 7.2 5.8 11.5 6.6 4.4 13.5 5.7 5.4 27.5 6.4 7.8 12.0 17.6 5.6 7.4 7.4 6.4 8.7 5.6 7.8 7.5 9.3 8.2 7.1 8.5 6.5 7.0 7.6 27.9 5.6 10.9 8.2 9.1 6.4 6.1 10.2 7.3 5.9 8.4 16.3 8.9 14.7 7.9 9.2 8.6 4.3 10.7 7.6 9.7 5.0 12.2 7.0 4.9 4.6 5.8 6.1 7.2 8.5 7.9 9.6 11.2 9.4 6.0 12.7 10.7 6.0 17.8 6.0 9.4 10.6 15.7 8.7 4.4 8.9 5.1 6.8 6.9 15.1 8.4 5.2 8.4 9.2 32.6 6.7 6.1 7.7 12.0 7.0 11.1 8.4 9.3 9.8 5.5 24.1 7.0 7.6 11.7 14.7 7.9 7.8 3.2 5.5 7.4 11.0 20.3 7.4 5.8 7.2 6.7 24.7 24.2 15.2 10.4 7.9 9.8 14.7 13.1 7.9 9.8 3.4 7.0 4.3 8.9 10.7 9.7 8.1 7.6 7.7 8.6 9.2 9.6 9.0 1.2 7.6 5.3 5.6 7.2 5.0 7.5 7.1 8.3 8.8 6.4 7.8 7.4 6.4 8.2 7.3 8.9 8.8 20.4 10.4 49.1 53.0 60.1 5.1 1.4 11.4 7.0 19.6 19.1 18.3 16.3 6.1 15.8 11.7 0.0 7.8 31.2 17.4 9.1 6.9 19.0 18.1 28.6 10.9 5.5 8.4 3.1 8.6 16.6 8.5 11.8 8.4 17.4 10.7 0.0 9.6 21.9 29.7 6.5 16.0 27.0 29.8 50.1 21.5 11.4 17.7 10.4 FKBP8 "FKBP38, FKBPr38" ENSG00000105701 "FK506 binding protein 8" Q14318 19 18531751-18544077 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Host-virus interaction" "Isomerase, Rotamase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Late spermatids: 972.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 32.5;neutrophil: 31.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 32.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025346, HPA045177" Supported Supported "Endoplasmic reticulum,Mitochondria,Cytosol" NA NA Mitochondria "Endoplasmic reticulum, Cytosol" "CAB025346: , HPA045177: AB_2679244" "unprognostic (1.61e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (9.22e-2)" "unprognostic (2.54e-2)" "unprognostic (2.26e-1)" "unprognostic (2.10e-2)" "unprognostic (1.49e-1)" "prognostic favorable (7.76e-4)" "unprognostic (8.51e-2)" "unprognostic (1.61e-1)" "unprognostic (2.97e-1)" "unprognostic (6.89e-2)" "unprognostic (1.12e-2)" "unprognostic (2.32e-1)" 44.3 38.1 75.9 27.5 82.1 82.5 26.5 43.4 113.7 35.2 31.9 41.2 34.6 31.1 31.4 27.2 48.7 39.3 34.5 43.4 69.6 62.1 28.9 42.7 34.3 31.1 55.3 54.3 56.1 60.4 28.8 42.2 36.6 51.2 36.5 12.9 31.9 73.1 46.1 56.7 35.1 31.6 34.6 46.3 36.7 31.9 49.5 26.9 32.1 38.8 24.2 30.7 36.3 45.8 4.3 4.3 32.5 6.9 3.1 6.6 9.1 36.9 26.5 20.8 39.5 21.5 33.8 52.2 29.9 31.9 22.9 31.8 25.1 50.5 21.2 48.7 36.7 15.4 20.1 12.8 41.7 6.5 25.8 60.9 19.8 34.6 30.2 37.0 19.6 43.6 44.1 40.2 20.6 13.1 44.1 23.5 41.3 41.4 50.5 19.9 61.6 35.6 58.7 42.5 33.2 38.5 37.4 17.3 72.4 30.8 24.2 23.1 42.1 21.0 17.3 37.3 16.5 20.4 57.2 27.4 28.7 26.2 55.9 22.7 38.6 22.2 24.6 64.8 31.5 25.4 6.3 5.6 32.5 6.0 5.8 5.5 4.1 6.1 6.6 4.3 4.3 4.7 5.3 31.0 3.1 6.9 4.3 6.0 9.1 75.9 82.1 43.4 113.7 69.6 62.1 55.3 54.3 51.2 26.9 8.9 1.4 107.1 128.1 84.6 57.2 2.0 71.4 2.7 5.7 96.0 13.7 219.4 210.5 151.9 314.6 76.6 289.8 233.6 111.8 173.9 174.8 132.3 54.0 55.9 208.7 93.8 197.7 79.8 159.9 972.7 188.7 127.3 192.3 254.3 108.6 104.6 130.6 224.5 155.6 222.1 41.3 97.0 149.9 203.6 97.7 103.1 261.7 163.0 127.0 126.6 FKBP9 "FKBP60, FKBP63" ENSG00000122642 "FK506 binding protein 9" O95302 7 32957404-33006931 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 7.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 58.4;fHDF/TERT166: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012595, HPA055256" Approved Approved "Golgi apparatus,Vesicles,Mitochondria" "Intracellular and membrane" No No "Golgi apparatus, Mitochondria" Vesicles "HPA012595: AB_1848629, HPA055256: AB_2682761" "unprognostic (1.23e-2)" "prognostic unfavorable (4.22e-4)" "unprognostic (6.94e-2)" "unprognostic (6.25e-3)" "prognostic unfavorable (5.80e-4)" "prognostic unfavorable (2.02e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (3.40e-2)" "unprognostic (9.59e-2)" "unprognostic (2.58e-1)" "unprognostic (3.63e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-2)" "unprognostic (6.31e-2)" "unprognostic (1.97e-1)" "unprognostic (8.90e-3)" "prognostic unfavorable (7.02e-6)" 35.4 21.1 9.7 12.5 13.6 0.9 43.7 4.5 16.3 33.6 18.3 9.3 16.8 8.8 31.3 30.9 23.7 24.1 28.8 44.4 9.7 11.9 18.2 10.1 30.6 17.5 10.8 9.7 25.9 26.0 12.9 16.0 35.2 13.2 23.7 21.2 30.4 16.0 25.6 17.1 28.0 13.4 37.0 12.8 10.7 17.4 16.3 6.4 2.9 18.9 19.4 11.1 23.7 23.6 0.4 1.4 7.4 4.1 0.3 0.1 0.9 7.1 13.6 5.3 21.9 50.4 58.4 7.1 38.7 40.3 12.8 20.4 5.9 17.0 0.0 15.8 71.8 20.5 14.0 7.8 18.9 14.7 0.0 2.3 1.2 14.6 5.8 21.0 0.0 2.1 37.9 11.5 11.4 11.1 30.5 16.1 0.0 2.7 1.4 26.0 6.9 0.0 3.6 1.1 14.3 7.2 0.0 14.3 0.0 14.3 2.4 5.0 12.1 22.1 11.3 13.7 14.1 7.9 3.5 21.5 21.0 20.2 13.0 8.8 4.6 8.9 0.0 20.5 0.0 41.7 1.5 4.1 0.9 0.1 2.6 0.1 0.4 0.1 0.0 1.4 0.3 0.1 0.1 7.4 0.3 0.7 0.3 0.0 0.9 9.7 13.6 4.5 16.3 9.7 11.9 10.8 9.7 13.2 6.4 11.9 20.0 0.0 12.5 30.5 7.7 38.3 15.3 6.7 7.9 17.4 9.8 17.1 5.0 16.3 0.5 65.3 16.9 0.0 36.7 25.2 46.6 8.5 5.7 10.5 6.7 11.1 11.7 58.9 6.2 0.7 33.9 4.5 57.3 3.6 27.2 34.3 30.2 17.5 51.9 7.4 4.5 45.3 51.9 0.9 0.9 25.0 11.0 1.3 21.4 8.6 FOXK2 "ILF, ILF1" ENSG00000141568 "Forkhead box K2" Q01167 17 82519713-82644662 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027523, HPA073491" Approved Supported Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA027523: AB_10601013, HPA073491: " "unprognostic (2.39e-1)" "unprognostic (8.28e-2)" "unprognostic (2.05e-1)" "unprognostic (9.52e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (3.35e-2)" "unprognostic (2.25e-1)" "unprognostic (5.19e-2)" "unprognostic (2.18e-2)" "unprognostic (2.26e-1)" "unprognostic (3.80e-3)" "unprognostic (2.24e-2)" "unprognostic (4.89e-2)" "unprognostic (1.12e-1)" "unprognostic (1.52e-2)" 16.8 21.2 17.5 14.3 19.2 8.7 19.1 21.3 30.5 17.7 17.1 17.1 16.9 11.2 22.2 13.7 24.2 14.6 13.4 17.1 14.9 14.9 13.0 13.6 15.2 13.6 13.7 17.2 17.6 19.2 25.4 19.8 18.6 15.6 14.9 11.7 13.8 17.1 16.3 41.5 21.6 12.6 19.9 10.3 13.2 15.5 32.3 15.8 21.8 18.6 12.4 13.9 16.4 16.4 4.0 5.9 4.1 2.9 4.1 4.4 1.6 21.7 23.3 21.8 23.8 12.6 13.9 14.6 12.8 14.8 22.5 22.9 22.6 14.0 18.6 9.3 15.8 24.8 12.7 23.2 14.8 21.3 12.7 22.2 19.2 15.4 22.2 19.9 21.4 12.9 13.1 27.1 23.7 27.1 14.0 22.7 20.2 25.6 19.1 12.3 13.0 36.3 13.6 12.5 18.0 17.8 23.9 18.6 15.4 10.3 18.4 36.2 26.7 12.7 32.4 30.2 24.3 22.8 24.8 17.7 29.7 20.8 19.9 25.8 22.1 19.5 24.1 16.0 17.9 15.6 4.1 2.9 3.3 4.4 2.2 3.5 4.0 3.3 4.2 3.3 2.8 2.6 2.9 0.5 4.1 2.3 5.9 3.4 1.6 17.5 19.2 21.3 30.5 14.9 14.9 13.7 17.2 15.6 15.8 47.6 21.9 9.3 7.3 33.1 18.1 17.3 5.1 13.4 18.2 14.0 11.8 10.2 3.3 8.5 11.5 12.8 10.5 0.0 9.1 7.5 13.1 10.0 2.3 11.4 16.3 44.5 10.5 12.9 14.6 18.8 8.6 9.2 11.8 9.0 13.5 9.1 10.2 11.5 12.4 5.4 16.1 0.0 19.6 13.2 9.5 37.6 8.1 6.9 12.1 8.9 FOXN4 ENSG00000139445 "Forkhead box N4" Q96NZ1 12 109277979-109309220 "Predicted intracellular proteins, Transcription factors" "Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.1" "Cell type enhanced" "Detected in some" 21 "Spermatocytes: 1.8;Spermatogonia: 2.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.8" "Region enriched" "Detected in single" 11 "basal ganglia: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 2.4;SCLC-21H: 6.4;SH-SY5Y: 6.6;U-266/70: 9.1" "Not detected" "Not detected" HPA050018 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA050018: AB_2680992" "unprognostic (1.09e-3)" "unprognostic (9.63e-2)" "unprognostic (1.60e-1)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (2.52e-2)" "unprognostic (1.18e-1)" "unprognostic (3.27e-2)" "unprognostic (7.93e-3)" "unprognostic (2.30e-1)" "unprognostic (1.02e-3)" "unprognostic (1.05e-1)" "unprognostic (1.43e-1)" "unprognostic (6.00e-2)" 0.2 0.0 0.1 0.1 2.7 0.0 0.1 0.2 0.1 1.4 0.3 0.1 0.1 0.0 0.6 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.2 0.9 2.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.4 0.1 0.4 0.1 0.1 0.0 13.1 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 6.6 0.0 0.1 0.0 0.1 0.2 0.5 0.0 0.0 0.1 0.0 0.0 9.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 2.6 0.0 0.0 0.0 0.0 0.0 GCAT KBL ENSG00000100116 "Glycine C-acetyltransferase" O75600 22 37807905-37817176 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 81.6" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 68.0;Hepatocytes: 55.7;Proximal tubular cells: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020460, HPA063924" Approved Supported "Nucleoplasm,Nuclear speckles,Mitochondria" Yes No Nucleoplasm "Nuclear speckles, Mitochondria" "HPA020460: AB_1849548, HPA063924: " "unprognostic (1.61e-1)" "unprognostic (1.80e-2)" "unprognostic (8.38e-2)" "unprognostic (1.05e-1)" "unprognostic (1.10e-2)" "unprognostic (4.17e-2)" "unprognostic (2.40e-1)" "unprognostic (1.37e-2)" "unprognostic (3.56e-2)" "unprognostic (2.76e-3)" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.36e-3)" "unprognostic (8.00e-2)" "unprognostic (1.97e-1)" "unprognostic (4.73e-3)" "unprognostic (3.99e-1)" 2.9 6.0 8.9 2.4 8.8 8.1 4.2 8.3 12.3 4.5 4.7 5.2 8.0 3.5 3.0 4.0 6.3 3.9 6.0 21.5 8.6 8.4 8.1 19.1 2.3 2.1 10.1 7.4 4.0 81.6 3.5 3.7 2.2 7.4 12.2 3.5 4.3 12.0 5.0 10.3 3.2 3.2 3.1 6.3 1.1 4.4 5.9 4.3 2.8 10.7 9.3 4.3 3.3 2.2 0.3 2.5 0.8 1.3 2.3 7.1 2.8 8.8 2.3 5.9 33.9 12.3 10.0 4.2 12.7 13.4 9.7 8.2 5.1 1.0 2.8 6.0 5.7 5.7 5.2 5.9 9.0 2.2 1.2 10.8 6.2 7.4 20.3 20.1 10.9 8.1 11.7 5.5 6.4 14.1 3.1 7.9 11.4 15.7 3.3 4.5 7.8 11.4 20.2 2.5 13.9 9.4 12.0 1.3 16.2 12.2 7.0 12.3 8.4 9.9 16.1 6.8 2.2 12.9 5.3 5.9 9.8 5.3 6.5 4.4 10.8 5.3 5.8 6.7 10.2 10.2 0.2 1.3 0.8 1.5 1.2 0.6 0.3 3.4 1.0 2.4 0.1 7.1 2.9 0.6 2.3 0.8 2.5 3.3 2.8 8.9 8.8 8.3 12.3 8.6 8.4 10.1 7.4 7.4 4.3 6.0 12.5 2.9 15.2 6.9 9.8 43.3 7.6 4.0 6.8 10.4 3.9 12.8 68.0 6.1 3.6 5.6 6.3 0.0 8.8 17.8 7.5 19.5 9.2 55.7 4.0 7.9 2.4 3.1 2.2 4.3 3.4 1.6 20.3 1.8 23.9 17.3 6.8 3.5 9.2 62.4 1.9 6.5 10.8 13.4 27.1 5.3 23.2 4.9 25.5 11.2 GIT1 ENSG00000108262 "GIT ArfGAP 1" Q9Y2X7 17 29573469-29594054 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 78.6;Late spermatids: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004059, HPA004186" Enhanced Supported "Focal adhesion sites,Mitochondria,Cytosol" NA NA 53000 "Focal adhesion sites, Cytosol" Mitochondria "HPA004059: AB_1078966, HPA004186: AB_1078967" "unprognostic (3.66e-1)" "unprognostic (4.46e-2)" "unprognostic (3.24e-2)" "unprognostic (6.30e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (2.54e-6)" "unprognostic (3.00e-3)" "unprognostic (2.79e-1)" "unprognostic (5.23e-2)" "unprognostic (2.12e-2)" "unprognostic (3.08e-1)" "unprognostic (8.48e-2)" "unprognostic (5.56e-2)" "unprognostic (7.30e-2)" "unprognostic (2.10e-1)" "unprognostic (1.69e-1)" 13.0 8.5 34.0 11.1 38.1 8.0 9.4 18.9 43.4 7.8 9.8 15.6 2.2 11.6 10.0 5.3 13.2 14.0 10.2 12.2 41.5 16.4 7.0 3.7 12.0 12.6 19.2 21.8 13.6 14.3 10.2 8.1 13.8 15.0 8.4 6.9 7.8 11.9 10.3 10.0 20.2 10.9 8.7 11.9 11.1 9.5 42.9 19.8 10.8 11.0 4.5 9.7 9.8 7.5 1.8 4.7 3.0 6.0 5.6 4.9 3.6 17.5 29.4 14.5 25.8 11.6 7.3 16.8 8.7 8.6 10.5 9.4 11.9 6.6 13.3 14.0 11.4 18.8 29.1 15.2 22.4 5.4 17.1 18.2 9.6 14.4 10.6 14.1 12.1 7.9 8.9 25.8 12.1 18.9 15.0 19.5 17.8 7.8 11.5 7.5 18.1 38.2 16.3 10.8 17.8 7.0 29.1 19.4 19.9 9.5 9.7 30.5 26.1 12.3 28.6 43.0 10.8 14.0 16.2 24.0 10.0 14.5 22.0 17.5 9.6 13.2 14.5 16.5 10.4 16.8 0.3 3.6 3.0 4.7 6.0 2.2 1.8 4.5 4.9 4.7 1.7 3.7 2.7 1.2 5.6 3.7 4.0 2.9 3.6 34.0 38.1 18.9 43.4 41.5 16.4 19.2 21.8 15.0 19.8 3.0 1.0 13.7 6.2 24.2 14.0 7.6 0.0 8.1 1.2 5.2 9.8 4.4 1.7 7.1 78.6 27.4 16.3 0.0 8.1 6.7 8.8 8.0 1.1 2.1 7.3 11.1 14.3 14.7 7.8 70.1 13.3 9.2 8.5 4.6 14.3 9.7 8.1 10.5 9.9 5.0 9.3 12.9 5.1 10.4 10.9 24.6 3.0 7.7 13.7 6.7 GLUL GLNS ENSG00000135821 "Glutamate-ammonia ligase" P15104 1 182381704-182392206 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Angiogenesis "Ligase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Late spermatids: 6809.8;Muller glia cells: 5699.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 92.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 92.2" "Cell line enhanced" "Detected in many" "ASC diff: 141.5;ASC TERT1: 100.1;HSkMC: 86.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007316, HPA007571, CAB008636" Approved Supported "Plasma membrane,Mitochondria,Cytosol" NA NA 28000 "Mitochondria, Cytosol" "Plasma membrane" "CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980" "prognostic favorable (4.81e-4)" "unprognostic (1.52e-3)" "unprognostic (3.89e-1)" "unprognostic (3.32e-1)" "unprognostic (1.25e-1)" "unprognostic (9.52e-2)" "unprognostic (7.58e-2)" "unprognostic (1.03e-1)" "unprognostic (1.26e-1)" "unprognostic (8.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.17e-1)" "unprognostic (1.38e-2)" "unprognostic (4.17e-2)" "unprognostic (2.06e-1)" "unprognostic (5.55e-2)" "unprognostic (4.53e-3)" 173.3 19.2 83.7 37.2 91.0 47.6 63.1 48.5 80.7 41.9 20.4 49.9 9.4 6.2 20.5 29.7 54.0 31.6 26.2 23.5 74.0 48.7 15.6 64.9 39.5 36.9 71.0 48.8 66.2 49.0 7.4 8.9 41.8 70.6 17.4 23.3 39.3 30.4 25.5 159.8 27.9 16.4 30.5 51.3 36.1 71.4 24.0 55.2 8.6 63.9 15.5 24.2 34.7 32.2 2.5 11.0 92.2 21.1 3.4 6.3 18.6 3.0 1.2 14.0 0.0 141.5 100.1 10.3 5.1 16.6 3.1 2.8 7.4 3.1 2.6 5.6 9.9 2.8 7.0 6.1 36.4 2.6 7.0 17.0 34.3 5.8 14.3 7.5 15.1 27.4 86.5 43.7 3.9 46.4 4.7 6.2 8.4 28.8 1.5 11.0 1.7 23.5 14.5 10.4 4.2 6.5 8.5 3.7 4.4 5.4 13.3 9.6 6.3 1.4 18.7 2.0 11.7 18.2 19.1 4.6 0.1 0.2 0.0 1.1 0.5 0.3 0.0 2.7 8.6 0.5 43.6 21.1 54.9 6.3 20.5 2.6 1.6 4.5 5.2 11.0 2.5 2.3 3.9 92.2 3.4 17.1 6.1 1.7 18.6 83.7 91.0 48.5 80.7 74.0 48.7 71.0 48.8 70.6 55.2 116.1 193.4 39.3 480.1 119.7 83.9 198.1 163.1 242.2 133.1 78.5 49.1 126.6 63.0 92.2 1437.2 175.0 45.7 210.2 99.7 54.7 230.2 354.1 758.5 179.4 734.4 41.3 312.5 129.5 692.2 6809.8 451.3 662.6 129.9 48.7 226.1 5699.1 116.5 83.4 352.5 40.4 128.3 90.5 209.3 38.8 52.4 112.0 196.8 96.9 130.8 1061.5 GPN1 "ATPBD1A, MBDIN, NTPBP, RPAP4, XAB1" ENSG00000198522 "GPN-loop GTPase 1" Q9HCN4 2 27628247-27651508 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036793, HPA036794, CAB037303" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB037303: AB_477173, HPA036793: AB_2675318, HPA036794: AB_10672230" "unprognostic (9.42e-2)" "unprognostic (1.44e-1)" "unprognostic (5.64e-2)" "prognostic unfavorable (2.88e-5)" "unprognostic (2.57e-1)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.71e-5)" "unprognostic (3.50e-2)" "unprognostic (8.27e-3)" "unprognostic (8.93e-2)" "unprognostic (4.05e-3)" "unprognostic (2.34e-1)" "unprognostic (1.21e-2)" "unprognostic (2.51e-1)" "unprognostic (1.13e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" 24.3 24.3 18.8 18.7 23.2 28.1 26.3 22.9 27.2 18.3 21.6 20.7 13.7 19.3 21.3 21.2 26.7 21.0 18.2 21.5 17.2 22.1 29.7 29.2 18.2 29.2 20.0 16.1 24.6 35.4 19.8 18.5 31.1 23.3 18.8 25.6 14.3 23.0 17.6 30.9 25.0 25.3 22.1 16.4 26.6 20.8 30.2 15.9 29.0 26.9 22.5 28.3 21.5 24.3 29.1 35.8 28.5 28.2 39.6 38.6 29.7 32.7 18.6 17.6 12.7 16.6 17.0 17.9 18.3 18.3 26.0 19.3 20.3 17.2 20.5 17.9 20.0 24.1 14.3 24.4 22.8 26.4 19.1 17.0 23.4 15.0 24.7 21.6 34.3 12.3 17.5 20.1 26.7 25.1 18.1 27.1 18.7 29.0 19.3 30.7 19.1 20.7 25.7 30.4 25.0 18.4 20.9 52.1 21.4 21.0 18.9 15.7 24.9 20.1 22.6 20.3 17.1 13.6 19.9 22.0 22.7 33.6 11.2 42.9 22.3 24.0 55.2 32.7 29.8 18.6 28.5 24.7 21.1 33.4 28.2 36.0 29.1 31.1 38.6 35.8 25.2 27.7 34.1 3.7 39.6 26.3 18.5 30.3 29.7 18.8 23.2 22.9 27.2 17.2 22.1 20.0 16.1 23.3 15.9 11.9 7.2 7.2 18.2 19.3 7.9 9.7 17.8 10.7 14.8 14.0 3.9 36.5 19.9 46.3 69.8 14.5 10.8 0.0 31.4 38.5 20.1 18.3 24.3 8.6 29.3 11.1 16.7 15.4 18.9 67.5 13.8 19.3 21.9 33.3 13.3 12.0 35.5 10.5 10.3 15.6 9.1 12.9 20.8 26.2 22.6 16.3 27.7 33.0 19.5 16.6 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.1 25.2 0.0 33.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 44.8 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.1 13.2 0.0 0.0 5.6 0.1 0.0 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 0.0 127.1 52.7 0.0 0.0 0.0 4.0 20.5 3.5 0.0 46.3 0.0 1.3 0.1 0.2 0.0 0.0 0.6 10.3 2.1 36.4 1.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 59.6 171.4 0.0 0.0 178.7 HINT3 FLJ33126 ENSG00000111911 "Histidine triad nucleotide binding protein 3" Q9NQE9 6 125956781-125980244 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 65.8" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 260.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027914 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA "Nucleoli, Mitochondria" Cytosol "HPA027914: AB_10602424" "prognostic unfavorable (4.99e-4)" "unprognostic (4.75e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.59e-1)" "unprognostic (1.71e-1)" "unprognostic (1.74e-1)" "unprognostic (4.88e-3)" "unprognostic (3.82e-1)" "unprognostic (1.27e-1)" "unprognostic (2.18e-2)" "unprognostic (1.05e-1)" "prognostic favorable (1.05e-6)" "unprognostic (4.09e-2)" "unprognostic (4.76e-2)" "unprognostic (9.56e-2)" "unprognostic (1.64e-1)" 11.4 16.3 27.4 8.0 23.3 7.2 15.6 19.4 24.3 13.1 13.1 24.8 10.6 10.4 11.5 12.6 15.2 11.4 10.9 19.0 28.1 23.0 15.1 18.5 13.9 7.0 28.7 17.0 10.4 12.8 16.3 13.4 12.1 20.7 20.5 12.1 10.3 16.0 16.2 65.8 11.6 10.5 15.2 40.8 6.8 16.0 21.9 17.0 7.7 15.9 16.8 7.4 16.1 8.8 11.0 11.1 15.0 13.2 7.9 9.9 7.0 7.0 5.6 7.8 16.1 3.1 8.4 9.7 7.6 11.0 5.9 6.1 13.6 3.9 15.3 14.2 5.1 13.1 10.6 9.9 6.4 6.9 14.4 12.8 6.4 8.4 11.4 14.4 10.1 10.9 6.6 14.3 5.9 15.0 15.2 8.8 11.4 19.9 10.3 5.8 10.6 8.0 7.3 2.6 14.4 5.4 6.7 5.3 5.1 12.1 12.9 15.7 9.7 6.9 9.9 35.6 5.9 10.0 15.5 6.2 4.0 5.6 19.2 10.8 15.0 17.2 9.7 11.4 9.6 5.1 14.4 13.2 11.4 7.2 8.4 7.8 11.0 9.2 7.5 11.1 10.4 9.9 8.7 15.0 7.9 10.8 6.9 9.1 7.0 27.4 23.3 19.4 24.3 28.1 23.0 28.7 17.0 20.7 17.0 74.5 57.0 16.0 9.5 16.1 22.3 37.6 10.2 24.1 31.8 15.7 7.9 16.0 28.2 27.0 260.9 11.3 12.3 0.0 17.5 5.7 10.8 19.4 9.2 16.3 23.3 6.4 15.6 6.2 14.5 54.5 9.2 17.0 20.3 9.0 22.7 30.7 20.3 28.1 16.3 21.4 23.9 6.5 13.7 89.1 27.7 15.2 22.1 7.0 19.9 17.1 HNRNPLL HNRPLL ENSG00000143889 "Heterogeneous nuclear ribonucleoprotein L like" Q8WVV9 2 38561978-38603586 "Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 114.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046084 Approved Approved Nucleoplasm,Mitochondria,Cytosol No No Nucleoplasm "Mitochondria, Cytosol" "HPA046084: AB_10960895" "unprognostic (2.27e-2)" "unprognostic (1.75e-1)" "unprognostic (3.63e-2)" "unprognostic (5.18e-1)" "unprognostic (2.10e-3)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.22e-4)" "unprognostic (1.52e-2)" "unprognostic (1.52e-1)" "unprognostic (1.80e-1)" "unprognostic (4.20e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (2.25e-1)" "unprognostic (2.28e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-2)" 16.6 19.5 14.9 13.3 16.2 47.3 20.0 22.1 17.5 18.2 16.4 10.8 17.0 16.2 21.9 19.4 14.4 17.6 16.5 14.3 17.8 11.8 12.5 11.6 17.6 12.1 13.2 19.2 19.9 16.8 18.8 16.4 13.8 10.9 16.8 13.0 13.5 14.0 22.8 13.1 12.0 13.6 14.2 12.8 12.0 16.3 24.8 12.4 40.0 19.2 11.5 11.5 20.8 26.4 1.0 6.9 5.3 3.6 3.6 21.7 3.5 16.8 7.9 23.2 13.6 11.3 10.7 14.5 15.9 13.1 14.0 11.7 8.9 9.8 0.2 14.3 14.2 14.9 10.8 14.6 11.9 14.4 25.1 12.7 12.3 14.9 22.5 10.7 22.9 12.7 8.4 9.5 11.5 12.9 13.8 14.5 11.3 20.8 38.2 16.3 7.8 24.9 12.5 23.3 16.3 14.5 4.9 16.3 8.2 11.9 22.2 15.9 17.8 14.0 12.3 11.7 13.5 10.4 9.9 15.0 10.5 15.7 11.4 13.0 20.9 20.9 0.1 9.0 5.7 12.7 5.3 3.6 5.1 6.2 1.8 11.0 0.2 15.1 11.6 6.9 1.0 4.6 2.9 2.5 3.6 0.7 0.1 21.7 3.5 14.9 16.2 22.1 17.5 17.8 11.8 13.2 19.2 10.9 12.4 17.9 18.9 4.2 29.5 25.4 12.6 14.4 2.5 10.7 19.4 26.2 7.9 22.8 16.6 20.6 114.5 19.1 12.9 0.0 21.3 24.7 25.6 21.8 9.2 6.4 22.1 6.4 13.8 19.6 15.4 35.0 25.6 26.7 37.1 31.5 16.9 24.6 17.7 17.5 49.1 16.3 10.4 38.8 23.7 68.1 29.6 18.6 18.5 17.5 18.7 17.6 HSCB "DNAJC20, HSC20, Jac1" ENSG00000100209 "HscB mitochondrial iron-sulfur cluster cochaperone" Q8IWL3 22 28742031-28757515 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018447, HPA031518" Uncertain Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA018447: AB_1853867, HPA031518: AB_2673919" "unprognostic (8.19e-3)" "unprognostic (6.48e-2)" "unprognostic (9.62e-3)" "prognostic favorable (3.78e-4)" "unprognostic (3.30e-1)" "unprognostic (7.02e-2)" "unprognostic (1.15e-1)" "unprognostic (2.53e-2)" "unprognostic (5.83e-2)" "unprognostic (7.38e-3)" "unprognostic (4.44e-1)" "unprognostic (2.81e-1)" "unprognostic (1.54e-3)" "unprognostic (2.19e-1)" "unprognostic (3.39e-1)" "unprognostic (2.12e-1)" "prognostic favorable (8.38e-4)" 9.6 18.8 13.1 9.2 13.9 4.9 12.4 13.7 12.9 14.1 11.6 9.1 20.3 13.7 11.5 8.8 11.8 10.4 11.4 9.6 12.3 8.3 12.9 29.5 7.3 15.5 15.8 9.0 16.5 15.2 6.2 16.1 8.7 10.6 15.9 7.7 8.2 28.2 17.5 14.6 9.2 10.0 8.9 12.2 10.9 12.8 6.0 13.2 6.9 14.4 8.1 10.3 15.0 10.5 12.9 11.3 7.7 14.4 9.7 8.5 5.8 9.3 6.0 2.5 3.8 4.6 11.8 4.8 6.9 9.7 10.3 6.3 2.6 3.4 10.6 3.3 3.8 2.5 6.6 4.8 4.5 4.9 10.0 19.5 3.6 4.7 7.4 9.8 6.6 5.4 7.9 9.9 5.7 9.0 5.3 7.8 3.2 5.6 9.3 4.1 13.5 3.0 6.1 6.0 10.3 14.8 6.0 7.8 11.9 11.1 2.7 8.5 7.7 3.8 14.6 18.4 2.1 6.0 4.1 4.1 14.1 7.4 13.3 6.2 13.1 10.7 9.1 9.9 4.9 9.3 7.7 7.9 3.6 6.3 14.4 7.6 12.9 6.4 7.4 11.3 9.9 7.0 8.5 0.4 9.7 11.0 5.9 4.8 5.8 13.1 13.9 13.7 12.9 12.3 8.3 15.8 9.0 10.6 13.2 20.8 15.8 20.1 22.7 10.3 4.8 6.0 22.9 32.1 26.1 19.2 5.9 13.2 24.9 21.9 3.3 15.8 10.3 0.0 24.7 12.0 16.6 18.9 22.0 33.0 23.7 4.8 19.0 17.2 14.9 2.6 17.3 18.5 13.5 19.8 13.1 9.7 21.0 7.0 11.0 37.1 8.1 6.5 15.6 12.2 16.1 13.7 11.1 17.8 19.7 12.8 HSDL1 SDR12C3 ENSG00000103160 "Hydroxysteroid dehydrogenase like 1" Q3SXM5 16 84122146-84145192 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 42.9;Rod photoreceptor cells: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045745 Supported "Vesicles,Intermediate filaments,Mitochondria" No No Mitochondria "Vesicles, Intermediate filaments" "HPA045745: AB_2679440" "unprognostic (2.16e-1)" "unprognostic (4.32e-2)" "unprognostic (2.09e-1)" "unprognostic (4.80e-3)" "unprognostic (3.66e-2)" "unprognostic (1.68e-1)" "prognostic unfavorable (3.50e-4)" "unprognostic (1.25e-2)" "unprognostic (7.43e-2)" "unprognostic (3.39e-2)" "unprognostic (6.42e-2)" "unprognostic (3.66e-1)" "prognostic favorable (4.20e-7)" "unprognostic (2.30e-1)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (1.14e-2)" 6.0 13.4 16.9 5.6 22.1 3.1 10.2 16.5 18.7 9.7 5.8 9.0 6.7 5.1 11.3 9.4 6.7 11.1 6.0 13.1 14.5 19.5 9.1 4.1 7.6 6.8 11.5 13.2 19.6 4.3 12.6 16.7 7.6 20.8 8.6 6.1 10.5 6.3 10.0 15.2 6.5 4.9 9.4 7.4 7.0 5.3 13.5 8.7 8.6 23.2 5.0 7.5 6.6 6.2 7.4 3.1 14.5 6.6 4.2 6.5 4.4 5.6 6.6 30.5 10.4 11.1 8.0 7.7 7.3 6.9 9.2 4.9 7.3 9.8 11.7 13.1 6.5 10.1 4.0 16.4 6.3 14.6 2.5 10.0 5.6 4.4 16.7 11.6 8.7 10.2 6.1 10.7 12.9 8.3 11.7 10.9 16.0 11.6 14.8 18.1 14.0 18.9 8.7 15.5 3.3 6.9 18.6 10.7 4.3 8.8 6.2 14.4 10.9 18.2 2.9 19.9 16.0 18.2 5.1 9.3 10.4 12.6 7.4 5.8 23.5 18.6 19.1 12.2 6.3 9.4 14.5 5.2 11.7 4.4 3.8 5.6 5.4 4.7 5.2 3.1 7.4 6.1 6.5 6.2 4.2 6.6 0.0 5.6 4.4 16.9 22.1 16.5 18.7 14.5 19.5 11.5 13.2 20.8 8.7 11.9 13.1 5.1 4.6 4.2 18.8 14.1 2.5 10.7 7.9 3.5 13.7 5.9 5.0 6.5 24.6 5.7 2.9 0.0 6.0 4.8 5.4 4.7 1.1 2.9 10.4 42.9 9.1 7.4 6.3 8.8 5.5 5.3 5.0 2.8 3.0 22.6 5.7 2.9 9.6 6.2 38.1 0.0 5.2 27.0 27.0 6.0 7.3 6.7 4.1 3.3 ICAM3 "CD50, CDW50, ICAM-R" ENSG00000076662 "Intercellular adhesion molecule 3" P32942 19 10333776-10339823 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 138.5;Hepatocytes: 150.6;Kupffer cells: 110.3;T-cells: 189.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 172.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 172.3" "Cell line enhanced" "Detected in many" "Karpas-707: 65.6;NB-4: 42.3;RPMI-8226: 49.2;U-266/84: 34.9;U-937: 34.5" "CAB002498, HPA049820" Enhanced Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA 370000000 Mitochondria "Nucleoplasm, Nuclear membrane" "CAB002498: AB_563593, HPA049820: AB_2680897" "unprognostic (6.85e-4)" "unprognostic (5.28e-3)" "unprognostic (3.09e-3)" "unprognostic (1.57e-2)" "unprognostic (5.34e-3)" "unprognostic (5.79e-6)" "unprognostic (5.05e-3)" "unprognostic (3.73e-2)" "unprognostic (1.73e-3)" "unprognostic (7.93e-2)" "unprognostic (3.45e-2)" "unprognostic (2.54e-1)" "unprognostic (5.62e-4)" "unprognostic (1.13e-1)" "unprognostic (1.06e-2)" "unprognostic (3.43e-1)" "unprognostic (1.84e-1)" 6.8 2.8 1.7 23.5 1.9 51.5 5.5 0.6 1.5 3.0 6.8 1.1 1.2 4.3 1.7 3.0 4.0 2.9 7.2 6.4 1.1 0.9 5.1 28.7 13.2 68.5 1.8 1.4 1.7 6.8 0.2 0.4 4.8 1.5 2.8 3.3 2.4 10.3 1.3 5.0 1.6 11.9 1.8 1.0 39.4 5.4 1.4 1.0 47.6 3.0 5.7 38.4 4.5 4.9 25.5 28.4 172.3 33.5 31.0 41.0 43.1 2.7 1.3 1.0 3.0 1.6 1.3 1.7 1.7 1.1 1.4 1.2 1.1 1.8 0.0 5.8 1.5 0.0 1.1 0.0 1.2 0.4 20.3 0.8 5.2 1.2 5.1 0.8 18.7 21.1 1.1 1.0 1.6 0.6 1.5 0.6 10.9 2.8 65.6 1.6 5.5 2.4 42.3 0.7 6.9 9.2 1.5 0.6 49.2 1.4 2.4 0.3 1.3 1.4 4.6 3.7 0.5 4.0 5.3 1.1 6.5 0.5 7.1 1.6 3.2 34.9 7.8 4.6 34.5 5.0 15.3 33.1 72.0 33.8 24.4 41.0 25.5 32.7 31.2 28.4 23.9 29.3 27.4 172.3 31.0 33.5 4.8 36.9 43.1 1.7 1.9 0.6 1.5 1.1 0.9 1.8 1.4 1.5 1.0 3.0 43.3 138.5 7.1 7.2 0.1 0.0 25.5 9.4 4.5 5.2 0.0 10.4 53.0 13.7 4.2 18.0 53.5 0.0 30.7 20.6 13.1 14.3 30.0 150.6 21.1 1.6 5.2 26.4 110.3 7.2 5.8 19.9 52.3 12.6 29.1 1.5 17.7 45.3 3.9 54.2 1.2 0.0 13.3 0.5 0.9 7.3 3.9 189.2 31.2 8.4 IFT57 "ESRRBL1, FLJ10147, HIPPI, MHS4R2" ENSG00000114446 "Intraflagellar transport 57" Q9NWB7 3 108160812-108222570 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" DNA-binding Ciliopathy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 14 "Ciliated cells: 679.9;Early spermatids: 1393.1;Late spermatids: 2088.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 22.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035514, HPA035515" Supported Approved "Nuclear speckles,Mitochondria,Cytosol" NA NA "Nuclear speckles" "Mitochondria, Cytosol" "HPA035514: AB_10601757, HPA035515: AB_10696505" "unprognostic (1.35e-2)" "unprognostic (1.37e-2)" "prognostic favorable (6.96e-5)" "unprognostic (2.98e-2)" "unprognostic (5.46e-3)" "unprognostic (1.02e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (3.59e-2)" "prognostic favorable (7.63e-4)" "unprognostic (5.04e-2)" "unprognostic (2.78e-1)" "unprognostic (1.68e-3)" "unprognostic (1.86e-1)" "unprognostic (4.70e-2)" "unprognostic (8.67e-3)" "unprognostic (6.12e-2)" 8.5 13.1 9.4 12.1 11.0 8.8 10.4 5.5 16.4 13.3 10.9 6.3 15.7 5.0 11.8 36.3 11.6 24.8 11.6 12.1 9.2 11.2 19.7 3.7 34.3 12.2 9.1 9.9 21.6 13.4 16.4 30.6 6.2 13.5 21.9 11.6 9.4 8.2 16.0 5.7 7.1 9.4 13.1 6.2 14.3 10.0 38.6 5.6 8.3 31.3 7.4 12.2 14.1 9.1 22.4 5.8 1.8 6.7 3.6 4.7 2.9 18.6 9.7 7.0 12.5 14.7 15.3 3.9 5.7 14.0 8.5 7.6 6.6 3.3 21.1 7.4 9.5 12.2 7.5 6.2 9.6 14.5 3.3 6.7 7.2 4.3 1.7 11.0 14.9 16.7 9.2 8.9 10.9 19.1 13.5 9.5 3.7 3.3 3.8 9.7 10.4 5.0 13.7 7.5 1.4 11.6 3.2 6.3 3.6 17.4 6.8 11.7 8.1 8.6 2.8 5.2 4.1 6.1 4.6 4.0 10.9 5.6 5.7 6.7 4.5 3.2 11.1 15.8 1.5 4.0 0.1 2.1 1.8 2.2 3.6 3.6 22.4 4.7 2.8 5.8 18.6 4.1 2.3 1.1 3.6 6.7 1.2 2.9 2.9 9.4 11.0 5.5 16.4 9.2 11.2 9.1 9.9 13.5 5.6 437.7 206.1 73.5 89.1 36.5 19.9 27.8 48.4 679.9 320.8 48.8 64.8 19.7 99.5 136.8 1393.1 36.5 31.6 23.3 116.3 16.0 63.9 111.6 42.8 4.9 12.7 27.0 54.9 30.7 7.3 2088.2 60.4 26.4 43.9 5.4 28.2 42.9 82.4 31.7 60.5 97.1 66.9 51.8 57.7 146.9 42.2 32.5 12.5 26.6 47.6 75.8 ILF3 "DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1" ENSG00000129351 "Interleukin enhancer binding factor 3" Q12906 19 10654261-10692417 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001897 Supported Enhanced Nucleoplasm,Nucleoli,Mitochondria No No 1100000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA001897: AB_1078703" "unprognostic (2.39e-1)" "unprognostic (9.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (7.53e-2)" "unprognostic (5.55e-3)" "unprognostic (1.11e-3)" "unprognostic (2.96e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.45e-2)" "unprognostic (1.04e-1)" "unprognostic (4.38e-2)" "prognostic unfavorable (9.65e-4)" "unprognostic (7.57e-3)" "unprognostic (7.61e-2)" "unprognostic (1.03e-1)" "unprognostic (6.20e-2)" 31.0 39.0 29.6 45.5 26.8 88.2 34.5 48.3 35.2 34.2 30.2 30.8 35.2 30.3 45.4 31.7 40.5 41.9 32.5 34.0 25.5 20.0 28.1 25.6 34.1 44.9 24.7 27.8 52.8 36.8 34.9 34.9 31.8 32.3 34.9 27.3 35.5 35.1 46.2 50.1 37.7 37.2 33.2 33.3 44.5 32.6 54.3 28.0 58.6 43.4 32.4 41.1 38.5 32.1 18.7 18.7 11.5 14.3 15.4 19.4 8.0 45.7 37.3 60.4 55.2 13.1 18.0 35.2 29.3 24.9 49.2 38.6 42.7 26.6 57.2 29.1 26.3 30.1 41.0 65.2 39.6 44.4 36.5 58.0 74.2 32.9 39.8 18.8 53.4 37.1 17.0 17.7 39.0 43.8 18.8 42.0 33.4 63.3 45.0 28.6 37.7 88.5 85.8 72.5 24.2 41.0 65.2 57.5 39.5 19.6 48.6 66.7 48.5 37.7 30.0 21.8 28.6 25.4 34.3 33.7 40.4 38.4 41.8 57.7 38.6 52.8 69.4 22.6 57.1 43.5 11.5 13.4 7.1 19.4 10.4 16.1 14.7 15.9 17.3 16.8 18.7 15.7 16.0 2.1 15.4 14.3 18.7 15.0 8.0 29.6 26.8 48.3 35.2 25.5 20.0 24.7 27.8 32.3 28.0 92.3 128.4 63.8 84.3 76.5 92.4 59.0 50.9 96.4 131.9 40.1 80.5 65.6 23.2 66.6 12.8 60.9 40.0 46.7 69.0 90.4 57.8 80.9 92.6 46.1 63.0 89.0 109.3 33.7 53.5 14.4 70.8 66.0 37.1 46.9 68.0 70.5 72.3 56.1 58.7 38.2 92.6 32.3 67.0 108.6 117.8 67.2 59.3 68.2 82.6 87.0 INTS6L "DDX26B, FLJ41215" ENSG00000165359 "Integrator complex subunit 6 like" Q5JSJ4 X 135520643-135582510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.2;Ciliated cells: 12.0;Club cells: 6.8;granulocytes: 23.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 16.5;U-937: 15.3" "HPA001552, HPA013200, HPA013335, HPA030747" Uncertain Approved "Nuclear bodies,Centrosome,Mitochondria" NA NA Centrosome "Nuclear bodies, Mitochondria" "HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589" "unprognostic (2.03e-1)" "prognostic favorable (5.39e-4)" "unprognostic (1.96e-1)" "unprognostic (7.42e-2)" "unprognostic (2.89e-2)" "unprognostic (1.43e-3)" "unprognostic (1.43e-1)" "unprognostic (1.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.33e-3)" "prognostic favorable (5.54e-4)" "unprognostic (1.05e-2)" "prognostic unfavorable (4.28e-8)" "unprognostic (2.87e-1)" "unprognostic (1.81e-1)" "unprognostic (5.37e-2)" "prognostic favorable (2.94e-4)" 4.2 9.8 5.5 10.6 6.7 15.4 5.4 22.6 6.1 8.4 7.8 7.4 3.8 3.6 7.8 4.6 6.4 8.6 6.6 5.9 4.8 3.2 4.4 1.7 5.6 15.6 6.8 6.2 11.5 2.9 3.7 11.5 4.5 6.5 6.5 10.0 5.3 18.2 7.9 1.5 8.3 9.3 5.4 4.9 13.3 4.5 9.7 10.4 17.8 4.6 2.8 15.0 8.6 7.5 5.5 3.6 2.2 2.7 2.7 9.0 4.0 0.1 0.0 6.2 7.2 1.8 2.1 0.0 1.5 3.2 1.8 5.6 0.6 2.6 6.2 5.3 1.3 4.5 4.6 7.0 2.0 1.4 4.6 2.5 5.2 0.5 0.0 1.6 5.3 0.4 2.8 2.0 2.1 2.1 3.2 2.3 4.1 3.3 9.8 1.3 4.5 5.2 16.5 2.9 6.4 2.6 4.3 2.2 5.0 1.5 2.5 1.0 2.3 2.1 2.1 0.2 2.8 2.2 10.0 1.3 4.8 2.7 0.0 1.7 11.3 8.9 9.2 1.6 15.3 0.9 0.0 2.5 2.2 5.1 2.2 6.1 5.5 5.8 5.9 3.6 4.9 9.0 5.8 1.6 2.7 2.7 3.5 3.1 4.0 5.5 6.7 22.6 6.1 4.8 3.2 6.8 6.2 6.5 10.4 11.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 12.0 6.8 3.5 0.0 1.5 0.0 1.1 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 23.3 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 ISL1 "Isl-1, ISLET1" ENSG00000016082 "ISL LIM homeobox 1" P61371 5 51383391-51394738 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 30.3" "Cell type enhanced" "Detected in many" 17 "Bipolar cells: 118.7;Horizontal cells: 41.3;Intestinal endocrine cells: 87.9;Syncytiotrophoblasts: 28.6" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Group enriched" "Detected in some" 5 "basal ganglia: 4.0;hypothalamus: 5.5;pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 82.3" "Group enriched" "Detected in some" 8 "basal ganglia: 13.8;hypothalamus: 17.5;thalamus: 6.5" "Group enriched" "Detected in some" 11 "basal ganglia: 8.5;hypothalamus: 8.6" "HPA048613, HPA057416" Approved Approved "Nucleoplasm,Nuclear speckles,Mitochondria" NA NA Nucleoplasm "Nuclear speckles, Mitochondria" "HPA048613: , HPA057416: AB_2683431" "unprognostic (4.97e-2)" "unprognostic (2.22e-2)" "unprognostic (1.69e-1)" "unprognostic (2.41e-3)" "unprognostic (5.52e-2)" "unprognostic (6.79e-2)" "unprognostic (9.21e-2)" "unprognostic (9.42e-2)" "unprognostic (5.55e-3)" "unprognostic (1.77e-1)" "unprognostic (1.48e-1)" "unprognostic (2.48e-1)" "unprognostic (9.11e-3)" "unprognostic (4.39e-3)" 2.2 1.5 0.0 0.0 4.0 0.0 0.1 0.0 0.2 14.4 1.6 0.0 4.2 2.3 1.3 0.5 0.2 0.0 0.2 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.4 0.0 2.8 10.0 2.0 13.2 2.5 6.4 1.0 30.3 0.1 1.1 0.7 0.6 0.1 0.0 10.7 1.6 0.7 3.1 0.3 0.2 0.4 2.4 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.8 1.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.6 1.2 0.9 0.0 0.0 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.8 0.0 0.8 0.0 0.0 0.0 5.3 82.3 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.0 0.0 0.2 0.0 5.5 0.0 0.0 2.0 0.7 0.0 0.0 0.0 3.5 1.3 118.7 0.3 0.0 0.0 0.0 0.0 3.9 20.5 0.0 0.0 13.2 0.1 0.0 0.0 0.0 8.9 0.4 1.2 0.0 0.0 2.3 41.3 87.9 0.0 0.0 2.7 0.3 0.0 0.0 0.0 0.6 3.4 6.8 0.0 0.0 0.0 11.3 0.0 0.1 0.7 0.7 0.9 28.6 0.0 0.0 3.7 LETMD1 "HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3" ENSG00000050426 "LETM1 domain containing 1" Q6P1Q0 12 51047962-51060424 "Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074361 Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Mitochondria "Nucleoplasm, Nucleoli" "HPA074361: AB_2686682" "unprognostic (2.16e-1)" "unprognostic (1.47e-1)" "unprognostic (1.08e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (2.11e-1)" "unprognostic (2.20e-2)" "unprognostic (3.05e-3)" "unprognostic (1.48e-2)" "unprognostic (5.05e-2)" "unprognostic (7.86e-2)" "unprognostic (6.57e-2)" "prognostic favorable (3.26e-4)" "unprognostic (4.07e-1)" "unprognostic (7.79e-2)" "unprognostic (2.58e-1)" "prognostic favorable (3.16e-4)" 25.7 27.5 23.0 18.1 31.2 17.1 27.1 23.1 37.5 18.6 26.8 18.8 21.5 31.9 22.9 22.4 16.2 30.0 23.5 16.4 21.2 19.0 29.3 35.1 16.6 18.5 20.6 21.3 34.3 38.6 28.5 20.2 12.3 21.6 19.1 26.1 22.6 28.2 24.0 23.8 18.5 28.5 18.7 21.4 17.5 22.6 15.5 14.3 19.9 34.1 10.7 20.1 20.3 14.8 11.3 7.2 2.9 11.6 8.6 17.1 9.3 7.4 6.7 5.0 13.5 22.8 37.4 5.1 7.7 12.8 8.1 9.2 16.2 15.4 19.7 9.6 8.3 5.9 13.9 10.3 10.4 9.4 7.1 12.9 14.1 9.3 12.7 15.1 12.7 10.3 31.5 33.7 9.6 22.8 24.8 8.2 19.1 14.6 14.3 11.1 11.6 8.9 12.3 3.4 9.3 18.3 7.6 6.1 10.7 10.2 11.4 15.0 6.9 5.8 13.1 17.6 5.3 20.7 11.6 6.2 5.1 5.5 8.4 4.4 13.0 20.2 8.4 9.5 8.3 3.6 2.5 7.3 2.9 8.6 7.8 12.5 11.3 14.2 10.6 7.2 8.1 17.1 15.5 2.4 8.6 11.6 6.4 12.6 9.3 23.0 31.2 23.1 37.5 21.2 19.0 20.6 21.3 21.6 14.3 20.8 22.7 30.4 41.1 44.1 20.2 12.5 22.9 25.4 11.4 22.7 9.8 40.0 77.9 12.6 6.3 19.6 22.0 23.3 28.4 18.9 32.4 29.0 25.3 16.3 26.2 17.5 26.7 20.3 41.0 11.9 30.2 21.2 37.1 17.2 34.4 24.4 16.0 28.1 28.7 31.5 16.5 25.8 38.1 20.6 19.4 38.8 23.3 42.4 49.8 24.8 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.2 0.1 1.3 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.8 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.3 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 31.4 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 LRP12 "FLJ12929, ST7" ENSG00000147650 "LDL receptor related protein 12" Q9Y561 8 104489231-104589024 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "basophil: 22.6" "Lineage enriched" "Detected in many" 22 "granulocytes: 22.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017245 Uncertain Approved "Nucleoli fibrillar center,Plasma membrane,Mitochondria" NA NA "Nucleoli fibrillar center, Plasma membrane, Mitochondria" "HPA017245: AB_1857532" "unprognostic (2.17e-1)" "unprognostic (6.80e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.67e-4)" "unprognostic (2.07e-1)" "unprognostic (2.15e-3)" "unprognostic (4.87e-4)" "unprognostic (2.96e-2)" "unprognostic (3.96e-1)" "unprognostic (4.59e-2)" "unprognostic (1.32e-1)" "unprognostic (3.39e-2)" "unprognostic (9.89e-2)" "unprognostic (7.56e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-1)" "unprognostic (4.05e-3)" 6.1 5.3 10.7 4.0 23.4 2.1 4.7 11.3 16.3 7.4 5.1 4.3 5.1 3.3 18.2 4.5 4.6 6.9 8.1 14.2 8.7 6.5 7.2 1.6 4.8 1.6 4.6 9.5 6.9 5.4 13.0 11.0 5.6 7.1 7.4 5.3 3.3 5.0 6.8 11.8 5.1 3.1 20.2 4.1 3.8 3.8 5.0 5.2 18.0 7.4 3.4 2.4 6.2 5.4 0.0 0.3 22.6 0.4 0.4 1.0 0.2 7.3 4.3 8.8 15.4 10.0 8.0 1.9 21.1 21.2 7.4 10.4 0.9 7.3 0.0 8.5 19.9 8.9 3.3 3.6 9.0 15.9 13.7 3.4 11.5 2.0 0.3 6.2 0.1 9.3 10.6 6.4 12.3 10.1 26.8 3.8 9.0 2.4 0.0 26.4 1.2 10.5 0.2 2.2 0.6 7.5 0.8 8.6 1.6 5.9 0.3 11.3 6.9 6.7 0.3 18.0 6.9 2.0 2.2 10.5 20.4 13.2 6.5 13.6 10.0 7.8 0.0 11.0 0.0 22.3 22.6 0.2 3.5 0.1 0.4 1.0 0.0 0.7 0.0 0.1 0.0 0.2 0.1 0.1 0.4 0.3 0.3 0.0 0.2 10.7 23.4 11.3 16.3 8.7 6.5 4.6 9.5 7.1 5.2 14.9 2.1 0.0 5.3 10.2 16.6 9.8 7.6 4.0 3.4 14.0 5.9 0.2 0.0 3.9 3.3 6.7 0.8 0.0 3.9 0.3 9.4 5.6 8.1 0.5 5.1 27.0 13.8 3.7 7.3 1.6 8.1 4.8 6.8 8.2 2.3 4.8 4.4 0.0 8.5 2.9 7.4 6.5 9.0 7.2 11.0 9.5 0.2 4.9 1.7 4.3 LRP4 "CLSS, LRP-4, MEGF7, SOST2" ENSG00000134569 "LDL receptor related protein 4" O75096 11 46856868-46918642 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Endocytosis, Wnt signaling pathway" "Developmental protein, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;skin 1: 33.0" "Cell type enriched" "Detected in many" 4 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 17.0;SuSa: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011934, HPA012300" Approved Uncertain Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Nucleoli, Mitochondria" "HPA011934: AB_1853286, HPA012300: AB_1853288" "unprognostic (1.46e-1)" "unprognostic (4.07e-2)" "unprognostic (2.86e-1)" "unprognostic (1.33e-2)" "unprognostic (4.39e-2)" "unprognostic (9.73e-3)" "unprognostic (5.29e-4)" "unprognostic (8.61e-2)" "unprognostic (2.29e-2)" "unprognostic (2.77e-1)" "unprognostic (1.92e-1)" "unprognostic (1.33e-1)" "unprognostic (7.59e-2)" "unprognostic (7.95e-2)" "unprognostic (2.76e-2)" "unprognostic (9.90e-3)" "unprognostic (6.79e-2)" 1.2 1.9 16.0 1.3 20.3 0.5 2.1 7.3 23.7 3.0 5.4 11.6 0.6 3.9 2.1 1.3 2.4 2.0 2.5 7.2 20.4 5.8 1.2 0.7 3.4 0.5 9.6 12.6 5.4 2.7 9.3 3.3 3.1 14.5 2.7 4.1 1.3 2.1 3.0 4.4 33.0 5.3 2.0 9.7 4.2 9.6 1.6 19.0 0.0 2.9 1.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.5 17.0 5.2 10.6 2.9 3.9 0.7 1.5 2.3 2.5 2.2 0.0 0.0 1.1 8.7 2.4 3.0 9.5 5.8 1.8 0.0 7.9 0.8 3.0 5.2 2.2 0.1 1.5 3.6 3.4 3.5 0.9 2.0 1.9 2.1 0.7 0.0 1.3 0.6 0.1 0.2 9.2 0.0 0.7 1.2 5.8 0.0 0.2 2.2 0.0 11.2 0.9 0.0 2.8 13.6 0.2 0.4 0.1 4.6 2.9 5.2 1.6 0.0 0.0 0.3 3.4 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 20.3 7.3 17.3 20.4 5.8 9.6 12.6 14.5 19.0 0.0 3.4 0.0 2.5 7.2 0.4 4.8 0.0 0.0 2.3 1.8 39.3 1.8 1.7 0.0 0.4 0.7 6.3 0.0 0.3 0.4 4.3 0.3 4.7 0.0 0.2 0.0 0.0 1.3 0.0 0.0 1.7 0.0 1.7 1.0 2.2 8.7 0.5 2.3 1.1 0.2 2.6 0.0 1.2 0.1 0.7 9.5 1.1 0.0 1.8 0.7 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 131.5;Late spermatids: 330.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" No No Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623" "unprognostic (4.84e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 9.1 9.5 7.5 5.3 12.7 7.4 7.3 12.7 15.4 7.7 10.4 8.1 6.1 15.8 6.9 7.6 9.9 5.0 8.8 10.8 7.5 6.5 17.7 42.3 6.2 6.3 6.9 8.4 5.8 18.1 9.1 10.8 5.9 9.8 6.3 9.5 9.3 8.6 6.9 18.0 12.1 18.2 7.8 6.7 6.3 9.1 24.1 5.2 17.7 7.4 8.2 8.6 7.9 7.3 4.8 6.0 21.8 6.9 3.4 7.0 4.2 2.9 7.1 7.1 9.1 10.2 14.4 3.0 3.1 8.7 5.3 6.3 5.5 6.3 5.9 5.7 7.3 6.6 6.5 5.1 9.8 7.8 3.6 7.5 4.0 3.3 5.5 9.0 3.9 6.5 8.5 13.6 5.0 10.0 12.0 16.7 9.5 3.5 5.9 11.0 5.6 10.6 6.5 2.9 22.4 2.5 6.5 6.0 5.3 11.3 9.3 3.2 4.1 7.3 4.0 11.4 11.2 6.2 7.4 6.0 5.2 3.6 4.0 6.0 12.1 16.7 3.6 6.7 3.8 9.7 15.6 6.9 21.8 5.5 5.5 4.3 4.8 5.2 5.7 6.0 4.1 4.8 4.1 3.6 3.4 5.3 5.0 7.0 4.2 7.5 12.7 12.7 15.4 7.5 6.5 6.9 8.4 9.8 5.2 14.9 2.6 9.7 11.4 12.2 20.0 13.3 10.2 10.7 6.8 10.4 21.6 15.0 23.2 11.2 131.5 10.5 25.7 23.3 25.7 18.2 9.3 9.5 2.3 32.1 16.9 20.6 8.7 11.1 19.8 330.3 11.8 8.6 13.5 17.2 15.4 14.3 13.6 20.1 8.1 54.9 19.0 0.0 12.0 42.3 35.8 13.8 10.9 15.0 13.6 11.9 MBTPS2 "KFSD, S2P" ENSG00000012174 "Membrane bound transcription factor peptidase, site 2" O43462 X 21839636-21885424 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Hydrolase, Metalloprotease, Protease" "Disease mutation, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005494, CAB009486" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009486: AB_2140370, HPA005494: AB_1079329" "unprognostic (7.97e-3)" "unprognostic (9.12e-2)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (2.65e-1)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (7.22e-2)" "unprognostic (3.32e-1)" "unprognostic (9.30e-2)" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (8.38e-2)" "unprognostic (7.76e-2)" "unprognostic (1.07e-1)" "unprognostic (3.61e-1)" "unprognostic (3.05e-2)" 12.0 17.4 9.3 7.2 13.9 2.5 12.7 20.8 18.5 11.8 9.3 13.4 6.9 7.6 14.7 9.1 9.3 10.9 10.1 11.6 9.9 10.7 13.9 26.0 8.6 6.6 10.6 13.0 18.7 12.2 17.9 15.6 22.3 17.4 15.7 9.1 12.4 14.1 13.1 14.5 8.2 8.1 14.6 14.6 7.5 9.1 6.9 7.0 7.1 13.1 7.4 6.7 11.4 9.1 3.9 6.9 1.5 4.8 4.6 5.9 3.3 8.9 18.6 8.9 9.1 11.3 14.0 4.3 13.3 13.6 12.7 11.1 7.4 12.3 7.8 6.9 14.2 24.8 8.4 12.3 7.6 15.7 5.8 9.8 3.8 11.8 6.1 15.5 8.2 3.8 13.2 8.3 19.1 14.1 12.9 9.7 4.6 10.6 8.7 14.4 5.6 3.3 4.3 8.3 4.7 13.8 4.2 16.6 8.7 8.8 4.6 2.2 18.3 18.7 11.9 16.4 12.4 15.9 7.1 11.5 16.0 3.7 23.2 9.9 10.7 13.5 3.8 17.8 3.4 15.3 0.1 4.3 1.5 4.5 4.8 4.2 3.9 3.5 4.1 6.9 3.8 4.7 5.6 0.5 4.6 4.8 4.8 5.9 3.3 9.3 13.9 20.8 18.5 9.9 10.7 10.6 13.0 17.4 7.0 8.9 7.8 3.0 3.4 4.8 11.7 12.0 7.6 10.7 6.8 7.0 17.7 5.6 0.0 5.1 0.3 4.6 3.3 0.0 7.7 5.4 8.9 6.6 10.4 16.1 8.0 28.6 2.4 10.4 9.5 0.9 9.8 4.4 10.1 3.6 3.3 7.7 5.3 3.1 12.4 7.5 14.0 0.0 6.9 2.8 1.7 2.4 4.0 4.3 4.2 4.1 MCUB "CCDC109B, FLJ20647" ENSG00000005059 "Mitochondrial calcium uniporter dominant negative beta subunit" Q9NWR8 4 109560205-109688726 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 39.3;lymphoid tissue: 45.3" "Cell type enhanced" "Detected in some" 9 "Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048776 Enhanced Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Vesicles, Mitochondria" "HPA048776: AB_2680518" "unprognostic (6.12e-3)" "unprognostic (1.70e-2)" "unprognostic (3.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.42e-1)" "unprognostic (1.70e-1)" "unprognostic (1.70e-2)" "unprognostic (3.06e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-2)" "unprognostic (1.26e-3)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.35e-6)" "unprognostic (2.48e-1)" "unprognostic (5.21e-2)" "unprognostic (1.21e-1)" "unprognostic (1.42e-2)" 11.6 2.2 4.1 21.0 3.2 8.3 16.6 0.4 3.7 8.2 4.9 4.6 1.4 3.5 12.3 5.5 9.2 6.3 7.3 14.9 4.5 4.7 3.9 2.1 7.8 44.2 3.5 2.6 7.5 2.1 2.3 5.1 9.9 6.5 5.4 6.1 4.1 6.5 2.2 4.3 7.6 8.8 8.4 8.5 13.8 4.2 3.6 1.9 45.3 4.7 9.5 24.8 7.3 9.0 14.0 15.7 1.1 16.0 20.0 39.3 25.7 10.4 4.5 2.5 12.8 2.8 7.4 9.7 9.0 5.5 9.9 8.9 0.2 8.5 36.7 1.9 7.7 5.5 3.0 9.4 5.5 8.8 23.3 7.4 4.4 5.0 0.6 4.9 8.9 0.1 4.7 1.5 6.0 5.1 7.0 13.2 13.6 1.3 23.4 7.5 12.8 20.4 0.1 11.6 1.8 6.5 7.8 19.4 4.1 11.6 4.6 10.3 4.5 9.7 28.9 3.0 2.1 3.6 0.4 9.4 3.9 5.1 20.6 15.6 9.1 6.3 8.9 12.0 1.9 2.7 0.0 16.0 0.2 6.3 9.7 9.0 13.5 26.7 19.0 15.7 14.0 39.3 22.2 1.1 20.0 7.2 11.0 22.4 25.7 4.1 3.2 0.4 3.7 4.5 4.7 3.5 2.6 6.5 1.9 8.9 6.9 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.5 5.2 0.0 107.3 0.0 22.4 0.0 0.0 0.0 0.0 99.3 82.0 0.0 0.0 1.1 0.0 95.7 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 25.2 0.0 0.0 50.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 61.4 0.0 0.0 0.0 METTL25 "C12orf26, FLJ22789" ENSG00000127720 "Methyltransferase like 25" Q8N6Q8 12 82358497-82479236 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039534, HPA041207" Uncertain Uncertain "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane, Mitochondria, Cytosol" "HPA039534: AB_10794749, HPA041207: AB_10794406" "unprognostic (1.60e-2)" "unprognostic (3.36e-3)" "unprognostic (2.06e-2)" "unprognostic (4.15e-2)" "unprognostic (1.56e-1)" "unprognostic (3.15e-1)" "unprognostic (5.73e-3)" "unprognostic (1.21e-2)" "unprognostic (5.20e-2)" "unprognostic (6.66e-2)" "unprognostic (7.00e-3)" "unprognostic (2.15e-2)" "unprognostic (2.59e-3)" "unprognostic (1.48e-1)" "unprognostic (1.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.44e-2)" 8.3 9.2 8.7 8.5 8.1 5.0 11.1 23.6 8.3 8.2 7.7 8.1 9.0 7.5 8.2 9.1 10.0 8.0 5.8 8.7 9.1 3.1 8.8 6.3 6.5 8.1 7.6 5.7 10.8 6.5 7.8 25.9 6.8 7.6 8.0 9.2 5.8 10.5 6.0 10.7 9.7 8.2 7.5 5.8 8.6 6.7 11.0 13.0 9.9 10.2 8.7 7.4 8.8 8.5 7.9 13.2 14.4 7.6 9.8 7.6 3.8 1.4 3.3 4.5 0.9 5.1 6.0 4.6 7.0 4.0 3.7 2.7 4.3 3.9 8.6 1.5 5.1 0.9 1.5 8.9 1.1 2.4 8.2 7.5 4.1 1.8 4.1 3.1 7.2 5.0 4.4 4.2 1.2 0.0 7.3 7.6 3.1 3.1 3.9 3.8 4.9 3.1 6.3 6.8 3.9 1.0 1.7 2.7 4.4 11.5 5.2 3.4 2.6 2.5 4.2 4.4 3.9 3.7 6.8 2.8 1.7 1.6 2.8 3.9 4.9 3.0 3.2 2.8 4.4 3.9 14.4 7.6 4.4 4.9 6.4 7.3 6.4 5.3 4.0 6.0 7.9 7.6 5.4 13.6 9.8 5.7 13.2 4.5 3.8 8.7 8.1 23.6 8.3 9.1 3.1 7.6 5.7 7.6 13.0 8.9 8.1 3.7 6.4 4.0 6.1 10.1 7.6 16.0 3.4 3.5 5.9 10.0 6.6 4.2 2.8 6.2 4.5 0.0 2.7 4.4 6.1 4.2 3.5 3.9 5.0 3.2 7.0 6.7 3.1 1.1 4.4 5.4 5.0 15.4 4.2 3.5 4.1 5.5 9.9 6.8 9.7 0.0 5.1 11.8 6.4 5.4 6.5 4.9 5.5 3.1 MPPED2 "239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638" ENSG00000066382 "Metallophosphoesterase domain containing 2" Q15777 11 30384493-30586872 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 31.0;thyroid gland: 30.0" "Cell type enhanced" "Detected in many" 21 "Cone photoreceptor cells: 269.0;Horizontal cells: 77.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 19.2;HAP1: 11.4;JURKAT: 10.0;RT4: 8.0;SH-SY5Y: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062575 Approved Nucleoli,Vesicles,Mitochondria NA NA Nucleoli "Vesicles, Mitochondria" "HPA062575: AB_2684797" "unprognostic (9.60e-3)" "unprognostic (6.12e-3)" "unprognostic (3.70e-3)" "unprognostic (4.56e-2)" "unprognostic (5.46e-2)" "unprognostic (5.04e-2)" "unprognostic (1.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.57e-2)" "unprognostic (1.13e-1)" "unprognostic (7.98e-4)" "unprognostic (6.82e-2)" "unprognostic (2.47e-7)" "unprognostic (3.64e-3)" "unprognostic (2.50e-1)" "unprognostic (2.22e-2)" "unprognostic (2.57e-2)" 2.9 7.0 6.3 1.7 19.3 1.1 5.5 4.6 8.9 31.0 4.2 1.8 4.4 1.5 8.3 7.9 1.6 11.1 1.9 4.6 8.5 9.7 12.2 1.2 1.1 0.9 7.0 6.7 1.2 2.5 5.0 10.7 2.5 11.2 15.6 1.4 7.1 12.1 10.1 5.7 1.0 1.4 5.1 4.6 3.1 1.9 3.8 3.4 9.1 30.0 1.2 1.0 4.7 4.9 1.3 0.7 0.3 0.2 2.0 4.8 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 11.4 0.0 0.0 0.0 2.1 0.0 0.2 0.2 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.8 0.0 0.2 3.2 0.1 0.0 0.0 3.1 0.2 0.0 8.0 0.1 6.1 0.0 0.0 3.1 1.3 1.7 0.0 0.1 0.0 1.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.3 0.2 0.0 0.9 0.0 4.8 0.0 0.0 0.6 0.4 1.3 1.3 0.2 0.2 2.0 0.0 0.7 0.1 0.2 6.3 19.3 4.6 8.8 8.5 9.7 7.0 6.7 11.2 3.4 0.0 2.1 0.0 47.3 0.9 23.4 3.1 0.0 5.3 0.0 43.6 269.0 0.2 21.6 2.9 1.6 5.0 0.0 0.0 0.0 0.1 4.1 21.0 4.7 0.2 3.2 77.9 0.0 0.6 15.9 0.5 0.3 2.3 5.0 0.0 0.0 40.1 0.1 0.0 3.2 2.2 17.1 0.0 1.4 0.1 0.7 1.0 0.5 0.0 0.0 18.4 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459476-88467419 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050166 Uncertain Supported "Nucleoplasm,Cell Junctions,Mitochondria" NA NA Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: AB_2681039" "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favorable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 11.0 28.3 14.2 11.9 14.7 5.4 13.2 15.8 15.6 7.3 12.4 8.5 10.0 11.1 9.6 11.5 13.3 10.5 8.3 40.8 11.8 11.3 19.3 38.7 7.4 10.4 13.2 13.0 11.4 8.9 8.1 9.2 13.7 13.8 9.0 13.8 7.8 9.3 9.5 57.0 8.2 9.3 11.1 11.4 9.7 12.0 13.7 11.7 12.2 10.0 17.9 11.0 11.1 13.4 31.8 24.6 13.2 24.5 24.3 31.9 25.1 10.0 32.2 10.6 11.3 15.2 11.1 19.6 14.4 13.5 21.8 19.5 39.6 22.2 23.9 14.8 13.0 19.5 24.6 40.7 17.7 17.6 9.7 32.4 19.9 23.2 41.3 9.5 19.4 15.5 12.8 21.6 16.4 11.4 11.0 18.8 23.7 21.8 10.2 15.8 21.5 16.3 24.6 16.4 18.6 19.6 18.8 14.6 18.1 16.9 32.3 16.1 10.5 13.7 21.6 29.5 18.6 24.3 24.2 11.6 17.0 16.1 9.0 20.7 9.5 19.6 19.4 18.7 21.4 12.8 9.9 19.6 13.2 26.8 24.5 30.5 31.8 28.7 26.1 24.6 28.4 31.9 28.4 3.5 24.3 17.6 20.9 26.9 25.1 14.2 14.7 15.8 15.6 11.8 11.3 13.2 13.0 13.8 11.7 0.0 6.4 19.3 18.4 12.2 20.3 64.9 30.6 16.0 10.3 34.9 25.5 77.8 101.2 30.3 48.5 15.4 23.1 0.0 32.9 37.0 13.4 13.1 21.9 82.5 31.2 14.3 27.2 17.2 12.6 6.8 13.3 9.2 6.8 63.1 17.9 17.8 28.5 17.5 17.7 80.1 22.7 25.8 10.5 30.3 24.5 20.5 67.5 22.7 28.6 26.5 MUL1 "C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218" ENSG00000090432 "Mitochondrial E3 ubiquitin protein ligase 1" Q969V5 1 20499448-20508161 "Enzymes, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026827 Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA026827: AB_10601137" "unprognostic (1.39e-1)" "unprognostic (2.73e-2)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (6.05e-3)" "unprognostic (1.01e-1)" "unprognostic (6.31e-2)" "unprognostic (5.86e-3)" "unprognostic (4.05e-1)" "unprognostic (9.10e-2)" "prognostic favorable (6.15e-14)" "unprognostic (1.59e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" 13.3 15.9 10.3 12.9 12.3 20.6 20.4 9.2 22.2 13.1 15.8 19.0 8.0 11.6 18.2 10.7 17.2 17.0 18.5 26.2 11.7 12.5 20.5 20.1 16.3 12.1 16.8 9.5 17.5 26.8 21.9 13.0 21.6 17.6 13.9 13.3 14.3 15.3 18.1 26.7 17.4 19.5 17.0 11.7 13.6 15.2 14.1 11.6 18.5 15.1 14.6 14.0 16.3 13.6 23.2 26.0 31.9 30.4 25.2 32.1 27.5 17.1 16.6 9.6 19.8 20.8 11.7 10.4 17.0 20.4 21.2 20.5 10.2 28.5 12.9 19.1 24.0 16.1 26.1 17.2 24.6 15.5 12.8 13.6 9.9 11.2 14.8 24.5 13.5 17.0 19.1 32.5 21.7 22.6 12.5 13.8 11.7 12.9 15.8 23.0 8.7 8.1 9.1 9.8 14.3 15.9 8.0 12.1 16.7 25.0 9.6 9.8 14.5 15.3 16.4 20.9 8.1 11.5 13.0 15.6 20.7 11.9 18.0 15.2 18.5 16.1 13.9 16.2 18.4 19.1 26.3 26.5 31.9 30.9 30.4 32.1 23.2 23.6 31.4 26.0 21.5 27.1 26.3 24.0 25.2 25.4 20.1 32.1 27.5 10.3 12.3 9.2 22.2 11.7 12.5 16.8 9.5 17.6 11.6 20.8 9.3 11.7 7.8 4.6 12.5 14.6 12.7 9.4 6.8 17.4 5.9 33.7 10.0 21.4 1.6 9.7 12.0 0.0 20.3 20.8 12.1 8.1 3.5 11.9 19.7 12.7 8.2 10.4 11.4 2.8 12.0 7.7 18.6 21.6 11.8 15.6 19.7 11.5 14.5 8.7 10.5 19.4 8.5 10.6 13.4 6.1 31.5 10.8 10.1 9.0 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;bone marrow: 72.8;esophagus: 64.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 81.1" "Lineage enriched" "Detected in many" 49 "granulocytes: 81.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 6.9 2.2 2.7 18.7 3.8 72.8 3.7 5.7 4.1 15.8 19.6 4.7 0.9 13.6 2.9 2.6 64.8 3.8 4.9 10.8 3.0 2.9 3.0 5.5 17.0 14.3 5.9 2.4 3.3 2.5 3.6 4.0 15.8 3.1 3.3 14.0 5.1 8.8 1.4 3.1 5.9 50.2 4.6 4.3 15.8 8.2 3.6 3.7 9.4 4.0 20.8 34.0 6.3 21.6 0.2 0.8 81.1 1.6 0.4 0.4 0.6 3.5 1.5 2.2 1.6 5.0 2.5 8.4 3.9 2.2 1.9 1.3 4.9 2.8 2.0 2.0 1.5 1.9 12.6 4.2 7.8 2.0 1.1 5.1 4.2 4.5 4.9 16.8 5.0 4.2 2.8 13.3 4.4 20.4 2.4 2.4 2.1 7.3 8.1 1.2 2.8 2.4 10.1 0.6 5.2 2.5 1.1 2.3 5.0 2.5 4.2 7.3 3.1 5.2 7.0 2.7 2.7 1.0 3.0 9.6 2.8 0.8 3.0 3.7 5.5 9.3 0.8 2.9 8.9 1.0 17.0 1.6 16.8 0.3 1.0 0.4 0.1 0.2 0.2 0.8 0.2 0.2 0.3 81.1 0.4 0.8 0.2 0.2 0.6 2.7 3.8 5.7 4.1 3.0 2.9 5.9 2.4 3.1 3.7 35.7 30.8 18.2 23.9 22.9 27.8 4.8 7.6 10.7 11.4 1.8 51.1 7.9 6.6 10.8 12.4 9.0 212.1 0.0 14.8 5.1 13.6 61.3 26.5 6.7 26.9 9.5 93.4 6.2 48.3 15.3 4.4 71.5 15.1 20.8 115.5 40.4 44.4 91.2 2.5 5.1 17.8 0.0 28.7 8.1 2.0 49.3 88.6 20.8 26.6 110.0 MYBPH ENSG00000133055 "Myosin binding protein H" Q13203 1 203167811-203175813 "Predicted intracellular proteins" "Cell adhesion" "Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 53.8" "Cell type enhanced" "Detected in single" 33 "Alveolar cells type 2: 2.2" "Group enriched" "Detected in many" 7 "glioma: 4.9;head and neck cancer: 20.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 6 "dendritic cells: 6.1" "Group enriched" "Detected in some" 5 "CACO-2: 17.6;HSkMC: 34.5;THP-1: 8.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA061383 Enhanced Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA061383: AB_2684497" "unprognostic (2.26e-4)" "unprognostic (2.04e-1)" "unprognostic (3.50e-1)" "unprognostic (1.06e-1)" "unprognostic (3.82e-2)" "unprognostic (1.32e-3)" "unprognostic (3.42e-1)" "unprognostic (6.84e-2)" "unprognostic (1.18e-1)" "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (1.75e-1)" "unprognostic (7.62e-4)" "unprognostic (1.51e-1)" "unprognostic (3.34e-2)" "unprognostic (1.14e-1)" "unprognostic (1.74e-1)" 0.8 0.1 1.1 0.8 0.8 0.3 0.4 0.4 0.6 0.1 0.1 0.0 0.0 0.1 0.4 4.4 3.9 0.2 0.1 0.2 0.4 0.3 1.1 1.5 0.2 0.3 1.3 0.0 0.1 0.2 0.1 0.6 0.3 1.0 4.2 0.1 0.0 8.8 0.1 53.8 0.2 0.1 0.1 0.4 0.4 0.1 0.2 2.1 0.9 3.9 12.7 2.0 0.3 0.8 0.0 6.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 34.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 6.1 0.0 0.1 1.1 0.8 0.4 0.6 0.4 0.3 1.3 0.0 1.0 2.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYD88 ENSG00000172936 "Myeloid differentiation primary response 88" Q99836 3 38138478-38143022 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.0" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 75.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 55.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009104 Approved Supported Vesicles,Mitochondria,Cytosol NA NA Cytosol "Vesicles, Mitochondria" "CAB009104: AB_2146724" "prognostic favorable (8.45e-4)" "unprognostic (1.19e-1)" "unprognostic (4.31e-2)" "unprognostic (2.51e-2)" "unprognostic (4.77e-2)" "unprognostic (4.38e-3)" "unprognostic (4.37e-2)" "unprognostic (3.63e-1)" "unprognostic (1.67e-1)" "unprognostic (7.28e-2)" "unprognostic (1.01e-2)" "unprognostic (7.30e-2)" "unprognostic (2.11e-2)" "unprognostic (4.41e-1)" "unprognostic (4.17e-2)" "unprognostic (1.65e-1)" "unprognostic (2.08e-2)" 25.0 11.3 5.9 19.5 6.9 18.1 14.7 5.2 4.6 10.0 13.4 5.8 5.0 15.1 9.5 12.3 25.5 9.8 12.4 10.4 5.3 3.2 15.1 47.9 25.6 40.1 6.2 3.5 13.3 10.3 5.4 10.4 17.8 6.7 11.3 14.3 8.8 13.9 5.4 3.9 12.5 30.4 10.7 7.0 39.0 12.5 5.8 5.1 28.5 10.4 17.5 30.8 13.9 13.7 7.8 34.7 49.0 68.0 8.3 14.3 34.6 8.1 12.2 1.8 10.8 8.6 11.2 3.8 8.1 13.2 22.8 24.3 7.6 10.0 17.6 4.8 14.5 5.2 10.3 14.4 8.1 7.6 13.6 3.0 9.5 6.2 11.5 7.1 12.1 24.8 12.9 8.6 12.9 4.8 4.3 13.0 13.5 4.1 7.2 12.0 8.3 19.8 3.9 7.7 17.2 12.1 8.5 2.3 7.5 11.7 19.3 0.8 4.0 11.5 55.1 7.1 1.5 8.6 13.7 12.0 4.5 2.7 20.7 7.7 10.7 11.8 13.1 8.7 21.1 9.7 38.3 37.6 48.1 12.2 56.5 10.4 7.8 11.0 12.2 34.7 6.7 7.7 10.9 49.0 8.3 68.0 16.6 14.3 34.6 5.9 6.9 5.2 4.6 5.3 3.2 6.2 3.5 6.7 5.1 6.0 14.6 17.4 10.4 12.8 0.9 1.5 7.6 10.7 11.4 5.2 0.0 12.2 6.6 22.7 0.7 10.5 25.9 0.0 24.0 20.1 9.1 11.9 24.2 27.6 30.3 0.0 9.2 9.8 75.0 0.6 12.7 48.3 3.3 18.0 16.3 3.5 43.6 34.5 9.9 9.2 0.0 12.9 7.0 2.1 0.4 15.1 10.1 20.3 13.1 37.7 MYH10 NMMHCB ENSG00000133026 "Myosin heavy chain 10" P35580 17 8474205-8630761 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Cell shape" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 96.0;Cytotrophoblasts: 123.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 56.0" "Low region specificity" "Detected in all" "CAB017180, HPA047541, HPA057198" Enhanced Supported "Actin filaments,Mitochondria,Cytosol" NA NA 130000000 "Actin filaments" "Mitochondria, Cytosol" "CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364" "unprognostic (4.67e-2)" "unprognostic (9.64e-3)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (2.40e-1)" "unprognostic (2.33e-2)" "unprognostic (2.75e-1)" "unprognostic (6.45e-2)" "unprognostic (4.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-3)" "unprognostic (1.69e-2)" "prognostic favorable (1.38e-4)" "unprognostic (2.02e-2)" "unprognostic (2.73e-1)" "unprognostic (5.58e-2)" "prognostic unfavorable (6.42e-4)" 18.3 12.3 12.6 5.4 24.7 7.9 9.6 15.6 30.8 16.9 7.3 5.4 5.3 1.9 19.9 12.4 5.0 18.0 18.2 25.7 15.1 12.9 23.7 13.0 40.0 4.2 9.5 16.7 21.8 6.9 14.7 18.4 35.9 19.2 12.9 3.1 8.6 4.7 19.6 3.3 5.1 3.9 15.7 4.9 3.3 7.1 5.3 5.9 2.7 9.7 2.6 3.0 9.8 7.4 0.5 0.2 2.8 0.1 0.0 1.1 0.2 13.3 8.8 56.0 18.7 7.3 8.8 25.2 11.2 10.1 13.6 14.6 23.7 2.0 0.1 7.4 11.0 7.4 1.3 27.8 13.4 15.2 0.3 22.6 15.5 5.7 20.6 17.2 1.3 1.0 12.5 4.9 17.5 6.8 8.4 21.8 18.1 21.5 0.0 8.4 5.3 16.4 0.4 26.3 0.9 1.9 26.3 16.6 0.0 15.4 5.6 4.6 25.2 17.5 0.8 17.9 44.9 4.7 0.9 0.7 12.8 9.4 0.0 9.6 2.1 2.6 3.4 0.0 1.2 28.6 0.0 0.1 0.1 0.3 0.0 0.3 0.5 0.3 0.6 0.0 0.2 1.1 0.5 2.8 0.0 0.0 0.2 0.3 0.2 12.6 24.7 15.6 30.8 15.1 12.9 9.5 16.7 19.2 5.9 20.8 13.1 0.5 8.0 4.1 35.4 26.9 7.6 26.8 14.8 96.0 47.1 123.2 14.9 10.8 44.7 37.5 0.0 23.3 1.6 73.0 63.0 8.6 1.1 13.1 13.8 33.4 2.4 60.2 3.8 18.2 3.4 1.4 1.7 1.0 1.4 23.8 2.7 0.0 37.4 12.9 34.3 0.0 10.8 8.2 29.6 3.4 64.0 2.2 1.7 3.1 MYMX MINION ENSG00000262179 "Myomixer, myoblast fusion factor" A0A1B0GTQ4 6 44216939-44218236 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 5 "adipose tissue: 27.4;blood: 12.2;pancreas: 9.0" "Cell type enhanced" "Detected in some" 24 "Distal tubular cells: 3.3;Exocrine glandular cells: 2.0" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 12.2" "Lineage enriched" "Detected in single" 121 "dendritic cells: 12.2" "Cell line enriched" "Detected in some" 31 "RH-30: 56.5" "Not detected" "Not detected" HPA051451 Supported Approved Vesicles,Mitochondria,Cytosol NA NA Vesicles "Mitochondria, Cytosol" "HPA051451: " "unprognostic (1.24e-1)" "unprognostic (8.55e-2)" "unprognostic (6.86e-2)" "unprognostic (6.51e-3)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (5.27e-2)" "unprognostic (2.10e-3)" "unprognostic (4.32e-1)" "unprognostic (1.77e-1)" "unprognostic (8.71e-2)" "unprognostic (2.70e-2)" "unprognostic (2.01e-4)" "unprognostic (1.63e-2)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "unprognostic (2.67e-1)" 27.4 0.0 0.0 1.0 0.0 0.0 2.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.8 0.0 1.1 0.0 0.5 1.4 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.7 0.0 2.2 0.0 0.1 0.0 0.0 1.8 3.2 0.6 0.0 2.8 0.4 0.0 0.4 0.5 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 56.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 12.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435961-78574874 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease mutation, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 10.9 16.0 11.8 9.3 11.2 6.4 13.4 19.4 11.8 11.6 13.0 13.1 13.5 12.0 17.6 13.9 10.8 12.0 9.9 12.7 11.3 12.2 22.3 26.8 9.0 10.2 13.4 8.4 15.9 20.0 14.0 17.3 9.4 13.8 13.3 13.3 23.2 12.7 13.2 24.4 9.1 11.1 10.6 10.8 12.6 11.3 11.8 10.3 17.3 16.0 7.7 14.1 9.7 10.7 14.6 13.5 6.7 9.4 16.2 16.6 8.7 7.3 10.3 10.8 7.1 7.6 6.4 9.0 6.1 6.0 9.5 7.9 17.7 7.9 18.2 15.9 3.9 9.2 9.7 18.2 11.9 13.3 11.9 9.8 12.8 8.0 15.0 6.3 13.7 4.8 4.5 7.7 8.4 15.0 8.6 8.1 15.4 19.3 5.0 10.6 8.6 14.2 22.2 11.8 30.0 12.5 14.9 17.7 24.6 12.7 10.4 12.9 8.1 9.1 11.7 15.7 12.2 11.0 5.5 4.9 13.0 15.3 14.8 10.3 8.4 14.1 40.1 2.5 12.4 8.8 6.7 7.9 3.5 9.8 8.3 12.0 14.6 11.3 10.8 13.5 12.6 16.6 14.8 1.7 16.2 9.4 10.3 8.2 8.7 11.8 11.2 19.4 11.8 11.3 12.2 13.4 8.4 13.8 10.3 17.9 17.1 9.0 12.7 11.9 5.3 8.3 2.5 10.7 7.9 5.2 2.0 17.3 24.9 8.2 11.0 6.3 5.0 0.0 6.5 20.2 10.4 14.0 8.1 16.3 10.6 0.0 11.5 2.5 6.5 3.9 7.2 6.1 16.9 1.0 7.7 5.7 6.1 13.3 4.6 22.1 8.7 6.5 8.3 7.4 18.1 12.0 12.8 5.1 13.7 7.5 NDUFB4 B15 ENSG00000065518 "NADH:ubiquinone oxidoreductase subunit B4" O95168 3 120596309-120602500 "Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.7" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 1416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051739, HPA064441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Mitochondria" No No Mitochondria "Nucleoplasm, Nuclear membrane" "HPA051739: AB_2681585, HPA064441: " "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.95e-2)" "unprognostic (4.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (1.62e-2)" "unprognostic (1.47e-1)" "unprognostic (4.35e-3)" "unprognostic (9.66e-3)" "unprognostic (7.97e-2)" "unprognostic (2.84e-1)" "unprognostic (3.69e-2)" "unprognostic (1.01e-1)" "unprognostic (1.12e-1)" "prognostic favorable (1.79e-4)" 25.5 68.2 37.6 20.1 37.7 22.4 59.4 40.7 51.6 25.6 37.2 19.1 25.6 33.6 23.2 32.2 30.2 24.3 27.8 130.2 32.5 30.8 53.3 46.9 25.4 42.0 37.3 29.4 25.8 36.5 34.1 32.8 18.5 36.7 26.8 34.8 24.6 33.9 29.5 195.7 27.3 30.6 37.6 32.4 22.6 28.7 26.6 25.6 31.1 25.9 64.8 25.4 32.3 29.1 64.5 73.4 52.1 60.5 39.1 79.7 49.0 51.3 37.5 44.9 44.9 28.3 33.8 36.5 28.9 38.4 37.6 41.6 36.4 39.5 26.1 58.7 32.3 47.2 49.8 34.6 36.8 28.4 40.0 39.8 40.3 39.4 36.6 17.2 35.4 47.8 30.5 49.1 18.3 24.1 45.6 46.9 49.7 23.8 40.2 40.3 40.3 70.0 51.3 35.7 84.6 102.8 40.6 25.6 57.4 60.9 32.1 50.6 51.8 33.9 38.0 61.5 31.3 64.0 56.5 36.0 33.3 43.9 14.1 40.2 49.6 44.7 78.9 52.6 49.9 45.1 46.2 46.2 52.1 45.5 60.5 47.4 64.5 63.5 51.3 58.4 47.2 54.8 53.4 28.1 39.1 60.5 73.4 79.7 49.0 37.6 37.7 40.7 51.6 32.5 30.8 37.3 29.4 36.7 25.6 151.8 116.9 147.4 227.4 197.5 114.3 1416.5 333.7 208.8 175.1 303.6 55.0 310.4 1039.5 474.7 797.6 248.2 436.8 93.5 541.7 349.0 180.0 247.2 169.9 411.5 288.6 79.4 286.7 153.4 221.7 73.1 254.9 235.4 411.7 399.5 378.0 175.1 503.3 436.8 260.6 758.9 123.5 252.2 270.2 329.1 90.3 219.8 294.7 162.0 391.3 307.0 NDUFV2 CI-24k ENSG00000178127 "NADH:ubiquinone oxidoreductase core subunit V2" P19404 18 9102630-9134345 "Enzymes, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003404, HPA077896" Supported Supported Nucleoplasm,Mitochondria,Cytosol No No Mitochondria "Nucleoplasm, Cytosol" "HPA003404: AB_1079466, HPA077896: AB_2686866" "unprognostic (1.18e-1)" "unprognostic (3.89e-2)" "unprognostic (2.89e-1)" "unprognostic (8.22e-2)" "unprognostic (1.32e-2)" "unprognostic (6.72e-3)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "unprognostic (6.72e-3)" "unprognostic (1.32e-3)" "unprognostic (2.39e-1)" "unprognostic (6.84e-2)" "unprognostic (1.70e-1)" "unprognostic (5.51e-2)" "unprognostic (1.31e-1)" "unprognostic (6.56e-2)" "unprognostic (1.95e-3)" 20.0 34.5 25.2 18.0 23.7 31.1 25.6 20.6 37.3 15.6 26.1 13.1 20.3 23.1 14.7 21.5 27.5 13.9 17.6 82.6 22.7 23.8 40.7 89.1 17.2 29.9 26.7 19.4 11.2 36.3 14.9 14.9 21.6 26.2 20.8 27.8 17.8 20.1 20.2 122.6 17.4 24.4 23.5 20.8 19.3 25.2 19.0 12.7 20.5 20.5 59.5 22.7 20.4 14.1 55.6 74.7 49.3 45.1 27.0 53.5 48.1 18.6 19.6 22.7 21.1 16.8 24.0 19.2 23.5 37.4 31.1 29.6 36.6 15.4 28.8 21.6 22.0 28.7 9.5 22.0 24.4 29.8 14.5 19.4 18.4 20.2 49.3 19.4 51.2 22.9 20.1 20.5 19.2 20.8 22.5 33.5 26.0 29.3 91.0 28.5 23.4 35.7 44.9 18.9 103.3 24.4 17.0 16.8 109.2 49.6 30.3 23.8 17.7 23.2 26.5 29.5 16.9 24.8 39.0 20.5 39.7 28.2 28.4 30.5 26.3 39.0 32.2 28.3 22.7 25.6 49.3 39.9 44.1 30.2 45.1 37.6 55.6 45.5 35.7 56.6 43.6 40.0 36.9 18.0 27.0 41.6 74.7 53.5 48.1 25.2 23.7 20.6 37.3 22.7 23.8 26.7 19.4 26.2 12.7 74.5 120.4 122.8 254.8 131.4 96.8 61.3 175.8 207.5 127.4 143.1 82.5 309.8 742.8 337.2 214.8 108.5 232.3 46.7 461.4 265.4 107.6 372.3 115.7 324.6 267.7 89.0 102.4 92.7 98.1 135.7 113.1 187.8 219.4 393.1 177.0 104.6 465.3 175.4 95.8 576.3 143.4 103.5 138.2 182.6 170.4 129.0 242.0 118.9 207.0 348.6 NGDN "C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD" ENSG00000129460 Neuroguidin Q8NEJ9 14 23469688-23509862 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000944 Approved Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA000944: AB_1079483" "unprognostic (2.63e-3)" "unprognostic (7.65e-2)" "unprognostic (2.84e-1)" "unprognostic (4.16e-3)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (8.87e-2)" "unprognostic (1.72e-3)" "unprognostic (5.64e-2)" "unprognostic (3.87e-3)" "unprognostic (7.10e-2)" "unprognostic (1.65e-1)" "unprognostic (6.36e-2)" "unprognostic (9.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.58e-1)" "unprognostic (1.70e-1)" 20.1 17.6 17.2 19.3 23.6 35.7 26.9 28.9 25.8 17.8 17.8 21.2 18.7 15.0 29.1 22.3 17.4 21.7 12.1 14.8 17.6 15.7 20.6 21.0 15.5 20.4 23.5 17.4 27.2 16.6 20.9 20.7 19.7 19.1 19.7 19.4 17.4 24.0 19.9 32.8 22.7 17.9 21.0 21.6 19.7 17.5 19.0 25.2 19.6 23.7 17.2 22.8 17.3 19.7 42.0 26.7 18.9 23.4 35.2 44.6 28.2 11.0 21.9 16.8 15.7 16.3 11.8 22.2 14.6 15.3 31.3 25.4 21.6 20.2 27.4 10.8 13.3 22.2 19.2 33.2 18.1 36.9 18.2 17.5 24.5 13.3 66.7 22.2 32.4 17.5 14.7 23.1 24.6 29.4 12.4 15.8 21.2 27.1 19.6 15.2 26.2 24.1 24.5 21.2 25.4 29.5 19.7 20.1 14.0 20.0 21.0 17.2 19.4 17.3 20.8 23.9 17.8 12.9 20.8 11.9 14.8 17.6 13.9 21.2 24.5 42.5 39.8 6.4 16.6 15.8 17.5 21.5 18.9 31.6 23.4 33.5 42.0 34.3 32.1 25.3 36.6 44.6 35.1 6.6 35.2 22.4 26.7 37.4 28.2 17.2 23.6 28.9 25.8 17.6 15.7 23.5 17.4 19.1 25.2 32.8 26.9 41.2 49.3 62.7 21.0 17.7 17.8 28.1 29.6 26.2 15.7 50.7 28.2 31.1 4.1 34.3 17.4 23.3 31.3 36.0 37.0 25.4 43.9 18.1 26.5 23.8 23.6 16.0 16.4 4.5 32.5 29.5 30.4 36.1 18.8 20.7 28.1 19.9 26.5 27.0 24.7 19.4 38.7 57.2 69.0 59.1 47.8 41.5 22.0 44.2 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90278141 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 103.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Yes No Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 13.3 21.3 49.2 11.0 43.2 19.4 18.7 27.6 61.5 18.5 15.6 13.8 8.4 9.3 18.9 21.0 13.1 15.2 14.1 19.1 38.9 42.2 11.2 13.3 15.3 11.9 38.9 37.7 19.4 18.9 21.1 17.1 12.3 30.9 15.5 12.1 11.4 14.4 14.5 47.6 17.7 11.3 12.4 25.7 14.0 13.9 13.8 14.0 3.8 23.3 15.4 11.4 12.7 15.4 5.2 2.4 6.0 3.1 4.2 4.8 2.5 2.9 7.4 9.8 15.4 8.6 3.7 1.2 4.2 3.3 4.0 2.9 3.5 1.7 4.7 2.8 5.0 3.4 4.9 9.5 2.4 5.8 1.9 8.8 4.5 4.5 5.4 5.5 5.2 3.4 5.1 8.7 3.7 4.8 3.8 3.6 4.8 5.6 5.8 2.4 3.5 4.9 2.2 4.6 3.6 4.4 7.5 5.5 2.3 4.2 13.1 9.8 12.3 8.1 6.5 3.5 7.0 2.6 7.4 5.8 9.6 4.1 6.2 7.5 3.8 20.0 5.0 4.2 5.4 7.8 6.0 2.3 3.6 3.2 3.1 4.0 3.5 3.1 2.7 1.2 5.2 3.7 4.4 5.0 4.2 1.9 2.4 4.8 2.5 49.2 43.2 27.6 61.5 38.9 42.2 38.9 37.7 30.9 14.0 17.9 20.6 6.7 10.6 6.4 10.7 7.8 2.5 103.1 36.4 5.2 9.8 5.1 5.0 27.1 1.5 8.4 7.3 0.0 20.6 3.7 5.0 7.7 19.7 3.4 3.7 15.9 25.4 5.5 4.0 2.2 8.3 5.9 8.5 17.2 15.6 13.3 25.7 17.5 8.1 6.7 10.4 12.9 8.6 4.8 3.6 4.4 5.6 8.5 15.7 6.4 NLRX1 "CLR11.3, NOD9" ENSG00000160703 "NLR family member X1" Q86UT6 11 119166568-119184016 "Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 14.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061516 Supported Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA 35000 Mitochondria "Plasma membrane, Cell Junctions" "HPA061516: AB_2684548" "unprognostic (7.58e-2)" "unprognostic (3.71e-1)" "unprognostic (6.36e-2)" "prognostic favorable (2.47e-5)" "unprognostic (5.60e-3)" "unprognostic (2.59e-2)" "unprognostic (2.06e-1)" "unprognostic (2.43e-2)" "unprognostic (8.80e-2)" "unprognostic (1.17e-1)" "unprognostic (3.49e-1)" "unprognostic (3.29e-1)" "prognostic favorable (2.59e-6)" "unprognostic (3.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.83e-2)" "unprognostic (4.22e-2)" 4.8 6.1 1.9 3.3 3.7 3.6 3.6 2.5 4.9 8.9 5.1 2.9 8.0 2.9 5.6 5.3 34.9 6.7 4.9 8.7 2.9 1.6 4.3 4.4 3.4 3.4 1.8 2.7 2.9 6.2 5.6 2.5 3.3 3.0 4.4 2.0 5.4 5.6 4.8 14.3 11.6 3.2 4.6 2.4 4.5 4.0 3.2 1.3 3.8 4.3 38.9 37.5 5.3 8.5 0.6 2.0 14.3 3.3 1.3 1.3 1.9 4.1 12.2 1.3 9.7 4.2 4.8 1.9 5.5 6.4 2.8 4.8 0.7 10.2 7.4 16.9 7.0 4.1 10.3 3.7 3.1 0.9 9.5 4.0 9.7 4.2 6.6 6.4 3.4 5.7 5.4 13.2 3.6 7.0 5.6 5.6 9.9 0.1 4.9 2.8 10.9 5.7 8.2 6.0 5.3 6.8 11.2 1.7 2.4 6.6 5.3 1.8 6.4 8.1 4.3 3.5 2.0 14.0 10.1 6.5 5.5 4.9 4.9 2.8 1.8 1.9 2.5 0.8 10.4 3.9 2.8 3.3 14.3 0.9 1.5 1.0 0.6 0.8 1.3 2.0 0.4 1.0 1.1 8.1 1.3 1.3 0.9 1.3 1.9 1.9 3.7 2.5 4.9 2.9 1.6 1.8 2.7 3.0 1.3 0.0 6.4 1.7 1.6 2.3 1.2 10.8 5.1 6.7 2.3 7.0 2.0 3.0 1.7 6.0 1.5 3.0 4.2 0.0 3.4 1.7 2.5 1.8 0.0 9.6 5.7 0.0 2.4 4.3 5.3 2.7 1.1 1.9 1.7 5.4 4.1 5.6 5.1 7.0 1.1 4.3 3.2 0.0 2.1 1.9 1.9 4.1 0.5 0.5 4.5 0.9 NOL7 "C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1" ENSG00000225921 "Nucleolar protein 7" Q9UMY1 6 13615327-13632739 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029185 Supported Supported "Nucleoli,Mitotic chromosome,Mitochondria" Yes Yes "Nucleoli, Mitotic chromosome" Mitochondria "HPA029185: AB_10601274" "unprognostic (8.76e-2)" "unprognostic (8.94e-2)" "unprognostic (8.38e-2)" "unprognostic (1.15e-2)" "unprognostic (3.75e-1)" "unprognostic (5.77e-2)" "unprognostic (2.50e-3)" "unprognostic (1.57e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.64e-5)" "unprognostic (1.26e-1)" "unprognostic (2.03e-2)" "unprognostic (8.04e-3)" "unprognostic (2.58e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "unprognostic (4.79e-2)" 35.8 40.5 45.2 41.4 42.3 44.9 36.6 26.7 38.7 30.5 36.7 25.9 29.2 37.2 35.2 36.7 38.6 33.0 36.6 53.4 39.9 38.4 56.9 58.6 28.8 36.6 41.6 30.2 42.4 42.6 54.0 40.5 45.6 36.8 39.5 32.4 23.1 42.3 35.6 59.3 30.6 46.4 36.7 47.7 45.2 34.8 32.5 40.4 34.3 49.5 36.9 36.0 43.3 56.0 50.7 45.5 38.3 38.0 28.8 49.6 30.9 29.8 15.5 14.6 21.0 11.4 13.2 29.7 27.4 14.9 25.7 24.4 29.4 12.6 38.5 54.3 16.6 31.4 18.5 22.0 20.7 25.2 21.6 36.0 33.1 15.4 49.4 24.5 49.1 26.1 12.4 21.8 23.5 14.5 13.4 16.7 21.7 51.3 10.5 22.2 19.2 27.9 54.5 19.1 17.5 26.6 30.2 20.8 59.2 25.6 9.9 37.2 23.9 16.0 38.8 35.8 19.0 24.1 17.9 25.3 23.7 22.3 24.3 48.1 24.6 47.7 47.0 13.6 29.1 35.8 16.0 30.2 38.3 31.0 35.3 36.6 50.7 45.5 38.3 35.9 41.4 49.6 37.8 14.0 28.8 38.0 45.5 46.9 30.9 45.2 42.3 26.7 38.7 39.9 38.4 41.6 30.2 36.8 40.4 86.4 58.0 93.0 81.6 80.6 62.4 203.3 63.7 148.5 80.8 54.1 21.6 114.5 104.5 133.3 133.2 97.2 61.4 70.0 226.4 127.6 86.4 80.3 87.8 56.9 100.9 46.1 35.6 46.6 45.5 19.9 76.5 83.5 96.2 155.9 59.8 89.8 148.3 72.9 74.6 135.1 46.0 64.7 96.7 142.1 122.5 79.2 129.9 82.8 73.6 94.7 NR3C1 "GR, GRL" ENSG00000113580 "Nuclear receptor subfamily 3 group C member 1" P04150 5 143277931-143435512 "Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Receptor, RNA-binding" "Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004248, CAB010435" Supported Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "CAB010435: AB_2155784, HPA004248: AB_1078976" "unprognostic (1.38e-1)" "unprognostic (1.93e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.43e-2)" "unprognostic (2.74e-1)" "unprognostic (4.19e-1)" "unprognostic (1.39e-1)" "unprognostic (2.46e-2)" "unprognostic (3.87e-2)" "unprognostic (2.15e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.72e-6)" "unprognostic (9.06e-3)" "unprognostic (1.02e-1)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" 27.7 8.6 13.5 26.1 14.9 29.6 23.5 30.1 19.2 14.9 14.2 17.0 10.5 13.0 14.7 12.9 18.2 13.7 14.7 17.4 13.4 14.1 13.5 27.3 22.0 16.1 18.3 12.8 15.5 12.5 21.9 18.9 31.9 13.6 14.3 10.3 14.2 12.0 15.2 40.4 18.3 14.8 16.8 17.2 17.5 13.4 7.3 18.2 37.1 18.0 15.1 18.2 14.8 32.2 11.1 13.6 33.7 11.8 10.9 9.6 7.3 10.1 20.7 1.5 0.0 13.6 15.2 1.8 15.9 19.1 13.8 15.9 1.5 13.6 9.0 7.3 23.3 16.1 9.6 0.1 12.5 17.1 5.0 7.1 2.3 28.0 4.5 12.8 9.3 7.2 11.0 16.2 22.6 22.1 17.2 5.1 4.1 3.3 34.3 12.1 3.6 5.4 6.6 4.1 1.7 4.4 1.9 14.4 19.1 4.0 0.7 2.7 2.1 27.8 4.0 6.6 1.8 1.8 13.4 12.2 33.4 6.6 15.9 12.0 6.9 6.3 14.1 17.5 9.6 11.6 25.4 9.8 17.9 9.3 11.8 7.7 7.6 9.6 8.9 13.6 11.1 9.2 8.9 33.7 10.9 10.5 12.4 5.8 7.3 13.5 14.9 30.1 19.2 13.4 14.1 18.3 12.8 13.6 18.2 62.5 66.3 52.2 35.5 52.2 11.3 38.3 43.3 45.5 46.6 24.4 15.7 34.4 14.9 27.4 129.9 67.3 15.8 0.0 28.6 30.5 63.9 36.5 86.6 160.0 47.2 35.0 27.0 55.3 56.4 113.7 58.4 78.4 50.6 53.3 2.3 41.2 29.3 21.0 67.1 50.1 55.0 148.8 81.5 18.0 35.6 49.2 30.6 85.5 12.0 12.3 P4HA1 "C-P4Halpha(I), P4HA" ENSG00000122884 "Prolyl 4-hydroxylase subunit alpha 1" P13674 10 73007217-73096974 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 105.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 94.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007599, HPA026593" Enhanced Supported "Endoplasmic reticulum,Vesicles,Mitochondria" "Intracellular and membrane" Yes No "Endoplasmic reticulum" "Vesicles, Mitochondria" "HPA007599: AB_1854891, HPA026593: AB_1854892" "prognostic unfavorable (9.01e-4)" "prognostic unfavorable (3.19e-5)" "unprognostic (2.76e-3)" "unprognostic (3.04e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.19e-5)" "unprognostic (2.30e-1)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.28e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.15e-2)" "prognostic unfavorable (9.40e-9)" "unprognostic (3.14e-1)" "unprognostic (4.22e-2)" "unprognostic (1.02e-2)" "unprognostic (5.75e-2)" 16.8 14.4 16.5 10.4 20.2 7.0 47.6 9.9 18.2 18.5 10.9 11.3 7.4 5.6 14.8 12.2 11.6 22.4 14.1 23.9 17.0 10.9 19.0 39.9 18.1 7.5 33.5 4.9 22.3 13.1 11.1 8.6 33.5 25.4 17.9 9.4 8.6 8.5 10.4 63.5 10.3 7.8 15.1 45.8 9.7 11.1 9.7 30.9 4.1 19.4 7.5 7.3 34.4 105.7 6.9 14.8 10.2 17.3 3.4 7.3 6.1 15.2 3.9 11.4 22.1 35.2 27.1 9.5 44.7 40.5 17.3 41.6 6.5 11.9 5.2 17.1 44.2 10.5 17.3 7.1 16.3 37.9 6.6 2.7 4.4 3.7 7.7 14.7 8.1 3.1 16.4 9.5 14.7 19.5 94.8 8.1 4.4 6.8 2.7 14.9 4.0 3.2 7.8 4.1 7.1 17.3 2.9 7.6 9.3 9.7 6.6 1.0 6.4 9.1 27.0 10.6 26.9 4.1 7.6 7.7 21.2 8.7 5.9 10.4 15.6 5.6 2.5 38.0 11.8 10.3 0.8 13.5 10.2 5.2 16.4 6.7 6.0 6.2 6.0 14.8 6.9 4.6 4.7 7.4 3.4 17.3 11.8 7.3 6.1 16.5 20.2 9.9 18.2 17.0 10.9 33.5 4.9 25.4 30.9 6.0 27.9 18.6 25.1 32.3 12.9 37.9 2.5 56.2 31.8 22.7 25.5 25.0 0.0 26.6 10.0 23.3 10.7 0.0 17.0 76.6 76.1 22.0 39.3 25.1 39.6 11.1 9.9 19.0 44.8 4.7 48.1 41.1 42.2 36.1 7.6 33.4 37.2 18.2 44.2 22.8 17.6 38.8 31.1 35.7 35.8 20.8 27.8 13.8 6.5 17.3 PAGE1 "CT16.3, GAGE-9, GAGEB1, PAGE-1" ENSG00000068985 "PAGE family member 1" O75459 X 49687450-49695993 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 126 "testis: 18.2" "Cell type enhanced" "Detected in some" 30 "Sertoli cells: 32.3;Spermatocytes: 65.7;Spermatogonia: 164.4" "Cancer enhanced" "Detected in many" "liver cancer: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 49.0;Karpas-707: 37.8;U-266/84: 58.3" HPA003473 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Mitochondria" NA NA "Nucleoli fibrillar center" "Nucleoplasm, Mitochondria" "HPA003473: AB_1079558" "unprognostic (3.00e-1)" "unprognostic (1.99e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 37.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.7 58.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 5.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 32.3 0.0 65.7 164.4 0.0 0.0 0.0 0.0 0.0 PAM16 "Magmas, Tim16, TIMM16" ENSG00000217930 "Presequence translocase associated motor 16" Q9Y3D7 16 4331549-4355607 "Disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 54.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 36.3" HPA062721 Approved Nucleoplasm,Microtubules,Mitochondria NA NA "Nucleoplasm, Mitochondria" Microtubules "HPA062721: AB_2684849" "unprognostic (2.69e-2)" "unprognostic (1.64e-1)" "unprognostic (4.06e-1)" "unprognostic (6.81e-2)" "unprognostic (6.98e-2)" "unprognostic (9.68e-2)" "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.99e-1)" "unprognostic (1.39e-1)" "unprognostic (4.79e-2)" "unprognostic (2.18e-2)" "prognostic unfavorable (5.73e-5)" "unprognostic (7.25e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "prognostic favorable (1.33e-4)" 10.9 15.2 12.9 8.4 14.1 17.0 10.0 9.3 15.1 7.0 9.5 5.6 8.2 14.0 7.8 11.8 11.2 7.5 7.5 19.9 11.1 10.7 9.2 33.7 9.8 10.9 9.8 11.3 8.5 26.1 7.1 10.3 8.0 9.2 8.8 8.0 7.8 13.2 11.0 54.5 12.6 10.1 8.2 8.3 9.5 10.1 16.2 7.3 7.3 12.0 17.8 9.6 8.4 9.9 16.0 19.8 11.2 15.3 11.5 14.3 12.3 3.9 7.7 4.2 10.3 2.8 3.9 10.9 9.5 2.3 3.6 2.9 5.4 5.8 11.5 10.6 2.8 3.7 8.1 3.9 4.2 1.7 11.2 25.4 12.0 7.2 3.8 4.6 8.4 9.0 5.8 5.4 4.3 4.7 3.2 2.8 8.1 14.1 5.5 3.0 10.6 7.6 14.7 6.8 2.5 17.2 14.5 3.5 11.1 3.7 3.8 16.0 12.4 8.2 7.0 9.7 3.3 9.2 10.2 3.5 7.2 9.3 36.3 10.4 8.2 8.8 14.3 2.6 8.2 6.8 0.2 15.3 2.3 12.3 9.5 10.5 16.0 11.2 11.3 10.7 15.5 14.3 13.7 11.2 11.5 10.2 19.8 12.7 12.3 12.9 14.1 9.3 15.1 11.1 10.7 9.8 11.3 9.2 7.3 3.0 4.5 2.2 0.9 3.5 0.5 0.4 10.2 6.7 5.7 0.0 0.0 1.9 6.6 3.1 2.6 0.7 2.1 0.0 2.6 2.3 2.7 1.0 1.1 10.9 1.5 1.6 0.0 4.3 7.8 0.8 4.6 1.1 1.7 7.2 2.1 0.3 5.2 3.4 3.5 3.0 0.6 6.5 1.4 8.9 12.9 5.1 1.0 1.7 3.4 1.0 PARP9 "BAL, BAL1" ENSG00000138496 "Poly(ADP-ribose) polymerase family member 9" Q8IXQ6 3 122527924-122564577 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 35.1;BJ hTERT+ SV40 Large T+ RasG12V: 41.9;SK-MEL-30: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066708 Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA066708: AB_2685707" "unprognostic (3.06e-2)" "unprognostic (4.80e-2)" "unprognostic (1.55e-3)" "unprognostic (6.70e-3)" "unprognostic (1.11e-1)" "unprognostic (6.38e-2)" "unprognostic (4.73e-3)" "unprognostic (3.39e-3)" "unprognostic (1.31e-1)" "prognostic favorable (6.65e-4)" "unprognostic (1.00e-3)" "unprognostic (5.63e-3)" "unprognostic (1.56e-3)" "unprognostic (3.06e-2)" "unprognostic (3.70e-2)" "unprognostic (9.65e-3)" "unprognostic (1.56e-2)" 27.1 20.2 8.7 17.2 12.4 9.1 13.8 2.9 13.9 13.1 13.1 9.9 7.4 10.4 23.3 10.1 15.6 12.3 14.9 8.5 7.4 6.0 17.8 38.6 18.9 17.5 8.5 6.0 12.1 14.4 16.0 20.3 11.9 10.3 15.1 10.1 11.5 19.1 6.6 8.6 5.7 21.2 14.8 16.3 27.3 11.1 5.4 10.3 21.8 17.5 9.0 19.1 13.7 9.8 7.3 11.9 38.2 18.0 13.0 10.6 9.1 8.0 2.7 1.0 0.7 6.3 13.0 0.9 2.7 14.7 35.1 41.9 4.2 8.9 1.8 6.0 5.4 22.1 8.9 2.3 4.8 7.3 14.0 1.6 8.7 2.8 2.2 6.7 2.8 5.8 10.6 4.7 5.0 1.2 7.0 7.5 5.6 0.8 7.5 1.4 3.5 8.9 3.5 0.4 1.6 7.6 9.5 9.9 0.6 13.4 4.6 0.6 2.4 7.2 1.2 32.4 0.5 3.8 3.1 4.5 1.5 4.4 0.3 1.6 4.7 2.4 3.3 5.2 3.1 2.7 14.4 12.7 15.3 9.2 17.7 8.6 7.3 9.8 10.3 11.9 5.0 7.5 9.1 38.2 13.0 18.0 1.4 10.6 9.1 8.7 12.4 2.9 13.9 7.4 6.0 8.5 6.0 10.3 10.3 38.7 36.9 16.7 9.4 6.4 0.8 5.2 10.2 61.6 44.3 19.2 0.0 4.3 1.7 24.9 1.3 19.0 15.3 0.0 34.9 16.2 11.4 10.4 9.3 43.1 36.1 0.0 10.3 21.5 31.3 2.6 17.0 29.4 6.8 32.5 9.7 14.7 28.4 7.2 22.6 18.9 0.8 19.4 9.6 1.0 0.9 5.8 1.4 12.7 6.6 15.5 PCBP3 "FLJ44028, PCBP3-OT1, PCBP3OT" ENSG00000183570 "Poly(rC) binding protein 3" P57721 21 45643694-45942454 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.4" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 151.7;Cone photoreceptor cells: 47.1;Horizontal cells: 109.7;Late spermatids: 60.8;Rod photoreceptor cells: 75.1" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in all" 5 "cerebellum: 47.4;pons and medulla: 23.0" "Cell type enhanced" "Detected in many" "eosinophil: 5.9" "Group enriched" "Detected in many" 6 "B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6" "Cell line enhanced" "Detected in some" "ASC TERT1: 14.9;HDLM-2: 27.2;HSkMC: 20.9;SH-SY5Y: 23.6;U-87 MG: 12.6;U-937: 15.1" "Region enriched" "Detected in all" 5 "olfactory region: 280.8" "Region enhanced" "Detected in all" "olfactory region: 184.8" "HPA030247, HPA073145" Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA030247: AB_10601244, HPA073145: " "unprognostic (3.88e-2)" "unprognostic (1.19e-1)" "unprognostic (2.01e-4)" "unprognostic (9.89e-4)" "unprognostic (2.74e-1)" "unprognostic (1.40e-1)" "unprognostic (4.10e-2)" "unprognostic (2.42e-1)" "unprognostic (3.87e-2)" "unprognostic (1.64e-3)" "unprognostic (1.12e-3)" "unprognostic (1.97e-2)" "unprognostic (1.96e-6)" "unprognostic (8.67e-2)" "unprognostic (2.32e-2)" "unprognostic (8.04e-2)" "unprognostic (1.97e-2)" 6.5 11.7 6.0 11.2 6.7 12.3 6.3 47.4 12.6 3.8 7.9 7.0 2.2 3.1 9.3 12.4 1.4 3.2 4.4 2.7 6.5 7.3 2.2 1.1 1.8 5.0 6.9 3.7 3.4 3.5 0.6 14.8 2.3 23.0 1.5 3.0 20.2 1.7 1.9 1.1 1.6 4.8 12.3 7.3 11.6 3.4 20.5 6.1 22.6 0.8 0.0 4.6 2.3 1.8 2.9 0.0 5.9 0.4 0.6 1.6 0.5 0.0 0.0 0.2 0.0 6.9 14.9 0.0 0.8 0.2 1.6 0.7 0.0 0.0 0.0 0.3 4.0 1.9 0.0 0.8 0.0 0.2 27.2 0.1 0.0 0.0 0.0 7.0 0.0 0.0 20.9 0.1 0.2 0.4 0.0 0.0 1.0 0.0 0.1 0.9 0.3 7.7 1.6 0.4 0.0 1.3 0.0 0.0 1.1 0.0 0.0 2.6 23.6 0.5 0.0 0.0 0.7 0.0 4.2 0.0 0.0 0.0 6.1 0.0 0.3 1.5 0.0 12.6 15.1 0.5 4.4 0.4 5.9 1.6 0.3 0.3 2.9 0.9 0.0 0.0 1.9 1.5 0.2 1.4 0.6 0.2 0.0 0.8 0.5 6.0 6.7 47.4 6.0 6.5 7.3 6.9 3.7 23.0 6.1 0.0 0.0 1.4 0.1 0.2 151.7 2.8 0.0 0.0 1.2 1.8 47.1 0.0 0.0 0.1 29.4 0.5 0.0 0.0 0.2 0.1 1.3 0.9 0.0 0.0 0.4 109.7 2.9 2.5 0.0 60.8 7.8 0.2 3.3 0.0 0.0 29.6 1.4 0.0 12.0 0.0 75.1 0.0 5.3 25.0 12.0 0.0 0.0 0.0 0.0 0.3 PCDHA5 "CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5" ENSG00000204965 "Protocadherin alpha 5" Q9Y5H7 5 140821604-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 13.6" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 2.2;Horizontal cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.6;EFO-21: 7.5;T-47d: 7.7;WM-115: 2.8" "Low region specificity" "Detected in many" HPA044557 Approved Approved "Nuclear speckles,Plasma membrane,Mitochondria" NA NA "Plasma membrane" "Nuclear speckles, Mitochondria" "HPA044557: AB_10970597" "unprognostic (4.95e-2)" "unprognostic (6.23e-2)" "unprognostic (2.06e-1)" "unprognostic (8.81e-4)" "unprognostic (5.10e-2)" "unprognostic (6.25e-3)" "unprognostic (6.74e-2)" "unprognostic (9.79e-2)" "unprognostic (2.46e-2)" "unprognostic (4.49e-2)" "unprognostic (1.44e-2)" "unprognostic (1.10e-4)" "unprognostic (9.30e-4)" "unprognostic (1.07e-1)" "unprognostic (1.39e-1)" "unprognostic (8.17e-5)" "unprognostic (2.11e-1)" 0.9 1.2 3.4 0.5 3.6 0.6 0.6 13.6 10.2 0.6 0.6 0.4 0.0 0.5 1.2 0.5 0.4 0.5 1.1 0.3 1.6 2.0 1.1 0.4 0.7 0.4 1.3 5.1 0.6 1.2 0.4 2.5 0.4 2.3 0.6 0.5 0.0 0.4 0.4 0.4 0.5 0.5 0.7 1.1 0.4 0.7 0.9 0.1 0.0 0.5 0.0 0.3 0.5 0.2 0.6 0.6 1.6 0.5 0.3 0.3 0.2 0.0 2.6 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.5 0.1 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.6 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.3 0.0 0.1 7.7 0.1 0.1 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.8 1.5 0.5 0.5 0.3 0.3 0.2 0.4 0.3 0.2 0.1 0.6 0.3 0.3 1.6 0.3 0.4 0.6 0.2 0.2 3.4 3.6 13.6 7.2 1.6 2.0 1.3 5.1 2.3 0.1 0.0 2.2 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 70.5" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 117.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 13.5 14.9 13.4 8.6 17.2 4.2 10.4 13.9 23.3 9.2 13.3 10.6 9.3 12.2 8.9 8.6 10.9 6.7 7.7 46.1 14.4 12.8 15.0 25.7 7.8 6.8 14.7 14.1 7.7 13.1 14.6 14.7 15.8 22.1 12.0 12.7 8.9 12.4 14.1 70.5 8.8 12.3 11.5 12.0 6.6 13.7 15.7 9.0 5.9 9.1 19.0 8.7 13.0 10.7 12.8 19.5 12.1 21.7 15.0 14.9 9.8 9.1 24.0 13.9 5.5 10.2 12.1 13.6 17.1 14.0 19.4 18.9 31.0 8.5 12.6 11.2 14.4 22.7 17.8 26.9 14.4 19.3 11.3 22.5 11.8 25.3 35.6 22.2 22.3 14.0 12.3 17.9 10.6 14.5 11.2 14.0 10.8 25.3 11.6 15.2 15.6 13.8 13.8 11.3 25.2 14.4 12.1 24.9 10.9 29.0 24.1 14.7 10.7 15.1 22.9 23.4 14.5 25.7 13.8 9.7 14.4 16.2 14.8 18.9 11.1 22.0 15.6 11.3 11.0 14.5 8.6 13.6 12.1 11.5 15.0 10.8 12.8 10.9 9.4 19.5 11.7 13.3 9.6 2.8 15.0 21.7 5.2 14.9 9.8 13.4 17.2 13.9 23.3 14.4 12.8 14.7 14.1 22.1 9.0 32.8 21.1 9.0 18.1 23.1 25.5 117.0 20.4 18.7 19.4 5.2 27.5 53.6 54.7 18.3 35.0 10.9 12.8 23.3 12.6 28.3 19.4 19.1 5.7 22.1 23.1 19.1 8.6 9.8 15.0 31.1 10.0 15.5 20.3 28.9 16.0 18.1 13.9 14.4 12.7 22.7 23.2 0.0 20.9 40.9 33.4 22.2 69.5 10.4 19.0 16.9 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926066 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 62.2" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 71.4;Early spermatids: 99.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 39.5;hTERT-RPE1: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Yes No "Nucleoplasm, Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavorable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favorable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 5.1 32.3 11.0 4.6 38.9 5.9 7.9 7.5 62.2 7.5 4.3 4.7 1.6 3.3 7.7 8.6 8.0 6.1 9.6 22.9 10.1 8.0 6.3 2.2 6.0 5.6 5.1 32.5 9.7 9.3 20.6 4.2 6.6 4.4 5.2 6.2 4.4 6.6 4.7 31.8 3.2 5.5 5.5 3.4 5.8 5.5 12.9 4.8 4.1 9.3 7.0 5.8 7.7 5.1 11.0 12.7 7.8 21.5 2.8 19.5 8.8 7.9 3.9 8.6 3.6 7.1 13.1 2.8 6.3 7.0 7.4 8.7 4.1 29.6 4.4 21.2 10.0 39.5 17.7 3.6 5.3 11.0 0.4 1.8 2.1 4.9 1.4 8.2 1.0 3.0 8.4 10.5 12.6 20.2 39.3 16.7 4.0 0.7 7.3 9.0 1.9 6.2 3.2 3.9 8.6 5.1 1.5 5.1 0.8 5.1 5.5 0.8 3.7 4.1 0.4 19.3 7.3 1.3 1.2 29.6 9.0 5.8 21.0 7.4 4.1 1.7 3.7 11.5 3.7 7.9 3.1 15.4 7.8 5.6 14.3 5.3 9.3 9.1 7.2 12.7 11.0 5.5 4.8 1.8 2.8 21.5 2.1 19.5 8.8 11.0 38.9 7.5 62.2 10.1 8.0 5.1 32.5 4.4 4.8 11.9 5.6 13.4 11.2 11.6 34.7 71.4 22.9 22.7 17.0 15.7 7.9 3.5 5.0 24.3 99.2 14.7 6.0 0.0 11.9 3.2 11.6 13.3 5.8 2.5 5.7 9.5 9.8 14.1 20.8 22.0 10.6 16.2 10.1 2.8 5.2 19.0 22.2 7.0 12.7 8.6 10.6 6.5 12.7 7.2 9.7 9.5 3.7 10.1 8.9 17.0 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.8" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1" "Cancer enhanced" "Detected in many" "testis cancer: 102.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3" "HPA007534, HPA007949, CAB008376" Enhanced Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane" "Cell Junctions, Mitochondria" "CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 27.7 2.0 6.3 29.8 10.9 0.5 30.3 5.0 6.7 21.4 12.8 11.0 4.1 2.5 16.8 15.3 8.9 19.8 23.7 18.6 5.7 6.5 1.9 0.8 17.8 10.4 10.0 2.4 18.4 3.9 0.7 2.3 71.8 13.5 11.3 6.4 26.6 6.0 8.6 21.9 10.0 7.6 18.6 17.5 0.7 15.1 9.7 7.9 3.2 5.7 9.7 9.9 27.3 28.9 0.4 0.2 3.1 0.4 0.3 0.4 0.1 0.0 0.0 30.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 72.6 1.7 0.0 0.1 50.4 9.0 0.0 0.1 9.2 0.0 0.0 0.0 44.7 0.0 0.0 6.1 16.8 3.8 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.1 48.3 8.5 7.3 0.1 0.0 0.0 0.0 0.1 18.1 0.0 0.0 1.0 0.4 0.6 0.2 0.2 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.3 3.1 0.3 0.2 0.2 0.2 0.1 6.3 10.9 5.0 4.8 5.7 6.5 10.0 2.4 13.5 7.9 98.3 9.1 0.0 29.7 12.9 1.2 6.9 0.0 6.7 29.6 0.0 3.9 1.8 0.0 0.4 0.5 7.4 0.0 0.0 0.0 1.6 108.5 3.5 1.1 0.0 6.5 0.0 0.0 7.4 0.0 0.4 18.7 4.1 6.8 202.8 0.0 85.7 0.5 0.0 59.1 0.0 2.8 0.0 6.2 0.9 8.6 6.0 2.4 0.0 0.0 3.4 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in many" 16 "Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "BEWO: 93.4;HUVEC TERT2: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" No No 20800 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavorable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.3 0.4 0.0 93.4 0.8 0.8 0.4 0.5 2.2 0.1 0.0 2.0 0.6 0.0 0.1 0.4 4.2 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.1 1.0 1.7 0.4 0.1 44.0 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.4 0.0 0.7 0.0 11.6 0.0 0.1 0.2 7.0 3.8 0.0 0.1 1.6 5.9 0.0 0.1 8.9 0.0 2.3 0.0 3.7 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 8.9 5.8 0.8 13.0 21.9 0.8 2.8 0.0 1.4 7.9 0.0 13.7 75.1 0.0 0.9 0.1 15.8 0.5 0.0 0.4 1478.5 42.9 3.3 5.8 0.0 33.1 0.0 6.8 7.4 0.3 0.6 12.0 4.5 20.3 0.0 1.1 1.9 0.6 0.2 18.4 0.4 7.5 103.5 62.6 0.2 3.4 17.1 1775.1 0.9 1.7 4.7 PINX1 "FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1" ENSG00000254093 "PIN2/TERF1 interacting telomerase inhibitor 1" Q96BK5 8 10764963-10839884 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023139, HPA023146" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoli "Nucleoplasm, Mitochondria" "HPA023139: AB_1855384, HPA023146: " "unprognostic (4.01e-1)" "prognostic favorable (2.45e-5)" "unprognostic (7.80e-3)" "unprognostic (3.35e-2)" "unprognostic (4.10e-1)" "unprognostic (4.61e-2)" "unprognostic (1.83e-2)" "unprognostic (3.40e-2)" "unprognostic (9.73e-3)" "unprognostic (2.49e-1)" "unprognostic (1.40e-1)" "unprognostic (4.37e-1)" "unprognostic (2.59e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (1.45e-1)" "unprognostic (2.08e-2)" 14.3 14.4 9.9 16.0 13.9 14.8 13.8 14.5 16.5 12.6 14.2 12.6 7.1 11.5 15.7 8.9 19.3 10.7 9.3 11.7 10.6 10.1 13.1 19.4 11.2 19.2 13.2 10.9 16.1 17.2 7.6 10.7 13.3 17.6 11.4 12.0 15.6 14.9 8.5 21.2 19.0 11.3 15.9 11.1 14.8 11.7 24.0 9.7 18.7 12.4 17.8 19.6 11.5 14.3 9.8 8.8 4.4 8.4 8.9 16.0 8.4 6.4 8.7 9.4 8.9 8.0 6.5 10.8 9.9 4.5 10.9 7.4 9.1 5.7 17.4 3.5 5.3 13.4 13.1 23.8 18.3 14.1 7.0 7.1 7.3 6.1 9.8 9.0 7.8 4.6 5.4 11.7 8.6 16.1 3.9 15.1 11.9 23.1 10.8 10.7 7.7 25.5 9.8 21.6 28.3 9.7 20.9 11.5 15.9 8.1 8.0 7.8 8.1 6.6 7.9 21.7 12.0 8.4 9.7 9.1 6.6 14.3 8.4 12.7 4.9 12.7 31.7 6.8 14.8 14.9 1.5 6.8 4.4 12.5 8.4 16.0 9.7 10.9 13.1 8.8 9.8 15.0 11.6 0.4 8.9 7.3 6.8 12.3 8.4 9.9 13.9 14.5 16.5 10.6 10.1 13.2 10.9 17.6 9.7 3.0 4.1 9.9 14.8 23.7 5.2 3.3 7.6 10.7 9.1 3.5 11.8 14.9 10.0 0.0 29.6 11.4 4.0 0.0 0.0 9.6 8.0 5.2 13.9 6.6 14.3 3.2 8.1 11.6 4.0 22.3 8.6 9.6 6.8 0.0 3.9 6.2 0.0 4.8 6.0 8.2 21.5 0.0 6.2 24.9 25.1 25.0 40.3 11.7 7.7 8.0 PLD5 FLJ40773 ENSG00000180287 "Phospholipase D family member 5" Q8N7P1 1 242082986-242524696 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 54.8;retina: 37.7" "Cell type enhanced" "Detected in some" 16 "Early spermatids: 6.3;Horizontal cells: 3.2;Late spermatids: 9.5;Leydig cells: 4.6" "Cancer enhanced" "Detected in single" "glioma: 0.7" "Region enriched" "Detected in all" 4 "cerebellum: 54.8" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 4.0;AF22: 14.0;HDLM-2: 6.9;SH-SY5Y: 3.9;U-2 OS: 4.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028389, HPA050367" Approved Vesicles,Mitochondria,Cytosol No No Mitochondria "Vesicles, Cytosol" "HPA028389: AB_10602145, HPA050367: AB_2681105" "unprognostic (5.20e-2)" "unprognostic (1.05e-1)" "unprognostic (9.14e-2)" "unprognostic (1.25e-1)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (8.77e-2)" "unprognostic (4.36e-1)" "unprognostic (1.95e-1)" "unprognostic (2.08e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-5)" "unprognostic (2.79e-2)" "unprognostic (4.46e-1)" "unprognostic (3.44e-3)" "unprognostic (2.18e-1)" 1.1 5.4 5.0 0.4 3.7 0.4 1.6 54.8 7.6 2.2 0.8 7.7 0.0 0.4 3.5 0.9 1.6 1.8 0.8 0.8 4.4 4.6 1.5 0.5 0.8 3.3 5.4 2.5 6.6 3.1 1.4 7.2 1.5 12.7 2.7 0.6 37.7 2.2 9.3 0.8 0.6 0.5 2.9 6.0 2.2 0.8 4.2 6.2 0.0 1.0 0.0 1.5 0.4 1.0 0.4 0.2 1.0 0.2 0.3 0.4 0.0 0.0 4.0 14.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.6 0.0 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.0 0.5 2.7 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 3.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.0 0.2 0.3 0.3 0.2 0.3 0.2 0.3 0.3 0.1 0.4 0.3 0.4 1.0 0.3 0.2 0.2 0.2 0.0 5.0 3.7 54.8 5.5 4.4 4.6 5.4 2.5 12.7 6.2 0.0 0.0 0.0 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 9.5 4.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.5 0.0 0.7 0.5 0.2 0.1 0.2 0.0 0.0 0.0 PLK2 SNK ENSG00000145632 "Polo like kinase 2" Q9NYY3 5 58453982-58460260 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 180.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 10.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 147.8;T-47d: 51.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB009624, HPA069329" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "CAB009624: AB_2167745, HPA069329: " "unprognostic (4.82e-2)" "unprognostic (1.08e-2)" "unprognostic (2.38e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (7.75e-4)" "unprognostic (1.22e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (2.44e-2)" "unprognostic (1.06e-2)" "unprognostic (1.01e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (6.56e-2)" "unprognostic (1.43e-1)" "unprognostic (3.46e-1)" "unprognostic (1.95e-3)" 11.4 3.7 19.6 4.0 40.2 4.4 23.4 1.3 39.4 20.6 5.7 3.7 5.0 5.1 19.2 7.1 17.7 9.5 18.2 28.1 18.8 5.1 6.9 17.6 17.7 3.8 4.2 20.6 11.8 12.6 3.8 3.3 25.9 8.7 8.7 8.7 12.6 22.1 6.2 8.7 20.9 6.1 15.4 2.7 54.7 4.7 19.8 7.4 1.0 8.9 16.6 7.5 14.2 15.5 1.2 2.9 3.0 1.6 10.4 1.2 0.6 16.4 14.9 5.2 0.4 2.7 4.5 2.0 3.5 5.9 11.7 6.8 1.1 14.6 0.0 23.2 12.6 28.5 20.7 0.2 8.1 10.7 0.0 0.4 0.0 6.7 1.2 14.8 0.0 0.4 2.6 11.3 4.5 12.7 147.8 23.5 0.0 0.0 0.5 23.1 6.0 0.0 0.0 0.9 1.6 2.4 0.8 14.3 0.0 30.8 3.3 0.3 0.7 10.8 2.1 9.5 9.7 51.9 0.2 30.0 3.2 8.7 1.4 28.1 0.0 0.0 0.0 2.5 0.0 14.4 3.0 0.7 2.3 0.1 1.6 0.0 1.2 0.7 0.0 2.9 0.9 1.2 0.6 1.9 10.4 0.6 2.0 0.5 0.6 19.6 40.2 1.3 39.4 18.8 5.1 4.2 20.6 8.7 7.4 17.9 18.6 2.7 128.0 125.8 2.8 105.2 22.9 18.7 68.2 17.4 3.9 55.6 8.3 96.4 5.7 109.7 37.3 0.0 69.2 180.6 32.4 45.1 9.2 6.0 13.5 0.0 80.9 51.5 8.9 2.3 11.8 11.2 23.6 5.4 25.3 3.5 71.6 40.7 10.3 2.5 2.7 0.0 79.3 72.4 10.4 90.5 108.6 6.4 24.3 54.0 PNPLA3 "adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon" ENSG00000100344 "Patatin like phospholipase domain containing 3" Q9NST1 22 43923739-43964488 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Hydrolase, Transferase" "Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 31.1;retina: 39.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 13.5;LHCN-M2: 15.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA058058 Approved Approved Nucleoli,Mitochondria,Cytosol NA NA Nucleoli "Mitochondria, Cytosol" "HPA058058: AB_2683590" "unprognostic (4.74e-3)" "unprognostic (4.52e-2)" "unprognostic (1.76e-1)" "unprognostic (2.31e-1)" "unprognostic (1.36e-2)" "unprognostic (1.89e-1)" "unprognostic (8.93e-2)" "unprognostic (1.02e-1)" "unprognostic (2.63e-1)" "unprognostic (2.93e-1)" "unprognostic (2.33e-2)" "unprognostic (1.05e-1)" "unprognostic (1.39e-3)" "unprognostic (2.52e-3)" "unprognostic (5.91e-2)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" 2.8 0.4 0.5 0.7 1.0 0.3 4.0 0.3 2.4 0.8 1.3 0.4 0.0 1.0 0.5 1.9 0.4 1.1 0.5 0.9 0.8 0.6 4.6 31.1 1.4 0.4 0.3 1.8 0.5 0.2 0.6 0.2 0.4 2.2 0.2 0.2 39.3 0.9 0.2 2.2 5.3 0.6 0.2 0.5 0.6 0.3 0.5 0.3 0.0 0.2 0.0 0.3 0.2 0.4 1.2 0.7 1.8 0.6 0.9 0.8 0.0 3.9 1.3 13.5 5.5 3.8 4.3 0.4 2.4 1.4 3.3 7.2 3.9 7.1 0.0 2.1 4.0 1.9 3.4 8.4 3.9 2.8 0.0 0.7 0.2 3.2 7.2 6.2 0.0 0.2 4.9 3.1 10.6 0.5 5.7 0.4 0.1 0.0 0.0 15.3 0.6 0.2 0.0 9.2 0.4 0.0 0.0 7.3 0.1 1.5 0.2 1.2 0.1 2.7 1.1 3.8 2.4 4.2 4.6 0.4 1.3 4.1 0.1 0.1 0.0 0.0 0.0 11.6 0.0 4.8 1.5 0.6 0.4 0.5 0.4 0.3 0.7 0.4 0.3 0.2 1.2 0.6 0.8 1.8 0.9 0.3 0.7 0.2 0.0 0.5 1.0 0.3 2.4 0.8 0.6 0.3 1.8 2.2 0.3 0.0 0.0 0.0 0.5 0.3 37.1 1.1 15.3 0.0 0.0 0.0 17.7 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.4 0.0 42.7 0.6 0.0 1.7 0.6 2.6 0.0 0.3 0.0 1.7 0.0 0.5 1.3 1.5 0.0 0.7 5.0 34.3 0.0 0.0 0.4 0.7 0.1 0.0 0.0 0.0 0.4 PPOX "PPO, VP" ENSG00000143224 "Protoporphyrinogen oxidase" P50336 1 161166410-161178013 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis, Porphyrin biosynthesis" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030123 Uncertain Approved Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "HPA030123: AB_10603987" "unprognostic (1.17e-1)" "unprognostic (4.73e-2)" "unprognostic (9.88e-2)" "unprognostic (2.13e-2)" "unprognostic (3.24e-1)" "unprognostic (1.64e-2)" "unprognostic (9.58e-3)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.17e-1)" "unprognostic (2.18e-3)" "unprognostic (7.12e-3)" "prognostic unfavorable (9.89e-4)" "unprognostic (6.12e-2)" "unprognostic (2.23e-1)" "unprognostic (3.27e-1)" "unprognostic (1.80e-2)" 7.3 14.8 11.6 9.1 12.1 31.7 10.2 23.5 16.5 11.0 9.9 13.2 8.5 6.0 11.7 13.5 7.5 33.2 9.5 9.5 11.5 12.5 12.0 9.1 10.2 11.2 14.2 16.1 13.0 13.1 10.5 12.3 10.1 12.1 11.0 6.7 14.4 11.3 14.6 8.5 15.9 7.1 10.0 10.6 12.0 8.2 6.9 13.7 9.2 11.0 6.1 8.7 8.7 8.2 9.8 11.5 6.9 7.7 12.3 16.7 8.9 7.1 6.6 9.9 6.4 7.5 8.0 3.3 4.9 5.7 6.1 8.1 7.7 6.9 5.6 11.9 3.4 3.1 4.9 7.6 7.9 5.5 3.9 15.0 6.7 14.8 17.6 8.0 2.2 3.7 6.4 8.0 5.9 8.4 9.2 11.5 5.2 19.9 8.7 4.4 6.7 8.9 7.1 7.1 9.0 14.1 10.9 6.8 13.2 11.6 3.1 7.8 12.7 6.0 8.7 9.9 12.5 15.8 10.5 4.0 5.6 6.2 4.9 6.3 15.5 11.3 8.6 5.7 4.9 4.3 6.9 7.7 5.5 12.7 7.7 8.4 9.8 9.8 8.8 11.5 8.6 8.6 8.8 1.6 12.3 5.3 7.2 16.7 8.9 11.6 12.1 23.5 16.5 11.5 12.5 14.2 16.1 12.1 13.7 3.0 13.6 4.5 7.2 10.6 16.2 7.7 7.6 62.9 13.6 7.0 21.6 17.7 18.3 8.8 8.4 9.1 4.9 0.0 4.9 8.3 10.3 3.6 5.8 5.8 8.0 14.3 5.8 8.0 4.3 10.0 9.5 7.9 1.7 10.0 6.5 9.6 6.4 3.6 6.3 14.8 17.3 6.5 6.7 9.6 6.1 13.0 8.7 13.1 7.6 4.7 PPP1R3D PPP1R6 ENSG00000132825 "Protein phosphatase 1 regulatory subunit 3D" O95685 20 59936668-59940297 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 6.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041146 Approved Approved Nucleoli,Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" Nucleoli "HPA041146: AB_10793870" "unprognostic (2.50e-3)" "unprognostic (3.55e-3)" "unprognostic (6.90e-2)" "unprognostic (1.23e-1)" "unprognostic (7.23e-2)" "unprognostic (5.87e-2)" "unprognostic (5.73e-2)" "unprognostic (2.39e-3)" "unprognostic (5.54e-2)" "unprognostic (3.27e-1)" "unprognostic (3.52e-2)" "unprognostic (1.20e-1)" "unprognostic (1.48e-2)" "prognostic favorable (9.14e-4)" "unprognostic (4.71e-2)" "unprognostic (1.47e-2)" "unprognostic (5.71e-2)" 8.2 6.1 9.3 8.2 9.5 9.9 17.2 8.6 9.5 9.1 8.2 6.4 7.1 9.5 9.0 6.5 13.3 7.4 6.5 11.3 8.4 7.8 7.8 2.0 10.0 16.8 9.5 5.4 8.8 17.5 13.3 12.1 9.8 9.3 12.0 5.6 7.6 9.1 11.2 12.9 9.1 10.1 7.1 8.9 11.2 9.6 4.7 6.6 4.0 8.0 8.8 8.9 9.1 8.8 0.7 1.2 6.0 3.5 0.8 1.0 0.4 4.0 2.5 1.7 3.5 3.9 4.1 14.4 5.4 5.8 6.6 3.2 3.9 5.6 1.7 6.7 4.5 4.1 12.0 3.5 3.8 4.3 3.9 2.8 4.5 3.3 2.1 3.6 1.8 12.7 2.9 10.6 2.3 2.0 3.5 3.6 1.1 0.8 0.4 4.2 6.3 1.5 5.9 1.2 7.7 6.0 1.9 0.8 2.6 4.4 6.6 3.3 2.0 6.7 20.3 5.8 3.4 7.4 6.6 3.8 3.9 1.6 4.1 0.8 1.4 3.5 0.4 2.9 6.5 2.4 0.6 1.6 6.0 1.0 0.7 0.9 0.7 0.7 0.8 1.2 0.6 0.9 0.6 4.2 0.8 3.5 0.5 1.0 0.4 9.3 9.5 8.6 9.5 8.4 7.8 9.5 5.4 9.3 6.6 8.9 0.3 2.4 4.4 1.1 6.1 4.7 7.6 4.0 4.5 5.2 2.0 12.2 5.0 1.9 0.3 5.8 4.2 0.0 2.7 3.7 2.6 5.9 5.7 0.2 4.6 12.7 1.7 9.2 8.9 0.0 2.8 3.4 5.0 1.0 3.1 10.3 3.0 6.5 4.2 5.0 10.8 6.5 4.0 0.2 4.3 2.8 4.1 7.5 2.8 7.8 PPP1R3E FLJ00089 ENSG00000235194 "Protein phosphatase 1 regulatory subunit 3E" Q9H7J1 14 23295643-23302848 "Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 61.2;Early spermatids: 92.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 30.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA061600 Approved Approved "Microtubules,Mitotic spindle,Mitochondria" Yes No "Microtubules, Mitochondria" "Mitotic spindle" "HPA061600: AB_2684566" "unprognostic (3.45e-2)" "unprognostic (1.57e-2)" "prognostic unfavorable (6.89e-5)" "unprognostic (4.05e-1)" "unprognostic (2.85e-2)" "unprognostic (1.29e-2)" "unprognostic (7.12e-2)" "prognostic favorable (3.10e-4)" "unprognostic (1.73e-2)" "unprognostic (1.18e-1)" "unprognostic (1.77e-3)" "unprognostic (2.41e-1)" "unprognostic (8.67e-3)" "unprognostic (8.46e-2)" "unprognostic (2.88e-1)" "unprognostic (8.12e-2)" "unprognostic (5.46e-2)" 4.2 7.6 14.5 8.2 22.5 5.5 6.8 27.3 22.9 6.5 5.8 17.5 8.4 9.7 8.2 16.6 4.3 6.5 5.4 4.7 12.4 12.6 9.3 6.9 5.1 13.6 27.0 20.7 11.8 7.1 11.7 14.3 4.4 20.8 9.3 9.6 7.4 6.3 10.4 13.6 16.9 8.8 5.8 21.6 11.0 7.8 11.5 25.9 5.9 13.8 4.9 12.3 5.2 7.0 3.0 1.1 1.6 4.7 0.9 1.7 1.0 0.8 2.2 2.7 1.9 5.2 2.3 1.3 0.9 1.6 1.5 1.3 1.2 4.2 8.0 0.6 1.1 1.6 5.6 1.6 0.8 1.8 2.9 1.6 1.4 4.2 2.8 1.4 1.6 3.3 1.9 3.3 0.9 4.6 2.5 0.7 4.4 1.3 7.3 1.2 1.9 1.5 2.6 0.6 2.6 2.0 2.4 1.8 5.1 0.8 1.8 3.3 0.9 1.3 1.1 0.8 1.4 1.4 0.6 1.2 1.8 1.0 3.1 0.6 30.7 3.2 3.7 1.4 2.9 1.1 0.5 1.3 0.5 1.5 3.9 1.7 3.0 0.5 0.7 1.1 2.3 1.7 1.0 1.6 0.9 4.7 1.0 1.0 1.0 14.5 22.5 27.3 22.9 12.4 12.6 27.0 20.7 20.8 25.9 3.0 3.7 10.8 7.8 4.9 61.2 7.7 2.5 2.7 4.5 19.2 35.3 6.1 5.0 1.8 92.4 6.0 10.7 0.0 2.9 1.6 3.9 5.5 3.5 6.4 6.2 30.2 8.1 8.6 7.8 50.4 25.3 8.2 10.1 1.0 6.4 22.9 2.8 4.8 24.4 5.9 38.7 12.9 2.8 24.7 9.1 8.0 4.3 10.1 8.3 7.8 PRODH "HSPOX2, PIG6, PRODH1, PRODH2, TP53I6" ENSG00000100033 "Proline dehydrogenase 1" O43272 22 18912777-18936553 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Proline metabolism" Oxidoreductase "Disease mutation, Schizophrenia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 48.9" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 24.6;Melanocytes: 20.3;Suprabasal keratinocytes: 13.2" "Cancer enhanced" "Detected in many" "testis cancer: 11.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 10 "OE19: 39.9;RPTEC TERT1: 19.8" HPA020361 Approved Approved Nucleoplasm,Vesicles,Mitochondria NA NA Mitochondria "Nucleoplasm, Vesicles" "HPA020361: AB_10963116" "unprognostic (2.46e-2)" "prognostic favorable (1.54e-4)" "unprognostic (1.40e-1)" "unprognostic (3.70e-2)" "unprognostic (3.80e-2)" "unprognostic (1.20e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-2)" "unprognostic (2.49e-2)" "unprognostic (6.56e-2)" "unprognostic (3.12e-2)" "unprognostic (1.61e-2)" "unprognostic (7.44e-2)" "unprognostic (1.07e-1)" "unprognostic (1.21e-1)" "unprognostic (5.34e-2)" "unprognostic (3.94e-2)" 3.8 2.3 20.8 2.8 19.3 2.0 3.3 9.8 21.3 2.0 3.5 16.2 0.1 13.8 2.3 2.2 8.8 2.4 2.2 4.6 22.2 10.8 9.9 6.6 8.6 2.3 14.9 21.8 2.4 2.2 1.9 1.5 2.4 13.5 2.6 2.6 7.4 2.1 2.4 15.5 13.0 48.9 1.9 12.6 2.2 2.1 3.5 9.8 0.1 4.3 4.1 3.7 2.1 2.3 0.4 0.4 0.0 0.0 1.0 0.3 0.0 0.0 0.4 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 1.4 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.4 39.9 0.0 0.0 0.0 0.2 19.8 0.4 0.0 0.1 0.4 0.6 0.1 2.9 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 20.8 19.3 9.8 21.3 22.2 10.8 14.9 21.8 13.5 9.8 14.9 24.6 0.0 0.2 4.5 0.0 1.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.0 0.7 0.0 0.3 13.2 0.0 0.0 0.4 0.1 PSTPIP2 ENSG00000152229 "Proline-serine-threonine phosphatase interacting protein 2" Q9H939 18 45983536-46072272 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7" "Cell type enhanced" "Detected in many" 5 "granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 38.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 37.7;HMC-1: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040923, HPA040944" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" No No 7100000 "Plasma membrane, Mitochondria" Nucleoplasm "HPA040923: AB_10794429, HPA040944: AB_10795485" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.53e-2)" "unprognostic (2.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-2)" "unprognostic (4.80e-3)" "unprognostic (1.87e-1)" "unprognostic (1.33e-1)" "unprognostic (5.83e-2)" "unprognostic (3.06e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (5.21e-2)" "unprognostic (3.55e-1)" "unprognostic (1.61e-1)" "unprognostic (1.93e-1)" 4.6 3.3 1.8 6.1 3.1 36.9 4.9 0.6 2.1 3.4 3.4 0.9 2.7 2.0 2.7 2.8 4.4 2.9 4.4 4.0 4.5 1.2 3.3 8.6 7.4 11.5 3.4 0.4 3.1 3.9 2.2 3.9 11.6 3.5 5.8 3.0 3.5 4.5 8.8 16.6 5.9 3.1 4.1 4.6 46.7 4.3 1.9 3.2 3.0 1.8 6.5 5.6 4.6 3.0 0.0 8.9 38.1 12.4 0.9 3.9 6.3 1.0 0.0 1.4 0.0 0.3 2.6 7.9 5.6 2.8 2.0 1.7 4.3 1.5 0.0 0.3 1.8 0.0 13.7 7.7 10.6 2.5 0.0 1.2 37.7 1.9 0.0 2.3 2.2 41.9 1.9 13.2 1.9 6.3 1.8 4.0 0.0 9.0 0.0 8.8 1.3 0.3 0.0 0.9 0.0 0.0 0.0 2.9 1.8 4.2 13.8 0.1 0.8 0.9 3.9 0.1 11.4 12.4 4.4 2.9 0.2 3.2 0.3 0.0 0.0 0.1 0.0 0.5 0.0 0.1 20.7 9.0 38.1 3.9 12.4 1.3 0.0 2.3 2.8 8.9 0.0 2.8 3.3 4.9 0.9 11.9 0.3 1.4 6.3 1.8 3.1 0.6 2.1 4.5 1.2 3.4 0.4 3.5 3.2 11.9 15.2 6.9 15.7 12.2 0.6 2.8 2.5 2.7 13.6 0.0 0.0 21.1 3.3 8.8 1.9 2.2 0.4 0.0 3.3 2.5 3.8 21.9 41.7 16.3 12.6 0.0 1.2 10.4 40.3 5.0 2.6 35.6 6.8 6.4 2.6 9.5 20.5 0.0 2.1 2.9 0.2 6.5 6.2 0.5 1.1 8.9 7.3 12.5 2.2 17.0 PUS10 "CCDC139, FLJ32312" ENSG00000162927 "Pseudouridylate synthase 10" Q3MIT2 2 60940222-61018259 "Enzymes, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044736, HPA049582" Approved Approved "Nucleoplasm,Nuclear bodies,Mitochondria" No No "Nucleoplasm, Nuclear bodies, Mitochondria" "HPA044736: AB_2679066, HPA049582: AB_2680824" "unprognostic (1.90e-3)" "unprognostic (1.35e-1)" "unprognostic (3.49e-2)" "unprognostic (2.44e-4)" "unprognostic (1.77e-1)" "unprognostic (1.86e-2)" "unprognostic (1.25e-1)" "unprognostic (1.72e-2)" "unprognostic (2.90e-2)" "unprognostic (8.21e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-1)" "unprognostic (1.16e-4)" "unprognostic (1.07e-1)" "unprognostic (6.60e-2)" "unprognostic (9.45e-2)" "unprognostic (1.15e-3)" 7.0 8.7 7.4 5.0 7.3 3.9 7.3 6.8 7.9 4.8 10.0 5.1 3.0 9.2 7.7 9.1 5.0 5.4 6.4 4.6 6.5 6.9 8.5 17.6 6.3 6.5 8.5 4.6 6.8 7.2 6.3 10.3 4.2 5.9 6.6 6.0 6.7 6.2 3.9 6.7 4.3 19.8 3.6 7.1 5.9 4.2 7.8 8.0 9.1 10.4 4.1 8.3 4.4 4.4 5.2 4.9 9.8 6.9 4.8 4.3 1.8 2.7 1.6 4.5 7.7 4.0 4.4 5.2 5.7 5.3 5.6 5.3 4.3 3.9 8.7 5.9 3.2 5.2 3.0 5.1 4.6 6.8 8.8 2.5 7.9 2.1 13.4 7.1 8.7 5.0 5.2 5.4 3.9 9.5 6.9 7.0 8.7 8.1 6.1 3.8 2.5 6.9 7.0 4.1 2.1 3.0 6.8 6.0 4.4 3.2 5.3 2.6 3.6 4.5 8.0 9.1 3.2 3.1 5.6 5.3 5.4 4.2 3.5 4.1 7.4 3.2 18.6 4.6 5.2 6.0 9.8 1.9 2.0 3.9 2.2 4.3 5.2 2.5 2.6 1.6 3.2 3.0 3.4 4.1 4.8 6.9 4.9 1.5 1.8 7.4 7.3 6.8 7.9 6.5 6.9 8.5 4.6 5.9 8.0 0.0 11.0 1.9 2.2 2.2 6.8 4.2 0.0 10.7 3.4 3.5 0.0 5.2 6.6 2.6 1.5 3.9 16.5 0.0 4.4 3.8 2.8 2.9 0.0 11.6 5.3 1.6 1.2 6.2 5.1 1.1 2.8 3.2 1.7 10.8 2.0 6.5 4.3 2.9 1.4 5.1 6.3 6.5 2.1 7.1 10.9 1.9 10.4 5.7 3.3 4.3 REXO2 "CGI-114, DKFZP566E144, SFN" ENSG00000076043 "RNA exonuclease 2" Q9Y3B8 11 114439386-114450279 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038450, HPA038451" Enhanced Supported "Nucleoli,Focal adhesion sites,Mitochondria" NA NA 390000 Mitochondria "Nucleoli, Focal adhesion sites" "HPA038450: AB_10672516, HPA038451: AB_10697391" "unprognostic (3.26e-3)" "unprognostic (2.36e-2)" "prognostic favorable (6.51e-4)" "unprognostic (6.84e-3)" "unprognostic (5.80e-3)" "unprognostic (1.06e-1)" "unprognostic (1.40e-3)" "unprognostic (1.78e-1)" "unprognostic (8.18e-3)" "unprognostic (2.49e-2)" "unprognostic (2.17e-3)" "unprognostic (1.02e-1)" "unprognostic (1.73e-2)" "unprognostic (6.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.69e-2)" "prognostic unfavorable (6.70e-4)" 21.8 31.1 13.5 15.8 14.2 16.2 30.0 14.9 12.6 31.4 36.0 11.2 24.0 8.4 38.4 24.8 33.5 17.7 23.9 64.3 13.3 10.5 35.7 28.6 20.1 13.9 17.0 13.1 28.5 27.7 61.2 24.9 45.0 15.3 32.0 17.7 11.6 61.6 22.8 27.8 22.7 15.8 44.6 15.7 18.6 31.5 29.6 14.5 9.9 20.0 25.2 15.2 34.9 40.6 15.5 28.6 19.0 7.9 18.1 30.5 12.2 27.8 16.2 6.3 16.9 50.7 53.8 15.0 47.3 37.0 23.9 30.5 42.6 47.7 15.3 47.7 41.7 36.3 17.8 14.1 41.8 39.5 14.9 10.9 16.9 22.4 26.5 66.7 12.3 5.4 37.2 40.1 30.2 32.1 42.0 42.7 15.9 31.2 9.4 53.5 6.6 8.9 15.5 19.4 22.3 28.7 7.9 20.6 55.8 34.2 22.7 11.2 7.0 21.7 16.8 19.9 27.5 34.1 6.5 40.4 30.8 36.8 23.7 28.9 7.4 8.8 25.9 21.2 29.1 16.4 19.0 6.0 8.8 14.3 7.9 16.5 15.5 21.6 17.9 7.8 11.7 19.9 16.1 1.5 18.1 7.9 28.6 30.5 12.2 13.5 14.2 14.9 12.6 13.3 10.5 17.0 13.1 15.3 14.5 98.3 49.6 36.3 126.2 123.4 12.0 342.7 43.3 89.7 68.2 90.7 2.0 149.0 235.4 121.0 59.3 101.2 22.2 93.5 62.0 153.2 153.3 156.6 32.2 67.6 83.4 4.8 77.7 89.6 17.6 35.4 195.1 39.5 229.5 53.3 64.2 27.2 110.2 31.6 166.2 264.0 6.7 51.8 115.4 227.9 71.1 142.2 225.1 37.4 70.7 116.6 RIMS3 "NIM3, RIM3" ENSG00000117016 "Regulating synaptic membrane exocytosis 3" Q9UJD0 1 40620679-40665657 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 47.7" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 10.7;Late spermatids: 23.5;Muller glia cells: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "MAIT T-cell: 1.8;plasmacytoid DC: 4.6" "Group enriched" "Detected in many" 9 "dendritic cells: 4.6;T-cells: 1.8" "Cell line enhanced" "Detected in many" "Daudi: 37.3;JURKAT: 13.2;SH-SY5Y: 17.7;U-87 MG: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055285 Approved Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoli, Mitochondria" Nucleoplasm "HPA055285: AB_2682771" "unprognostic (3.51e-3)" "unprognostic (7.18e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-4)" "unprognostic (3.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.44e-5)" "unprognostic (2.41e-1)" "unprognostic (1.53e-1)" "unprognostic (2.87e-1)" "unprognostic (2.54e-1)" "unprognostic (7.93e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.25e-2)" "unprognostic (3.11e-2)" "unprognostic (2.19e-2)" 1.3 7.2 13.6 2.2 19.2 3.7 3.1 21.5 47.7 1.4 3.4 3.4 0.0 1.1 3.0 2.2 2.9 2.1 1.3 1.5 7.8 17.4 1.4 0.7 3.1 2.0 7.4 22.3 2.5 1.1 4.0 0.5 3.8 4.9 3.2 3.8 2.0 2.0 4.1 0.6 2.7 1.7 4.8 3.4 1.7 2.5 3.1 4.4 0.7 2.8 0.0 2.8 1.7 1.0 0.1 4.6 0.1 0.3 0.1 1.8 0.1 1.9 0.7 2.9 3.1 0.1 0.0 0.4 0.0 0.0 0.5 0.6 0.3 0.6 37.3 0.0 0.0 1.4 0.3 1.9 0.3 0.3 6.4 0.9 2.1 0.2 1.0 0.1 0.3 1.7 0.0 1.5 0.1 0.1 0.1 0.1 13.2 1.8 1.4 0.0 3.4 5.5 0.2 1.8 0.3 0.2 2.5 2.6 6.9 0.5 0.5 10.0 17.7 0.4 1.8 1.2 4.0 0.4 10.4 0.0 0.3 3.0 0.0 0.5 0.3 2.7 8.2 16.3 0.6 0.3 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.5 0.2 0.2 0.1 0.0 0.2 0.0 0.1 0.3 4.6 0.4 0.1 13.6 19.2 21.5 47.7 7.8 17.4 7.4 22.3 4.9 4.4 6.0 0.0 0.0 0.2 0.5 6.3 1.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 10.7 0.1 1.7 0.0 1.3 0.1 0.3 0.4 1.1 0.0 2.4 4.8 0.0 0.0 2.1 23.5 0.0 1.1 0.0 1.0 1.9 12.8 2.3 0.8 0.7 0.3 0.6 0.0 2.2 3.3 1.1 0.1 0.2 0.0 0.6 0.1 RPS6KA6 RSK4 ENSG00000072133 "Ribosomal protein S6 kinase A6" Q9UK32 X 84058346-84187907 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 20.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 19.9;Collecting duct cells: 17.4;Cone photoreceptor cells: 23.6;Intestinal endocrine cells: 24.0;Rod photoreceptor cells: 18.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 11.0;PC-3: 11.9;RH-30: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002852, HPA003904" Uncertain Supported Nucleoplasm,Nucleoli,Mitochondria NA NA "Nucleoplasm, Mitochondria" Nucleoli "HPA002852: AB_1079854, HPA003904: AB_1079853" "unprognostic (1.17e-1)" "unprognostic (1.02e-2)" "unprognostic (3.44e-1)" "unprognostic (4.93e-4)" "unprognostic (1.71e-1)" "unprognostic (3.04e-3)" "unprognostic (2.09e-2)" "unprognostic (2.50e-1)" "unprognostic (2.86e-1)" "unprognostic (4.88e-2)" "unprognostic (3.38e-3)" "unprognostic (2.88e-1)" "unprognostic (2.12e-9)" "unprognostic (4.44e-3)" "unprognostic (1.30e-2)" "unprognostic (2.34e-2)" "unprognostic (8.49e-3)" 0.7 2.9 5.9 1.0 12.2 0.0 2.3 4.7 5.1 3.1 4.5 1.1 20.7 1.7 2.7 4.0 1.5 4.0 1.9 1.2 5.1 2.9 9.2 0.9 0.8 0.2 1.5 3.3 4.9 3.4 13.5 9.1 0.5 4.4 4.3 3.7 1.5 3.0 15.0 1.4 2.3 2.0 1.7 1.0 0.6 2.4 2.6 2.7 0.8 14.5 0.9 0.6 3.3 2.3 1.2 0.8 2.4 0.5 0.7 2.8 0.1 0.0 3.7 3.6 0.0 3.4 3.4 0.0 7.7 4.1 3.4 2.9 2.8 3.0 0.0 0.0 4.1 0.0 0.1 9.1 6.1 8.1 0.0 4.6 0.0 0.1 0.0 3.1 0.0 0.0 1.9 0.0 0.0 3.8 3.8 0.8 0.0 0.0 0.2 2.7 0.0 1.3 0.1 11.0 0.0 11.9 0.0 14.6 0.0 0.6 8.5 0.0 11.7 0.0 4.2 0.0 5.2 2.0 0.0 0.0 0.1 4.4 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 2.4 0.4 0.5 0.5 0.3 0.4 1.2 0.4 0.7 0.8 0.6 0.4 0.4 1.1 0.7 0.5 0.4 2.8 0.1 5.9 12.2 4.7 5.1 5.1 2.9 1.5 3.3 4.4 2.7 8.9 2.4 2.0 4.4 0.2 19.9 2.0 12.7 6.7 3.4 17.4 23.6 2.1 1.7 0.4 0.4 0.6 3.4 0.0 1.1 0.6 0.3 7.4 0.0 1.5 0.2 1.6 24.0 1.3 0.0 0.0 4.0 0.0 0.0 0.0 5.0 2.8 1.3 2.9 5.6 3.3 18.2 0.0 0.6 3.7 6.3 0.4 1.9 0.0 5.3 4.2 RSAD1 FLJ11164 ENSG00000136444 "Radical S-adenosyl methionine domain containing 1" Q9HA92 17 50478800-50485975 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA022436, HPA022967, HPA024459" Approved Approved "Nucleoli,Mitotic chromosome,Mitochondria" NA NA Mitochondria "Nucleoli, Mitotic chromosome" "HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: " "unprognostic (8.21e-2)" "unprognostic (4.11e-3)" "unprognostic (3.72e-2)" "unprognostic (1.83e-2)" "unprognostic (3.49e-2)" "unprognostic (2.93e-2)" "unprognostic (6.01e-2)" "unprognostic (1.07e-2)" "unprognostic (2.52e-1)" "unprognostic (1.13e-2)" "prognostic favorable (5.04e-4)" "unprognostic (1.06e-1)" "unprognostic (1.65e-2)" "unprognostic (4.89e-2)" "unprognostic (2.95e-1)" "unprognostic (7.85e-2)" "unprognostic (3.22e-2)" 13.5 22.2 16.1 16.8 23.9 8.9 14.1 32.2 20.3 16.8 13.1 12.7 13.5 13.9 13.8 15.1 8.8 12.9 13.6 25.7 13.7 11.6 18.5 28.2 14.0 16.6 19.0 13.7 20.9 46.0 20.3 12.9 10.1 16.3 12.8 14.9 12.6 21.4 14.0 37.0 13.5 12.0 13.7 23.6 16.7 16.0 8.8 19.1 11.6 15.8 20.9 14.0 11.7 12.4 7.4 5.8 3.8 4.6 6.7 10.9 5.1 5.7 19.7 9.5 15.6 16.3 13.3 3.4 10.2 9.9 13.1 11.1 19.5 7.4 15.7 22.6 7.1 13.0 5.5 10.7 14.2 11.3 17.3 19.5 21.1 8.8 18.9 11.4 12.7 14.9 9.7 15.7 8.7 16.9 10.9 12.7 38.8 16.3 15.0 10.9 13.5 21.2 9.3 3.8 24.6 21.3 8.7 10.9 14.2 15.8 8.8 5.2 17.8 2.6 12.2 13.1 12.6 18.4 13.0 8.9 13.7 14.6 10.4 11.9 23.5 16.4 6.1 10.3 18.2 9.5 1.1 4.1 3.8 9.5 4.6 9.9 5.1 8.2 9.4 5.1 7.4 10.9 10.5 0.0 6.7 4.3 5.8 6.2 5.1 16.1 23.9 32.2 20.3 13.7 11.6 19.0 13.7 16.3 19.1 3.0 12.5 11.2 4.6 9.0 12.3 23.6 12.7 1.4 6.8 15.7 2.0 15.8 19.9 10.9 7.3 13.7 8.7 0.0 25.4 9.6 10.3 5.5 3.5 15.8 14.2 7.9 24.2 6.7 7.8 5.4 14.4 9.6 16.9 10.8 12.6 30.7 11.1 3.5 10.3 8.7 7.4 12.9 12.4 8.4 21.2 8.7 8.5 13.1 13.0 2.8 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930896 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 34.4;Late spermatids: 42.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 5.8 16.5 9.9 7.2 12.8 11.1 7.4 10.7 20.4 8.0 9.2 11.3 11.4 12.3 9.0 9.4 12.9 11.5 8.2 12.3 8.3 8.6 13.4 20.6 6.3 11.0 10.9 7.8 9.5 14.4 11.2 11.4 10.7 15.0 11.0 8.5 11.8 13.6 9.9 15.5 15.6 9.9 8.1 7.2 11.3 11.1 8.8 11.5 11.4 13.8 9.5 12.6 11.0 8.3 6.3 12.7 0.4 7.2 6.5 8.0 4.3 5.7 17.4 7.0 4.1 2.9 6.0 9.6 4.0 5.5 9.5 7.5 14.2 7.1 6.5 5.8 5.7 3.8 5.4 7.3 11.4 2.4 5.5 9.4 12.9 7.5 12.2 6.9 11.0 12.9 9.1 6.2 6.2 4.3 4.7 6.7 10.5 11.1 6.4 4.8 12.2 8.3 10.0 7.1 9.0 3.5 12.0 6.3 7.1 10.1 13.9 12.0 7.6 5.4 14.5 3.6 2.7 7.4 7.4 4.3 5.9 6.8 4.6 3.9 4.7 2.7 5.1 3.8 7.7 4.9 0.0 4.1 0.4 8.0 7.2 6.4 6.3 5.9 8.0 12.7 5.7 4.3 4.9 0.3 6.5 6.4 5.0 6.6 4.3 9.9 12.8 10.7 20.4 8.3 8.6 10.9 7.8 15.0 11.5 6.0 6.4 9.5 3.4 3.8 7.2 8.1 10.2 4.0 4.5 5.2 7.9 34.4 13.3 13.2 10.2 3.2 5.1 0.0 11.2 19.0 5.1 2.3 5.7 8.1 11.2 4.8 10.9 6.2 6.2 42.6 4.4 3.5 3.3 6.4 7.1 2.9 7.8 3.5 4.6 5.6 13.4 0.0 2.1 1.5 7.2 3.6 24.4 6.9 16.6 2.6 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61447529 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 23.7 33.0 22.2 22.4 27.2 34.1 24.8 19.9 33.8 20.5 22.1 23.4 21.0 22.3 23.3 33.5 25.3 25.8 21.1 32.5 20.8 26.9 26.8 39.1 19.9 36.7 24.3 25.0 25.7 22.7 23.3 38.4 26.7 25.2 26.1 24.9 32.0 28.1 21.5 31.4 22.9 27.9 26.6 20.8 32.2 24.3 19.2 21.1 36.1 27.0 20.2 30.9 24.0 19.2 31.3 23.2 44.6 25.4 32.7 43.7 26.7 15.4 22.3 13.2 9.2 19.2 15.7 10.3 12.0 17.4 16.3 12.5 20.8 16.7 15.6 22.1 17.4 22.2 16.8 17.2 17.1 17.5 23.1 16.3 13.4 18.3 30.0 20.0 15.8 18.8 19.4 20.9 17.7 17.3 11.6 26.2 16.8 15.4 20.1 19.6 34.2 16.1 35.9 20.4 15.9 32.8 17.4 17.1 28.8 23.2 23.0 14.2 17.7 16.5 19.3 33.4 14.1 30.1 18.9 16.3 16.6 13.5 19.7 14.2 12.4 19.3 19.9 16.1 14.1 17.4 41.9 25.4 44.6 32.4 22.8 38.4 31.3 35.9 34.7 20.3 29.9 39.5 38.4 37.0 32.7 17.9 23.2 43.7 26.7 22.2 27.2 19.9 33.8 20.8 26.9 24.3 25.0 25.2 21.1 32.8 38.1 35.3 31.0 18.3 14.0 20.5 12.7 32.1 21.6 27.9 5.9 61.5 46.4 50.2 11.4 29.8 27.1 23.3 52.7 47.1 28.8 26.8 31.2 37.0 45.9 14.3 32.8 36.8 33.7 13.8 29.1 32.1 42.2 81.2 28.5 36.7 49.4 31.7 29.0 38.3 14.1 32.3 24.7 15.8 23.5 19.6 83.3 44.5 23.9 29.9 SDHB "SDH, SDH1" ENSG00000117118 "Succinate dehydrogenase complex iron sulfur subunit B" P21912 1 17018722-17054170 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 395.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002868, CAB009822, CAB068233, CAB068234, CAB068235" Enhanced Supported "Nucleoplasm,Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA Mitochondria "Nucleoplasm, Plasma membrane" "CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889" "unprognostic (1.06e-1)" "unprognostic (2.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.79e-3)" "unprognostic (1.58e-1)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (8.45e-2)" "unprognostic (5.51e-2)" "unprognostic (3.93e-2)" "prognostic favorable (2.93e-7)" "unprognostic (1.46e-1)" "unprognostic (2.75e-1)" "unprognostic (7.82e-2)" "unprognostic (3.82e-2)" 17.8 25.6 19.8 16.6 21.7 17.0 26.4 18.0 29.1 13.9 30.8 12.3 15.1 34.0 14.2 15.7 19.8 13.6 15.1 86.9 18.2 16.4 51.0 75.1 16.8 24.6 20.1 18.9 10.5 30.7 20.0 11.3 15.6 16.7 13.0 31.5 11.7 15.9 19.5 96.2 13.2 31.4 21.3 16.5 17.2 21.7 18.7 15.7 14.2 15.5 52.2 18.0 15.4 17.1 22.2 45.9 48.5 48.7 18.9 26.7 25.0 26.0 25.8 14.7 18.8 28.7 28.5 16.8 22.8 29.3 52.3 47.2 36.3 31.3 35.7 28.5 30.7 33.8 30.7 58.7 45.4 59.0 20.9 48.1 32.1 26.9 27.8 35.1 50.2 23.9 29.3 30.0 45.2 76.6 27.8 36.9 31.4 26.8 41.4 36.3 21.5 33.3 28.7 12.2 41.9 51.9 24.0 28.4 44.2 48.1 14.8 27.8 15.2 30.9 38.7 64.9 16.3 22.7 28.4 18.3 20.1 22.7 36.9 30.0 17.3 21.3 36.5 30.8 76.6 22.2 16.6 38.4 37.4 18.3 48.7 18.3 22.2 21.2 19.5 45.9 18.3 19.3 19.5 48.5 18.9 42.2 21.5 26.7 25.0 19.8 21.7 18.0 29.1 18.2 16.4 20.1 18.9 16.7 15.7 59.6 39.6 77.3 79.1 46.2 28.1 395.8 109.5 78.9 40.9 45.4 13.7 93.2 300.1 104.4 146.0 54.0 212.4 116.8 130.5 121.6 58.6 70.1 65.7 198.8 162.9 35.0 46.7 41.7 81.2 13.8 53.5 90.6 60.8 125.4 89.5 52.1 97.2 192.9 63.6 355.3 35.5 38.8 60.4 85.9 68.4 47.7 101.8 52.3 135.8 97.0 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140979933 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 20.2 16.9 14.9 13.4 20.5 36.5 25.2 18.7 31.3 23.5 19.4 18.3 17.3 22.3 25.6 37.3 12.2 25.1 13.7 29.5 15.9 19.0 29.0 3.1 22.4 18.6 15.6 16.7 32.6 33.9 29.7 26.3 19.1 21.6 20.6 14.8 21.1 17.5 17.7 60.6 16.2 17.2 20.4 18.5 14.1 23.6 24.4 12.2 15.4 23.7 15.1 12.7 20.7 18.5 17.0 14.9 15.7 13.1 18.1 16.6 10.9 23.8 5.4 17.5 14.3 16.1 20.6 22.1 9.0 11.5 10.1 14.3 14.9 11.4 19.9 22.4 7.6 14.5 16.0 21.2 8.8 20.7 15.2 17.2 16.4 13.0 9.4 24.2 23.4 10.2 23.2 29.6 7.4 22.7 22.7 10.6 14.7 8.7 12.9 14.7 10.3 13.9 16.1 17.4 5.9 10.1 15.1 15.6 28.2 11.9 8.2 11.3 18.5 12.2 22.2 39.1 16.0 15.4 13.3 10.7 14.1 7.9 24.9 8.6 26.2 17.0 23.2 18.2 9.8 6.9 10.5 10.4 15.7 11.4 13.1 13.3 17.0 11.7 12.5 14.9 16.0 16.6 15.7 1.8 18.1 13.1 10.9 10.2 10.9 14.9 20.5 18.7 31.3 15.9 19.0 15.6 16.7 21.6 12.2 92.3 107.7 22.2 58.2 60.7 96.5 82.2 38.2 133.8 62.6 68.0 125.7 48.2 54.7 22.9 5.0 40.0 22.6 0.0 33.6 33.4 49.8 72.0 63.6 0.4 22.8 87.4 57.0 29.4 35.2 11.5 55.3 36.5 54.0 29.7 27.0 70.1 26.8 17.5 55.9 52.8 122.5 58.2 54.2 29.3 61.1 47.6 41.3 41.1 40.3 64.7 SLC27A1 "ACSVL5, FATP, FATP1, FLJ00336, MGC71751" ENSG00000130304 "Solute carrier family 27 member 1" Q6PCB7 19 17468769-17506168 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.6;SK-MEL-30: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076520 Approved "Plasma membrane,Mitochondria,Cytosol" NA NA "Plasma membrane" "Mitochondria, Cytosol" "HPA076520: AB_2732311" "unprognostic (1.48e-3)" "unprognostic (3.03e-2)" "unprognostic (5.72e-3)" "unprognostic (5.84e-2)" "unprognostic (2.16e-3)" "unprognostic (4.36e-2)" "unprognostic (8.56e-2)" "unprognostic (3.36e-2)" "unprognostic (9.03e-2)" "unprognostic (1.85e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "prognostic favorable (4.70e-4)" "unprognostic (5.01e-2)" "unprognostic (2.25e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" 14.5 14.3 13.1 5.2 13.9 2.0 9.3 20.1 19.3 11.8 6.4 44.1 10.1 4.6 8.9 6.4 5.9 14.7 11.0 18.3 12.9 10.0 5.2 5.2 8.5 6.7 22.0 17.2 23.2 14.5 26.1 9.8 7.5 16.1 11.0 2.6 9.6 26.7 13.0 24.2 13.7 3.7 5.5 13.4 7.1 10.9 9.6 19.3 1.3 9.9 4.7 5.3 6.9 8.8 0.5 7.4 0.3 9.9 1.7 3.2 4.6 3.6 1.8 2.5 6.1 17.6 9.8 2.1 2.6 7.0 3.0 4.5 0.2 11.3 1.2 5.0 4.4 2.8 4.4 0.2 4.1 0.7 1.4 0.8 0.7 0.2 1.3 3.4 0.3 4.0 9.0 2.9 3.0 1.2 12.5 2.0 2.4 0.4 0.7 1.9 1.5 2.0 2.9 0.7 3.6 3.2 2.8 2.0 0.8 1.9 1.1 0.8 1.8 1.8 0.9 29.1 1.6 3.2 0.9 1.2 5.9 3.9 4.7 1.8 2.5 1.8 0.4 6.1 3.2 4.1 0.0 9.9 0.3 1.7 4.7 3.2 0.5 1.2 2.1 7.2 0.3 1.6 2.1 0.0 1.7 1.8 7.4 0.7 4.6 13.1 13.9 20.1 19.3 12.9 10.0 22.0 17.2 16.1 19.3 3.0 14.0 1.5 14.9 6.0 8.2 16.7 10.2 4.0 9.1 8.7 25.5 3.7 1.7 9.3 0.7 4.7 0.1 0.0 4.1 14.7 9.7 10.3 2.3 5.8 24.7 6.4 5.2 9.2 20.6 1.7 19.8 9.1 8.5 5.4 2.6 9.7 4.9 0.0 11.0 2.7 17.6 6.5 5.2 8.1 4.3 4.0 1.9 6.1 1.3 7.0 SMPDL3A "ASM3A, ASML3a, FLJ20177, yR36GH4.1" ENSG00000172594 "Sphingomyelin phosphodiesterase acid like 3A" Q92484 6 122789049-122809720 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 208.6;Proximal tubular cells: 122.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 10 "basophil: 31.2" "Lineage enriched" "Detected in many" 10 "granulocytes: 31.2" "Cell line enhanced" "Detected in many" "ASC diff: 22.3;hTCEpi: 18.3;OE19: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030148 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted to blood" No No 22000000 "Nucleoplasm, Nucleoli, Mitochondria" "HPA030148: AB_10601591" "unprognostic (2.60e-1)" "unprognostic (1.22e-1)" "prognostic favorable (6.11e-4)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (8.30e-3)" "unprognostic (3.37e-1)" "unprognostic (1.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (7.72e-2)" "unprognostic (2.27e-2)" "unprognostic (3.44e-2)" "unprognostic (8.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.8 15.9 4.0 8.3 5.4 8.1 24.9 9.7 9.9 35.3 46.7 3.8 8.0 19.2 10.0 9.8 9.6 5.1 8.5 11.9 4.5 4.1 20.1 36.9 13.0 29.1 4.7 5.6 6.2 24.6 16.1 7.0 23.2 6.5 19.6 28.5 7.6 9.5 13.7 56.1 32.1 63.6 10.9 4.9 37.7 13.1 3.8 3.2 3.3 7.2 18.0 7.6 18.7 24.3 0.1 0.4 31.2 3.2 0.0 0.0 0.5 0.1 1.2 3.0 1.4 22.3 10.1 9.6 5.0 13.5 1.5 3.3 1.6 1.3 0.0 0.7 3.1 4.1 2.4 0.8 2.5 1.3 0.0 2.6 1.1 5.1 4.2 14.3 0.0 0.0 12.3 18.3 1.4 2.7 6.0 2.7 0.0 1.8 0.0 6.2 4.4 0.0 0.1 0.5 28.0 3.9 0.0 5.3 0.1 7.4 2.0 2.2 0.0 0.7 9.1 12.7 2.0 1.5 0.7 5.2 3.0 1.7 0.3 3.2 0.0 0.0 0.0 4.3 2.3 6.7 31.2 1.7 0.4 0.0 1.9 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.5 4.0 5.4 9.7 9.9 4.5 4.1 4.7 5.6 6.5 3.2 3.0 16.2 2.2 20.4 47.7 2.8 3.6 22.9 5.3 3.4 5.2 3.9 117.9 48.0 19.1 0.1 5.8 208.6 0.0 22.5 35.4 27.9 13.5 9.3 67.1 54.3 3.2 46.8 24.5 86.5 1.1 14.4 9.9 33.7 1.0 51.3 11.4 17.1 87.7 13.4 122.4 5.9 12.9 8.3 0.9 3.9 66.5 96.2 4.3 33.0 12.8 SMYD2 "HSKM-B, KMT3C, ZMYND14" ENSG00000143499 "SET and MYND domain containing 2" Q9NRG4 1 214281102-214337131 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 75.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 109.6;Cytotrophoblasts: 142.7;Early spermatids: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029023 Uncertain Approved "Intermediate filaments,Mitochondria,Cytosol" NA NA Cytosol "Intermediate filaments, Mitochondria" "HPA029023: AB_10601605" "unprognostic (8.53e-2)" "prognostic unfavorable (1.53e-5)" "unprognostic (5.98e-2)" "unprognostic (1.00e-2)" "unprognostic (8.55e-2)" "unprognostic (2.53e-2)" "unprognostic (2.24e-2)" "unprognostic (1.72e-2)" "unprognostic (1.90e-3)" "unprognostic (1.65e-1)" "unprognostic (9.44e-2)" "unprognostic (2.77e-1)" "prognostic favorable (8.68e-4)" "unprognostic (2.65e-1)" "unprognostic (4.92e-2)" "unprognostic (8.10e-2)" "unprognostic (6.37e-2)" 5.9 5.7 8.8 5.6 7.3 2.7 10.0 5.0 23.9 4.9 4.7 2.1 3.1 4.8 3.8 6.7 7.3 10.4 4.5 75.7 7.0 8.4 7.7 9.7 8.1 8.0 5.3 10.0 4.7 7.8 2.9 7.5 10.6 6.9 4.6 5.8 3.1 6.2 3.0 29.5 4.3 4.7 3.8 4.7 6.2 6.2 8.9 2.2 8.0 7.8 5.1 5.6 5.2 4.0 9.3 5.5 8.1 5.9 17.6 14.5 7.3 24.5 7.1 9.7 6.8 10.0 17.5 41.3 13.9 11.5 17.6 20.0 28.0 21.0 12.7 14.3 15.7 9.6 11.6 9.2 25.8 17.1 10.6 10.7 4.1 12.0 22.3 9.0 17.8 2.9 18.7 14.6 12.2 9.7 12.2 12.7 12.2 12.9 3.2 15.7 12.8 12.4 11.2 8.7 14.4 9.7 7.7 23.5 10.8 17.4 18.0 9.6 22.4 10.8 38.9 28.6 23.3 30.3 11.9 14.6 13.7 20.2 7.5 21.5 13.1 4.9 14.6 17.8 14.2 15.6 6.7 5.9 8.1 9.5 3.2 11.2 9.3 14.5 12.7 5.5 4.8 12.7 11.6 0.6 17.6 1.2 3.8 14.5 7.3 8.8 7.3 5.0 23.9 7.0 8.4 5.3 10.0 6.9 2.2 17.9 11.9 11.2 14.0 18.3 3.8 109.6 22.9 48.2 12.5 3.5 0.0 142.7 26.6 32.4 113.6 10.8 12.7 0.0 17.4 93.2 12.2 8.9 3.5 15.5 33.9 14.3 4.1 22.1 17.4 93.5 10.9 9.9 15.1 10.8 15.2 15.2 22.5 10.5 3.5 27.8 4.6 12.9 15.7 15.2 43.7 15.7 71.9 12.8 20.8 7.6 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696343-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Enterocytes: 29.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 6.8 5.3 6.3 5.4 10.3 8.8 3.7 6.8 14.1 4.1 6.9 1.6 4.9 12.3 4.7 7.2 3.9 4.6 7.7 2.8 7.2 4.9 7.5 11.4 6.3 3.6 3.4 7.6 5.4 17.0 5.1 12.9 6.5 2.8 4.2 2.2 4.9 6.1 3.4 1.8 5.0 10.7 3.3 2.0 5.6 7.7 4.6 2.6 6.7 5.6 0.7 5.4 4.0 2.2 5.8 5.9 16.5 7.8 2.4 7.3 4.7 5.3 4.2 1.5 7.0 1.2 1.2 8.2 3.7 1.7 1.7 1.1 8.0 4.5 1.8 5.0 1.2 2.3 9.3 1.3 2.0 0.3 1.7 15.1 1.2 1.5 10.8 3.9 1.0 3.7 1.2 2.6 2.8 0.8 2.0 1.9 2.1 5.5 1.3 1.2 24.2 3.1 5.7 4.3 5.4 5.7 6.8 0.7 5.2 2.5 1.9 8.3 5.4 3.9 4.0 4.5 0.7 10.3 4.1 4.8 1.7 6.4 0.3 1.7 3.2 1.9 1.6 5.3 3.0 3.2 3.3 4.9 6.0 7.3 7.8 5.1 4.8 5.2 5.3 5.3 5.8 4.6 4.9 16.5 2.4 5.8 5.9 3.9 4.7 6.3 10.3 6.8 14.1 7.2 4.9 3.4 7.6 2.8 2.6 3.0 0.3 1.4 16.6 14.0 6.6 0.4 5.1 0.0 0.0 10.4 0.0 7.5 1.7 11.7 4.4 4.9 29.5 0.0 11.8 4.1 5.7 10.1 4.6 5.0 6.8 3.2 22.8 5.5 7.5 1.0 2.6 7.2 8.5 3.6 6.8 5.1 10.5 17.3 2.1 8.4 7.4 0.0 9.2 1.0 2.5 17.3 20.8 5.0 6.2 11.6 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.6" "Group enriched" "Detected in many" 24 "Early spermatids: 817.6;Late spermatids: 902.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favorable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favorable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 6.3 7.2 7.8 2.8 10.3 2.2 7.1 18.0 12.5 6.1 4.5 6.5 4.5 2.9 7.7 8.5 3.7 9.6 6.5 5.3 8.1 7.4 10.5 5.9 5.0 3.0 6.4 9.7 13.6 6.9 9.2 15.0 3.6 13.3 5.8 4.1 5.5 4.6 5.9 4.7 6.6 2.8 6.4 5.8 3.7 4.3 55.6 5.9 3.3 13.5 3.9 2.0 5.7 4.4 3.7 4.4 1.7 3.0 0.9 5.6 2.2 2.1 3.3 4.9 6.8 8.1 15.4 5.0 3.7 8.4 4.7 3.1 0.9 4.1 1.5 2.3 5.0 3.5 2.1 2.3 3.5 4.4 2.5 1.6 0.1 1.6 1.1 12.1 3.4 0.3 7.3 5.9 1.9 3.6 15.4 8.6 4.2 1.1 2.4 4.3 2.5 1.5 3.1 0.6 2.6 4.2 3.5 5.1 0.8 7.5 1.3 2.9 4.5 4.7 6.4 3.8 5.1 5.5 3.7 4.4 2.9 3.8 4.8 2.0 2.4 1.2 0.5 5.8 1.0 2.4 0.0 2.2 0.6 4.8 3.0 5.6 3.7 4.0 2.2 4.4 0.9 2.2 4.2 1.7 0.9 1.8 4.3 1.4 2.2 7.8 10.3 18.0 12.5 8.1 7.4 6.4 9.7 13.3 5.9 11.9 5.3 0.8 8.2 2.2 10.8 10.9 5.1 36.1 10.3 3.5 19.6 2.1 8.3 7.6 817.6 5.2 1.1 0.0 6.3 3.2 6.4 3.4 1.1 3.4 5.0 14.3 15.6 6.2 8.6 902.3 19.0 3.3 8.5 4.6 4.4 10.6 5.8 4.8 15.9 19.9 19.4 6.5 5.0 18.2 13.5 1.8 0.9 3.8 4.6 2.7 SS18L2 KIAA-iso ENSG00000008324 "SS18 like 2" Q9UHA2 3 42581840-42595114 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047377 Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria Yes No "Nucleoli, Mitochondria" Nucleoplasm "HPA047377: AB_2680020" "unprognostic (4.09e-3)" "unprognostic (1.90e-3)" "unprognostic (1.54e-1)" "unprognostic (1.19e-1)" "unprognostic (2.36e-1)" "unprognostic (1.57e-1)" "unprognostic (1.64e-2)" "prognostic favorable (7.03e-4)" "unprognostic (6.55e-2)" "unprognostic (4.51e-2)" "unprognostic (2.62e-2)" "unprognostic (2.94e-2)" "unprognostic (1.09e-3)" "unprognostic (1.44e-1)" "unprognostic (1.09e-1)" "unprognostic (1.96e-1)" "unprognostic (2.24e-3)" 12.7 11.6 24.5 17.8 26.4 29.9 20.8 25.2 23.8 14.0 14.8 14.4 9.1 19.4 9.1 20.6 16.6 10.6 11.8 10.8 23.5 20.6 15.8 26.2 11.9 34.8 20.5 15.9 13.5 29.0 10.9 16.1 10.7 17.4 22.2 15.5 11.3 18.6 10.8 10.1 14.9 19.3 8.4 24.0 19.7 15.6 6.4 14.9 20.4 18.7 14.7 32.0 16.0 11.1 48.0 30.0 32.8 25.9 31.0 53.5 32.9 16.1 7.4 14.9 13.5 19.2 15.6 9.3 10.5 12.0 15.7 17.8 14.2 14.8 22.1 9.6 7.2 16.5 9.1 17.8 14.7 17.3 11.0 20.8 24.0 14.5 23.8 13.8 31.3 18.9 12.2 9.5 12.6 11.9 10.9 17.1 19.7 21.7 33.4 12.6 15.3 22.0 38.9 23.6 21.8 18.2 11.7 10.9 30.7 17.4 20.4 8.4 12.0 8.9 14.0 14.1 16.8 18.3 29.3 10.0 9.2 15.1 22.1 19.1 24.3 38.4 37.5 13.6 34.4 8.8 19.0 23.5 32.8 38.4 25.9 51.6 48.0 50.5 45.3 24.9 40.8 43.9 44.1 31.1 31.0 19.2 30.0 53.5 32.9 24.5 26.4 25.2 23.8 23.5 20.6 20.5 15.9 17.4 14.9 11.9 11.8 77.1 64.6 95.1 14.4 16.1 38.2 14.7 15.9 26.2 7.9 47.4 48.0 38.3 2.3 39.4 43.1 23.3 43.1 65.4 37.6 63.9 45.0 58.7 58.5 22.3 52.9 28.3 37.6 2.5 31.9 41.0 49.0 61.3 42.2 24.6 41.3 53.7 14.9 68.9 23.5 12.9 39.1 13.2 24.0 120.8 31.2 95.9 48.0 96.2 SUCLG1 ENSG00000163541 "Succinate-CoA ligase alpha subunit" P53597 2 84423523-84460045 "Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 125.6" "Cell type enhanced" "Detected in all" 10 "Distal tubular cells: 792.5;Proximal tubular cells: 1327.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036683, HPA036684" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Intracellular and membrane" NA NA 330000 Mitochondria "Plasma membrane, Cytosol" "HPA036683: AB_10671708, HPA036684: AB_2675248" "unprognostic (6.84e-3)" "unprognostic (7.16e-3)" "unprognostic (2.58e-3)" "prognostic unfavorable (5.23e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-1)" "unprognostic (3.63e-2)" "unprognostic (3.49e-2)" "unprognostic (1.02e-1)" "unprognostic (2.00e-1)" "unprognostic (2.36e-2)" "unprognostic (9.24e-2)" "prognostic favorable (2.21e-8)" "unprognostic (4.94e-2)" "unprognostic (2.08e-1)" "unprognostic (2.81e-2)" "unprognostic (1.23e-1)" 26.1 23.3 18.0 15.0 18.9 10.6 23.8 18.9 19.5 14.1 50.1 17.7 23.2 53.9 13.9 19.6 25.0 13.5 14.0 57.7 17.4 17.3 125.6 44.1 12.8 13.3 19.2 17.0 12.7 33.9 36.2 16.3 13.8 17.3 17.1 39.4 16.9 39.3 24.9 57.6 15.6 71.6 26.5 17.1 12.1 21.9 13.3 16.0 16.9 28.8 42.8 15.2 24.3 16.3 26.6 43.5 31.6 40.3 35.2 39.1 46.8 20.8 23.0 18.2 22.1 34.2 23.1 31.5 23.8 20.4 30.7 22.5 52.6 17.3 28.8 16.5 28.5 24.7 30.5 37.4 28.1 36.5 27.7 34.0 25.0 19.8 29.9 29.0 25.4 20.4 27.4 23.0 25.9 35.3 18.8 27.3 23.6 25.3 23.7 27.9 31.9 36.0 23.2 9.5 78.5 41.2 22.9 42.2 31.5 41.2 25.4 22.1 12.3 19.0 39.5 37.9 17.8 24.1 20.0 22.1 24.1 23.4 29.5 29.2 20.8 29.5 24.8 28.2 35.3 21.2 31.6 34.4 28.7 31.4 40.3 34.6 26.6 29.2 35.1 43.5 20.2 32.4 34.2 18.5 35.2 40.0 23.7 39.1 46.8 18.0 18.9 18.9 19.5 17.4 17.3 19.2 17.0 17.3 16.0 59.6 67.8 89.4 89.8 31.5 32.1 379.6 132.5 91.0 108.1 134.3 21.6 202.1 792.5 102.4 24.5 56.3 282.3 23.3 99.5 100.2 83.9 68.7 90.0 177.6 116.1 42.9 102.0 59.5 64.6 28.6 50.6 82.9 113.1 78.5 140.8 56.0 65.8 217.5 69.6 1327.5 31.0 51.8 72.6 79.7 46.4 36.1 157.6 70.5 304.8 88.9 TAGLN "DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10" ENSG00000149591 Transgelin Q01995 11 117199321-117204782 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Peritubular cells: 2168.1;Sertoli cells: 2819.8;Smooth muscle cells: 4737.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "intermediate monocyte: 19.0;non-classical monocyte: 26.6" "Lineage enriched" "Detected in many" 10 "monocytes: 26.6" "Cell line enhanced" "Detected in many" "BJ: 136.7;BJ hTERT+ SV40 Large T+: 130.0;CACO-2: 122.7;EFO-21: 163.1;fHDF/TERT166: 139.3;hTERT-RPE1: 106.3;LHCN-M2: 96.2;U-138 MG: 126.7" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "midbrain: 176.0" "CAB001447, HPA019467" Enhanced Approved Microtubules,Mitochondria,Cytosol No No 8000000 "Microtubules, Mitochondria" Cytosol "CAB001447: AB_564012, HPA019467: AB_1857245" "unprognostic (1.36e-2)" "unprognostic (1.06e-1)" "unprognostic (3.57e-3)" "unprognostic (1.91e-1)" "unprognostic (6.58e-2)" "unprognostic (1.02e-2)" "unprognostic (2.39e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (1.24e-1)" "unprognostic (4.43e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.12e-7)" "unprognostic (9.58e-3)" "unprognostic (3.03e-1)" "unprognostic (1.10e-1)" "unprognostic (2.52e-3)" 73.3 22.6 2.3 67.6 5.9 0.2 60.8 2.1 7.7 278.3 328.7 6.1 156.2 22.3 399.7 156.8 337.9 133.3 227.5 48.7 3.1 3.0 49.5 12.9 44.1 38.6 7.1 11.8 159.2 9.3 1.5 8.0 36.2 14.9 237.5 51.6 39.1 24.1 347.5 36.6 17.9 81.0 481.9 9.1 26.0 114.7 65.1 2.1 1.1 47.3 30.0 11.2 473.0 78.1 2.6 1.4 0.8 26.6 0.0 0.3 0.9 1.2 0.3 21.4 0.5 10.0 9.0 18.0 136.7 59.3 130.0 48.7 122.7 1.9 0.2 163.1 139.3 0.1 3.2 0.3 1.1 37.0 0.4 0.2 0.3 4.6 8.3 55.9 0.1 0.3 23.7 4.6 19.0 2.4 106.3 0.2 0.2 0.2 0.4 96.2 0.2 0.1 1.0 6.5 1.1 0.1 0.1 1.6 0.6 0.2 1.7 0.1 0.5 2.1 0.7 0.1 53.6 0.6 0.3 14.6 126.7 21.3 0.9 5.8 0.6 0.4 1.0 0.7 0.4 0.3 0.8 1.1 0.0 0.1 19.0 0.2 1.6 0.0 0.0 1.4 2.6 0.1 0.0 0.1 0.0 26.6 0.7 0.3 0.9 2.3 5.9 2.1 7.7 3.1 3.0 7.1 11.8 14.9 2.1 35.7 6.7 4.5 353.2 56.7 9.9 1.2 5.1 13.4 5.7 38.4 17.7 30.6 0.0 230.9 2.4 73.9 6.2 0.0 68.1 27.0 232.5 54.7 1.1 9.3 37.9 1.6 2.9 944.1 20.6 8.9 44.8 43.3 91.1 9.0 9.0 3.3 40.6 3.5 2168.1 1.3 10.5 2819.8 4737.3 6.1 4.4 53.2 26.9 10.0 2.6 40.6 THAP3 ENSG00000041988 "THAP domain containing 3" Q8WTV1 1 6624866-6635586 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067114 Approved Approved Nucleoplasm,Nucleoli,Mitochondria No No Nucleoplasm "Nucleoli, Mitochondria" "HPA067114: AB_2685782" "unprognostic (1.82e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.89e-2)" "unprognostic (2.87e-1)" "unprognostic (1.61e-1)" "unprognostic (2.14e-3)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (4.63e-2)" "unprognostic (3.50e-3)" "unprognostic (4.30e-2)" "unprognostic (1.11e-2)" "unprognostic (4.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.67e-1)" "unprognostic (2.26e-3)" 14.2 17.2 16.4 11.4 16.8 12.9 31.4 21.5 20.3 16.5 16.6 13.8 11.8 12.0 15.2 13.6 11.8 16.3 11.9 19.0 16.0 14.5 17.2 17.3 10.8 15.5 18.1 14.1 23.7 28.8 12.1 14.2 11.4 17.6 17.0 7.2 11.5 24.8 16.7 20.9 14.2 11.4 12.7 13.0 15.3 12.0 11.9 16.3 11.6 22.6 9.0 12.9 17.2 21.6 22.2 18.0 10.6 14.7 17.0 22.0 15.0 9.9 9.4 8.6 12.4 14.3 12.9 8.3 9.0 11.8 24.0 15.0 12.6 6.3 8.8 12.2 9.9 8.9 7.9 13.6 8.0 8.4 15.1 22.3 10.1 12.6 11.2 17.9 7.1 10.5 12.0 10.3 15.1 13.3 14.7 10.3 15.5 10.2 11.4 8.8 6.9 12.4 16.2 7.4 11.7 16.0 11.9 10.5 12.7 10.7 2.4 11.4 12.9 11.0 15.2 20.8 7.5 9.7 12.9 9.3 12.8 7.7 8.7 14.0 12.9 13.7 11.6 10.8 15.4 7.2 10.2 14.7 10.6 20.1 11.7 20.2 17.1 19.7 20.8 18.0 22.2 22.0 18.5 9.0 17.0 9.1 16.4 19.3 15.0 16.4 16.8 21.5 20.3 16.0 14.5 18.1 14.1 17.6 16.3 0.0 6.9 9.8 10.6 12.5 10.9 5.6 7.6 14.7 3.4 8.7 5.9 12.9 16.6 9.6 5.3 14.0 11.6 23.3 9.0 15.6 14.6 13.0 5.7 10.0 13.4 4.8 7.5 10.4 13.2 2.3 17.3 8.3 10.1 22.6 7.7 9.8 9.8 8.4 21.9 15.1 6.9 12.9 20.6 8.1 16.0 12.9 13.7 9.2 11.5 13.7 THNSL1 "FLJ22002, TSH1" ENSG00000185875 "Threonine synthase like 1" Q8IYQ7 10 25016658-25026664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 26.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037585 Uncertain Approved "Nuclear bodies,Mitochondria,Cytosol" NA NA "Nuclear bodies, Cytosol" Mitochondria "HPA037585: AB_10696940" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (4.31e-2)" "unprognostic (5.26e-2)" "unprognostic (6.11e-2)" "unprognostic (8.91e-2)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (9.75e-2)" "unprognostic (2.63e-2)" "unprognostic (1.52e-1)" "unprognostic (1.71e-3)" "unprognostic (2.08e-1)" "unprognostic (3.21e-2)" "unprognostic (9.84e-3)" "unprognostic (3.06e-2)" 2.2 8.0 8.6 2.4 10.1 0.8 4.7 4.6 10.4 5.5 3.5 5.4 3.6 3.3 4.7 6.5 2.6 7.2 2.7 4.6 8.9 6.6 12.3 26.0 2.1 5.5 9.5 5.5 9.6 8.7 7.9 13.0 2.3 8.5 3.8 4.0 2.8 4.4 3.7 5.2 2.9 3.0 3.0 9.1 3.2 3.5 7.0 7.7 5.1 10.5 2.1 3.3 2.9 3.9 5.2 3.8 0.6 0.7 11.5 10.4 3.3 5.3 6.2 3.9 7.8 4.0 5.0 1.0 2.6 1.0 2.9 1.9 4.0 6.8 24.8 8.4 1.2 3.2 3.0 5.6 4.9 3.0 3.4 3.1 9.1 1.7 2.6 4.5 0.0 1.5 3.1 9.1 2.1 4.5 5.1 2.0 10.3 7.7 2.9 6.2 8.3 4.9 1.7 7.2 9.4 3.0 2.6 1.0 10.6 8.3 1.2 6.5 3.7 5.2 4.7 9.3 2.2 4.7 0.5 1.9 3.5 3.1 4.6 2.4 2.2 2.8 0.0 5.8 5.0 2.7 0.1 0.4 0.0 3.0 0.5 5.4 5.2 4.4 4.0 2.2 4.0 10.4 6.8 0.6 11.5 0.7 3.8 2.0 3.3 8.6 10.1 4.6 10.4 8.9 6.6 9.5 5.5 8.5 7.7 3.0 2.7 2.0 2.6 0.6 4.1 6.3 2.5 9.4 6.8 3.5 0.0 5.2 13.3 2.8 20.6 1.6 1.4 0.0 1.1 3.3 2.1 1.2 0.0 6.8 1.8 3.2 1.2 1.8 1.6 4.1 2.0 1.0 0.0 1.8 1.1 6.3 1.6 0.0 1.4 8.9 4.7 0.0 1.0 6.4 13.2 0.9 0.8 0.9 3.5 0.9 TMEM223 MGC3196 ENSG00000168569 "Transmembrane protein 223" A0PJW6 11 62771629-62792021 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014504 Approved Approved "Nucleoplasm,Nuclear membrane,Mitochondria" NA NA "Nucleoplasm, Nuclear membrane, Mitochondria" "HPA014504: AB_1853881" "unprognostic (1.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.87e-1)" "unprognostic (3.15e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-2)" "unprognostic (3.20e-3)" "unprognostic (1.97e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-3)" "unprognostic (1.29e-1)" "unprognostic (2.50e-1)" "unprognostic (5.20e-2)" "unprognostic (7.26e-2)" "unprognostic (1.66e-1)" "unprognostic (1.14e-3)" "unprognostic (9.75e-2)" 10.9 20.6 12.8 13.4 19.5 8.7 11.6 11.1 25.5 11.7 15.2 13.4 12.0 16.6 12.7 15.5 12.3 11.9 11.8 21.7 12.6 12.8 19.5 20.4 10.5 16.2 12.4 15.6 12.5 38.7 10.4 13.0 10.9 13.2 14.8 11.6 13.9 22.4 15.0 21.3 16.2 18.2 8.4 11.1 16.1 16.2 8.2 11.6 19.0 13.4 10.6 14.2 11.1 10.2 32.4 28.0 8.9 16.6 23.1 30.7 15.3 15.3 13.2 7.9 10.8 6.3 7.3 10.8 8.3 7.3 9.4 7.9 11.5 18.9 11.6 20.5 5.9 12.4 23.5 9.5 10.2 5.4 18.3 17.8 8.6 14.8 13.7 11.7 10.5 10.2 7.8 10.4 6.2 7.8 11.1 7.2 15.4 13.0 8.7 6.9 22.4 10.5 23.4 15.6 16.1 16.0 13.1 9.6 25.8 14.5 9.8 13.5 17.9 8.7 17.7 21.9 8.4 26.4 9.9 7.5 11.3 13.6 10.3 9.8 17.9 14.2 13.2 13.4 9.5 11.7 7.3 16.1 8.9 28.4 16.6 27.2 28.2 28.1 27.6 17.5 32.4 30.7 29.8 7.5 23.1 10.5 28.0 23.9 15.3 12.8 19.5 11.1 25.5 12.6 12.8 12.4 15.6 13.2 11.6 11.9 3.5 22.6 13.7 11.9 18.5 16.8 40.8 36.1 13.6 19.2 11.8 41.9 53.0 32.8 1.9 17.5 26.1 0.0 38.3 35.7 20.6 16.0 19.6 34.8 32.6 6.4 19.8 31.3 19.6 2.6 30.2 16.6 18.6 16.2 29.2 14.8 31.4 14.0 24.8 47.6 17.3 19.4 9.6 6.3 21.2 12.2 11.9 29.9 38.6 14.5 TNNC1 TNNC ENSG00000114854 "Troponin C1, slow skeletal and cardiac type" P63316 3 52451102-52454070 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "heart muscle: 431.6;skeletal muscle: 765.7" "Cell type enriched" "Detected in many" 8 "Cardiomyocytes: 2506.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 4.0" "Lineage enriched" "Detected in single" 7 "T-cells: 4.0" "Cell line enhanced" "Detected in some" "CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5" "Region enriched" "Detected in many" 4 "cerebral cortex: 88.3" "Not detected" "Not detected" "CAB002450, HPA044848, HPA056897" Enhanced Approved "Nucleoplasm,Actin filaments,Mitochondria" NA NA 260000 "Nucleoplasm, Actin filaments, Mitochondria" "CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269" "unprognostic (2.18e-2)" "unprognostic (1.70e-1)" "unprognostic (8.66e-2)" "unprognostic (3.43e-1)" "unprognostic (4.00e-2)" "unprognostic (1.88e-2)" "unprognostic (1.11e-1)" "unprognostic (1.43e-1)" "unprognostic (1.53e-1)" "unprognostic (3.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.15e-2)" "unprognostic (4.95e-2)" "unprognostic (2.31e-1)" "unprognostic (4.15e-2)" "unprognostic (4.86e-1)" 2.0 0.3 0.1 0.0 0.1 0.0 0.7 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 17.8 12.8 0.1 0.0 431.6 0.1 0.1 0.6 0.1 2.6 0.0 0.1 0.0 0.1 0.2 0.0 0.6 0.2 0.5 5.5 0.1 0.7 10.4 0.0 765.7 0.4 0.1 0.1 0.7 0.1 0.1 0.7 0.0 0.0 3.0 86.9 8.7 0.4 0.2 0.2 0.6 0.0 0.0 0.0 4.0 0.5 0.2 1.8 1.3 0.2 0.0 0.2 2.9 0.1 0.1 0.1 0.1 24.3 12.2 0.2 24.4 3.5 0.0 0.1 0.0 0.1 0.0 0.4 0.6 0.1 16.0 16.2 0.1 0.1 0.0 25.3 0.4 0.0 0.2 0.2 0.0 0.7 0.0 1.9 0.7 0.0 0.0 0.2 0.2 5.4 0.2 0.0 1.0 0.8 1.2 4.6 0.0 0.0 0.1 2.5 0.0 1.5 9.8 0.2 0.0 0.0 37.5 0.3 0.0 1.0 0.4 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.7 0.0 4.0 0.2 0.9 0.5 0.0 0.1 1.4 0.5 0.0 0.0 0.0 0.6 2.5 0.5 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.5 0.0 116.1 13.0 0.0 0.6 1.3 0.2 2506.5 0.0 0.0 7.9 3.5 2.0 44.2 23.2 6.6 0.6 0.0 0.7 0.0 11.8 4.0 14.0 0.6 0.0 0.6 4.1 0.0 318.5 0.6 0.0 3.6 20.8 1.0 5.0 0.0 0.3 1.5 4.4 0.0 166.9 0.5 0.0 0.0 15.5 1.2 0.4 0.6 26.0 0.8 1.5 4.1 TOMM34 "HTOM34P, TOM34" ENSG00000025772 "Translocase of outer mitochondrial membrane 34" Q15785 20 44942130-44960486 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.2;testis: 53.2" "Cell type enhanced" "Detected in many" 12 "monocytes: 303.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018845, HPA056875" Enhanced Supported Vesicles,Mitochondria,Cytosol NA NA Cytosol "Vesicles, Mitochondria" "HPA018845: AB_1858184, HPA056875: AB_2683264" "unprognostic (4.96e-2)" "unprognostic (6.88e-2)" "unprognostic (5.05e-2)" "unprognostic (1.36e-3)" "unprognostic (4.91e-2)" "prognostic unfavorable (4.47e-5)" "prognostic unfavorable (8.71e-6)" "unprognostic (2.55e-1)" "unprognostic (5.04e-2)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (2.11e-2)" "unprognostic (1.55e-2)" "unprognostic (3.04e-1)" "unprognostic (1.02e-1)" "prognostic favorable (5.45e-4)" "unprognostic (5.79e-3)" 4.4 17.9 14.9 6.4 56.2 8.7 7.3 4.2 18.1 7.2 7.1 5.3 5.6 5.8 7.1 25.6 7.2 24.9 6.8 6.3 35.3 11.0 11.9 7.9 5.9 8.8 8.6 14.4 13.9 8.2 11.2 10.5 15.1 13.9 7.6 9.3 8.0 6.3 9.0 6.3 5.5 5.6 7.7 5.7 5.8 7.0 53.2 5.6 7.0 8.3 7.2 10.4 8.8 6.3 18.8 26.1 9.5 11.5 8.7 12.3 10.7 33.1 11.7 10.4 22.1 9.6 9.5 23.5 19.3 28.2 24.2 17.7 47.2 12.5 22.8 16.7 15.1 24.7 21.0 25.4 41.8 28.3 4.0 11.8 17.9 15.5 33.2 12.3 11.7 11.1 10.3 11.7 33.8 60.8 21.3 24.6 9.4 20.3 9.4 22.9 21.9 12.3 16.2 12.2 17.7 44.5 10.7 11.0 24.6 19.7 18.7 17.9 10.6 26.4 18.4 22.8 8.4 13.8 10.2 14.5 32.0 21.1 15.3 28.8 8.2 9.6 18.9 29.2 14.0 12.4 8.3 11.1 9.5 10.4 11.5 11.0 17.3 10.9 11.0 26.1 18.8 12.3 9.7 3.1 8.7 11.2 13.7 12.3 10.7 14.9 56.2 4.2 18.1 35.3 11.0 8.6 14.4 13.9 5.6 6.0 8.6 13.0 69.8 12.2 3.6 9.0 7.6 64.3 18.2 12.2 3.9 98.4 26.6 29.7 14.0 10.8 6.7 0.0 26.6 29.1 11.6 59.4 9.2 9.6 19.7 3.2 11.5 5.5 3.9 24.2 6.4 10.5 6.8 303.0 8.2 13.2 32.2 9.3 6.0 16.5 4.1 0.0 12.2 45.4 36.6 9.7 47.3 6.9 12.8 47.8 TSPO "BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS" ENSG00000100300 "Translocator protein" "B1AH88, P30536" 22 43151514-43163242 "Cancer-related genes, FDA approved drug targets, Predicted membrane proteins" "Lipid transport, Transport" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 139.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 81.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB011232, HPA046260, HPA072304" Uncertain Supported Vesicles,Mitochondria,Cytosol NA NA Mitochondria "Vesicles, Cytosol" "CAB011232: , HPA046260: , HPA072304: " "unprognostic (5.29e-3)" "unprognostic (1.41e-1)" "unprognostic (3.31e-1)" "unprognostic (4.02e-3)" "unprognostic (3.95e-1)" "unprognostic (1.46e-2)" "prognostic unfavorable (1.61e-4)" "unprognostic (2.16e-1)" "unprognostic (1.17e-1)" "unprognostic (3.75e-2)" "unprognostic (1.07e-2)" "unprognostic (1.33e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-2)" "unprognostic (3.03e-1)" "unprognostic (1.04e-1)" "unprognostic (2.34e-3)" 33.9 21.2 9.8 17.8 11.0 117.3 48.7 2.7 8.1 24.9 23.9 12.3 10.3 20.5 12.3 13.6 83.2 14.3 36.8 32.1 8.0 5.4 18.0 22.0 39.8 40.0 15.4 5.2 13.3 13.2 4.0 6.7 15.5 9.7 23.1 9.7 16.4 34.6 9.2 13.2 46.6 23.0 12.7 11.4 27.2 39.0 10.5 10.0 9.4 17.9 44.3 50.0 19.1 41.3 22.9 99.9 91.4 139.5 28.5 43.8 104.8 47.6 23.6 1.6 22.4 9.0 29.9 1.8 35.6 17.4 17.9 19.1 4.6 36.5 0.0 24.7 27.6 8.8 39.5 4.5 27.6 2.3 7.9 18.6 4.8 25.9 1.6 32.7 10.8 24.4 23.2 45.5 10.6 9.5 21.1 42.4 0.0 3.9 9.0 18.3 39.9 0.1 30.2 1.9 24.6 59.0 10.7 0.0 81.4 22.9 28.8 2.3 11.0 16.9 33.8 41.5 0.0 12.7 42.0 43.7 22.3 16.7 22.7 14.9 3.6 0.6 0.4 28.9 35.1 28.5 43.8 139.5 75.3 28.4 86.3 22.2 16.3 39.5 27.8 99.9 22.9 30.4 24.5 91.4 28.5 57.1 17.7 43.8 104.8 9.8 11.0 2.7 8.1 8.0 5.4 15.4 5.2 9.7 10.0 148.9 135.1 105.0 344.2 325.8 2.2 79.7 336.3 127.2 167.2 195.4 2.0 9.0 313.4 570.0 2.1 215.5 499.4 46.7 512.5 126.3 307.4 297.1 261.1 99.0 745.0 3.2 187.3 163.2 688.0 6.1 76.5 573.3 686.7 477.9 485.1 116.9 963.2 644.9 148.2 97.5 17.1 103.5 217.3 1.1 4.9 468.6 16.7 155.6 529.3 666.0 TTC9B FLJ30373 ENSG00000174521 "Tetratricopeptide repeat domain 9B" Q8N6N2 19 40216058-40218399 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 47.9" "Cell type enhanced" "Detected in some" 26 "Bipolar cells: 37.7;Horizontal cells: 17.5;Rod photoreceptor cells: 7.3" "Cancer enriched" "Detected in single" 15 "glioma: 4.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "non-classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 19 "SCLC-21H: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042496 Approved Approved Nucleoplasm,Vesicles,Mitochondria "Secreted in brain" NA NA "Nucleoplasm, Mitochondria" Vesicles "HPA042496: AB_10795506" "unprognostic (2.31e-1)" "unprognostic (1.39e-4)" "unprognostic (5.09e-2)" "unprognostic (5.24e-2)" "unprognostic (8.47e-2)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (7.95e-2)" "unprognostic (2.78e-1)" "unprognostic (1.54e-2)" "unprognostic (3.69e-1)" "unprognostic (8.75e-6)" "unprognostic (1.39e-1)" "unprognostic (8.23e-2)" "unprognostic (1.95e-1)" "unprognostic (5.24e-2)" 1.0 1.8 45.5 1.4 10.3 1.0 1.0 24.6 47.9 1.0 1.2 1.2 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 22.3 14.0 1.0 1.0 1.0 1.0 7.5 9.9 1.0 1.0 1.0 0.0 1.0 7.1 1.0 1.0 0.3 1.0 1.0 1.0 1.0 1.2 1.1 2.5 1.0 1.1 1.1 1.0 0.0 1.0 0.0 1.0 1.0 0.0 0.1 0.5 0.0 1.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 25.1 1.3 0.1 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.4 0.1 0.0 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.5 0.3 0.0 45.5 10.3 24.6 31.3 22.3 14.0 7.5 9.9 7.1 1.0 0.0 0.0 0.0 0.0 0.0 37.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 17.5 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 1.3 0.1 0.2 0.7 0.0 7.3 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.2 0.1 TXNRD2 "TR, TR3, TRXR2" ENSG00000184470 "Thioredoxin reductase 2" Q9NNW7 22 19875517-19941992 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 49.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002007, HPA003323" Supported Approved Vesicles,Mitochondria,Cytosol NA NA 410000 "Vesicles, Mitochondria, Cytosol" "CAB002007: , HPA003323: AB_1080396" "unprognostic (3.17e-2)" "unprognostic (8.72e-2)" "unprognostic (4.30e-1)" "unprognostic (9.71e-3)" "unprognostic (7.25e-2)" "unprognostic (6.35e-2)" "unprognostic (3.21e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (2.83e-1)" "unprognostic (4.94e-3)" "unprognostic (2.49e-1)" "prognostic favorable (1.10e-7)" "unprognostic (2.47e-1)" "unprognostic (5.99e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" 9.8 30.2 8.5 8.3 10.1 11.6 7.4 19.0 15.0 8.3 10.3 9.0 7.6 9.2 11.9 12.3 8.8 8.4 13.0 22.6 8.3 7.5 13.9 40.9 10.8 8.4 7.8 9.7 11.9 13.0 9.9 9.9 14.0 7.1 17.9 4.5 10.0 15.2 8.8 16.5 6.0 10.2 5.4 5.6 11.2 14.6 10.5 6.8 4.9 12.6 9.2 10.5 7.5 7.9 4.8 9.1 5.8 12.1 4.8 4.9 4.9 6.4 13.3 1.2 5.2 2.4 3.4 3.0 6.2 7.3 11.2 8.3 12.4 6.7 3.6 15.1 6.5 11.6 11.4 6.2 8.5 4.3 6.8 15.3 6.0 10.6 7.3 4.6 6.7 2.9 3.3 6.5 5.7 4.9 4.6 31.8 0.7 33.2 6.1 8.7 15.6 2.3 10.0 6.1 15.9 9.5 3.4 29.6 3.3 6.8 7.0 6.6 5.8 10.7 13.9 7.1 2.1 11.4 9.1 17.7 8.2 49.4 6.8 13.0 6.1 4.4 2.2 7.9 5.1 10.3 3.2 12.1 5.8 4.3 9.2 3.3 4.8 3.8 3.9 9.1 3.6 4.9 4.0 1.3 4.8 8.7 3.4 2.4 4.9 8.5 10.1 19.0 15.0 8.3 7.5 7.8 9.7 7.1 6.8 14.9 27.1 5.2 19.2 3.8 20.0 13.6 17.8 13.4 10.3 19.2 9.8 51.6 49.7 18.7 21.0 11.3 13.5 0.0 27.8 19.6 12.5 19.5 1.1 47.4 23.3 9.5 1.2 10.4 20.5 14.1 14.4 12.1 5.0 25.2 12.1 19.0 19.9 14.0 8.5 44.0 9.5 6.5 9.1 8.6 12.8 4.5 35.1 11.7 14.7 12.7 UBE3C "KIAA0010, KIAA10" ENSG00000009335 "Ubiquitin protein ligase E3C" Q15386 7 157138913-157269372 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039915 Approved Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA039915: AB_10795264" "unprognostic (2.83e-2)" "unprognostic (9.27e-3)" "unprognostic (2.41e-1)" "unprognostic (2.29e-1)" "unprognostic (1.19e-2)" "unprognostic (3.14e-2)" "unprognostic (1.36e-1)" "unprognostic (7.02e-2)" "unprognostic (2.34e-2)" "unprognostic (1.58e-1)" "unprognostic (3.01e-3)" "unprognostic (8.64e-2)" "prognostic favorable (9.18e-6)" "unprognostic (9.74e-2)" "unprognostic (1.86e-1)" "unprognostic (1.87e-1)" "unprognostic (3.60e-2)" 24.7 21.0 14.0 17.9 23.1 12.4 19.8 25.5 29.9 21.3 23.4 17.2 15.3 17.4 28.8 16.8 26.8 18.8 24.8 31.8 14.4 13.8 21.2 30.5 16.7 16.7 14.5 15.1 20.7 22.1 29.6 20.3 21.3 22.3 19.0 21.0 20.2 31.7 21.5 51.2 21.2 23.9 25.7 16.1 20.5 21.8 35.9 11.1 20.3 15.6 24.5 24.4 23.1 19.1 2.5 4.0 2.1 4.6 3.7 6.6 2.9 22.8 18.2 11.7 23.3 21.0 22.1 12.9 25.3 21.9 21.4 21.7 16.3 19.1 12.4 22.5 27.9 27.9 14.5 18.1 23.3 25.4 22.5 16.6 12.6 12.7 11.7 20.9 18.8 18.5 19.5 21.6 23.7 19.7 16.3 24.9 10.4 18.3 13.8 30.2 20.0 18.4 11.9 18.5 20.5 21.9 10.6 13.1 25.4 22.1 25.2 18.7 19.3 24.9 21.5 18.5 13.6 11.1 13.2 22.3 27.0 5.8 66.1 31.3 13.9 13.9 12.5 31.0 28.1 30.8 0.5 3.5 2.1 4.8 4.6 6.6 2.5 5.2 5.2 4.0 2.5 4.9 5.9 1.3 3.7 4.5 3.6 5.2 2.9 14.0 23.1 25.5 29.9 14.4 13.8 14.5 15.1 22.3 11.1 20.8 19.5 9.7 13.9 24.5 31.4 31.5 28.1 16.0 9.1 24.4 62.8 12.2 8.3 17.0 8.4 19.9 22.1 0.0 15.2 14.4 14.7 19.9 9.2 39.2 13.9 30.2 23.5 24.5 21.2 8.5 14.4 15.0 5.0 12.6 20.6 10.9 22.5 10.5 24.1 16.5 42.8 0.0 17.6 20.4 27.4 29.1 12.6 13.8 22.4 27.3 UGP2 "UGP1, UGPP1" ENSG00000169764 "UDP-glucose pyrophosphorylase 2" Q16851 2 63840940-63891562 "Enzymes, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 185.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 93.6;T-reg: 29.9" "Group enriched" "Detected in all" 5 "granulocytes: 93.6;T-cells: 29.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034696, HPA034697, HPA064836" Enhanced Approved Nucleoplasm,Centrosome,Mitochondria NA NA 12000000 "Centrosome, Mitochondria" Nucleoplasm "HPA034696: AB_10670171, HPA034697: AB_2674287, HPA064836: AB_2685365" "unprognostic (1.00e-2)" "unprognostic (6.93e-2)" "unprognostic (5.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.65e-2)" "unprognostic (1.91e-1)" "prognostic favorable (2.50e-5)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-2)" "unprognostic (8.31e-2)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (3.93e-2)" "unprognostic (3.81e-1)" "unprognostic (8.44e-2)" 58.2 14.7 23.3 13.6 22.5 7.8 25.2 12.4 30.4 13.3 38.2 6.7 7.4 12.3 15.5 12.5 19.8 12.7 12.2 46.3 18.8 13.2 33.0 185.5 12.7 15.2 17.3 18.3 12.0 13.4 17.1 22.9 31.0 19.3 11.0 33.1 5.7 18.5 12.9 104.1 11.0 17.2 16.8 8.6 9.9 13.0 8.1 10.5 31.0 17.4 75.5 12.7 19.7 19.5 6.4 5.9 93.6 7.8 12.7 29.9 11.0 27.5 14.5 13.9 9.3 47.4 61.5 58.3 35.6 29.1 19.2 22.9 37.1 23.4 28.9 10.7 38.2 17.5 12.1 16.8 22.3 31.2 19.3 7.1 18.3 10.3 25.3 22.7 16.1 16.1 40.3 40.9 18.0 18.6 25.9 26.6 9.8 9.1 11.7 80.1 10.8 21.8 15.2 33.3 45.0 10.2 17.9 27.6 16.6 34.0 16.0 7.3 6.0 28.4 36.6 13.5 44.1 10.4 11.5 36.3 20.1 31.7 29.9 18.7 21.0 9.4 36.6 24.1 25.3 61.3 93.6 7.0 9.7 9.9 7.8 10.3 6.4 11.4 10.3 5.9 6.2 12.6 11.2 9.0 12.7 7.6 5.5 29.9 11.0 23.3 22.5 12.4 30.4 18.8 13.2 17.3 18.3 19.3 10.5 26.8 52.5 51.7 74.0 67.3 48.5 238.8 89.2 73.6 69.4 45.4 60.9 359.1 205.6 116.3 61.0 61.3 412.6 0.0 90.6 369.3 148.4 77.6 65.8 448.9 107.3 82.6 42.9 66.3 100.6 64.7 73.4 90.8 91.1 173.1 112.3 37.4 81.0 167.8 72.9 209.2 49.4 71.1 124.3 71.2 57.5 50.6 395.3 112.8 144.5 90.3 ULK4 "FAM7C1, FLJ20574, REC01035" ENSG00000168038 "Unc-51 like kinase 4" Q96C45 3 41246599-41962430 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 279.5;Late spermatids: 329.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017930 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA017930: AB_1858615" "unprognostic (3.16e-2)" "unprognostic (2.98e-3)" "unprognostic (9.72e-3)" "unprognostic (3.46e-2)" "unprognostic (2.58e-1)" "unprognostic (8.68e-2)" "unprognostic (1.87e-1)" "unprognostic (3.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.41e-1)" "unprognostic (3.75e-3)" "unprognostic (3.43e-1)" "unprognostic (1.91e-2)" "unprognostic (5.46e-2)" "unprognostic (1.61e-1)" "unprognostic (2.53e-1)" "unprognostic (6.12e-2)" 4.3 4.8 5.1 4.7 8.3 10.3 4.2 4.3 5.4 11.9 2.8 5.9 6.0 2.1 10.7 10.9 2.8 12.3 3.1 13.1 5.2 3.0 5.4 3.4 5.5 4.2 3.1 4.2 4.5 3.6 13.5 19.7 9.0 5.8 4.4 2.8 6.7 4.2 4.5 1.4 3.5 3.3 5.1 5.7 4.4 3.4 27.5 3.4 6.3 7.1 1.7 8.4 4.0 6.0 6.4 5.1 10.7 6.3 2.6 10.3 5.2 7.3 1.7 2.7 3.0 1.1 1.7 4.6 2.5 2.6 3.1 2.6 0.9 2.2 8.6 1.4 5.8 3.0 3.7 3.2 1.9 2.8 1.1 0.9 1.6 5.4 2.9 3.9 5.6 1.7 1.6 2.2 15.0 3.1 3.9 2.1 5.9 1.9 7.2 2.2 5.9 7.0 4.5 3.3 1.8 3.1 1.6 8.5 3.7 6.5 7.1 1.4 9.9 2.6 1.2 2.1 1.8 3.0 1.8 6.2 2.0 2.2 13.2 2.1 4.3 8.0 3.6 11.0 5.9 2.4 5.7 5.8 5.8 8.0 6.3 6.5 5.6 8.6 7.2 5.1 6.4 6.5 9.2 10.7 2.6 3.2 4.6 10.3 5.2 5.1 8.3 4.3 5.4 5.2 3.0 3.1 4.2 5.8 3.4 8.9 5.8 1.9 2.8 1.8 5.4 12.8 5.1 53.5 4.5 3.5 51.1 2.8 0.0 2.3 279.5 4.4 1.1 0.0 2.1 3.9 3.3 1.2 1.1 5.9 6.5 11.1 1.7 1.8 4.1 329.6 6.1 5.6 0.0 6.4 1.1 11.2 2.8 0.0 3.9 5.0 25.1 6.5 3.3 29.9 8.7 3.1 3.5 4.4 1.7 0.8 UPP2 "UDRPASE2, UP2, UPASE2" ENSG00000007001 "Uridine phosphorylase 2" O95045 2 157876702-158136154 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 40.1;liver: 22.1" "Group enriched" "Detected in some" 4 "Distal tubular cells: 11.6;Proximal tubular cells: 23.3" "Cancer enriched" "Detected in some" 6 "liver cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035225, HPA035226" Approved Nucleoplasm,Vesicles,Mitochondria NA NA Nucleoplasm "Vesicles, Mitochondria" "HPA035225: AB_10604002, HPA035226: AB_10696503" "unprognostic (1.87e-1)" "unprognostic (2.33e-1)" "unprognostic (4.22e-3)" "unprognostic (1.36e-3)" "unprognostic (2.29e-1)" "unprognostic (1.55e-1)" "unprognostic (3.53e-2)" "unprognostic (5.51e-2)" "unprognostic (5.11e-2)" "unprognostic (1.23e-2)" "unprognostic (4.65e-3)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (4.89e-2)" "unprognostic (2.78e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-2)" 1.2 0.4 1.8 0.3 4.1 0.3 1.6 6.9 2.0 0.4 0.3 1.5 0.7 0.3 1.2 2.4 1.0 0.4 2.5 0.8 2.9 1.2 40.1 22.1 0.3 0.4 1.2 0.9 0.6 0.4 0.3 3.9 0.4 1.3 2.3 0.3 1.1 1.7 0.7 0.3 0.6 0.4 0.3 2.3 0.3 0.3 0.4 1.0 0.0 0.5 0.0 0.7 0.4 0.2 0.8 0.0 1.0 0.1 0.0 0.2 0.0 0.3 0.2 0.6 0.6 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 1.8 0.2 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.9 0.0 0.7 0.8 0.9 0.0 0.0 0.0 0.1 1.1 0.6 1.2 1.4 0.3 0.0 0.3 0.6 0.6 0.4 0.4 0.5 0.0 0.4 0.8 0.1 0.0 0.2 0.2 0.0 0.0 1.2 0.1 0.4 0.3 1.2 0.4 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.1 0.0 1.8 4.1 6.9 2.0 2.9 1.2 1.2 0.9 1.3 1.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.6 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673687 "Disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 10.0 13.4 8.9 11.4 8.5 10.6 14.7 8.7 9.9 7.3 15.4 4.7 19.7 16.5 7.3 8.5 14.5 6.5 12.4 13.2 8.0 8.7 10.7 13.4 5.6 8.3 8.5 8.7 9.5 15.4 5.3 7.6 6.2 7.7 12.3 4.9 7.1 22.9 14.1 27.8 8.6 14.8 6.0 6.2 9.6 12.2 5.7 5.4 6.4 13.5 12.3 9.1 8.0 18.1 23.7 21.2 15.2 20.8 14.0 19.4 15.5 12.0 24.5 3.6 5.6 2.2 2.2 3.0 4.8 1.6 3.6 3.6 14.3 10.5 7.8 10.0 1.6 4.9 12.0 3.4 5.6 1.1 3.9 12.7 4.4 12.8 9.1 3.0 7.1 3.6 2.1 4.8 3.2 3.6 2.3 2.8 3.8 9.4 5.7 2.0 36.8 6.9 17.5 4.0 4.8 13.9 8.1 5.5 13.9 2.7 6.0 7.3 7.4 5.3 19.4 7.1 1.1 18.4 6.7 3.6 7.9 9.3 8.2 10.6 8.8 4.8 8.1 6.5 6.2 5.7 9.1 20.8 15.2 18.1 14.4 17.1 23.5 18.0 15.9 15.8 23.7 16.6 13.3 8.9 14.0 12.7 21.2 19.4 15.5 8.9 8.5 8.7 9.9 8.0 8.7 8.5 8.7 7.7 5.4 41.7 23.5 61.4 42.6 0.0 20.8 31.7 66.2 22.7 29.6 61.1 15.7 44.7 119.3 51.7 1.4 26.8 115.3 46.7 67.1 41.2 21.0 70.4 4.7 99.1 47.7 17.5 33.9 39.9 38.4 2.3 44.8 22.9 0.0 43.3 98.1 39.6 57.0 91.2 33.9 137.3 26.2 38.8 31.1 2.7 33.7 0.0 24.3 25.9 101.8 45.4 USP48 "FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31" ENSG00000090686 "Ubiquitin specific peptidase 48" Q86UV5 1 21678298-21783606 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030045, HPA030046" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA030045: AB_10670833, HPA030046: AB_10603325" "unprognostic (1.35e-1)" "unprognostic (3.72e-1)" "unprognostic (5.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.23e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (6.09e-8)" "unprognostic (1.04e-2)" "unprognostic (3.01e-3)" "unprognostic (9.30e-2)" "unprognostic (7.54e-2)" "unprognostic (4.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-1)" "unprognostic (5.70e-2)" "unprognostic (2.80e-2)" 20.1 38.8 18.6 28.9 30.9 30.9 22.1 48.2 27.5 19.9 18.4 25.6 15.4 17.6 21.3 17.6 19.0 17.4 20.5 17.8 16.9 15.8 15.5 18.3 18.3 26.2 26.6 22.5 27.0 19.8 24.6 35.4 23.1 26.8 21.6 22.0 22.1 24.5 16.3 17.0 23.9 22.2 22.2 19.7 29.1 26.2 15.8 23.6 25.8 23.9 14.0 29.0 19.8 21.0 13.7 10.5 33.7 9.6 5.6 11.2 5.6 14.9 7.1 16.8 12.1 14.6 18.0 16.6 18.8 12.8 12.7 16.8 6.5 15.3 16.8 12.7 17.0 9.9 13.8 20.6 15.2 19.3 16.3 14.1 35.9 26.5 11.8 13.0 18.0 19.2 14.6 13.1 12.8 14.3 17.4 37.2 12.8 28.2 47.5 15.5 7.4 14.9 23.4 10.5 15.3 12.8 21.0 16.9 19.6 14.5 12.6 20.5 12.8 17.7 16.3 42.5 23.5 8.3 21.8 26.4 13.7 11.2 16.7 10.9 38.2 27.1 16.7 13.2 22.3 20.0 33.7 9.6 16.7 6.4 4.6 7.6 13.7 9.5 9.5 10.5 12.8 11.2 7.0 8.9 5.6 5.0 7.7 10.1 5.6 18.6 30.9 48.2 27.5 16.9 15.8 26.6 22.5 26.8 23.6 50.6 38.5 34.3 22.6 19.7 74.8 58.2 22.9 32.1 20.5 19.2 58.9 51.8 21.6 25.0 51.8 24.5 18.7 70.0 17.5 50.1 30.9 20.6 47.5 21.2 26.0 47.7 20.8 28.3 22.2 33.0 32.2 24.7 55.6 47.7 26.9 29.1 20.0 17.5 48.4 16.5 69.2 32.3 25.0 42.9 48.2 22.5 27.2 35.5 30.2 17.1 VASN SLITL2 ENSG00000168140 Vasorin Q6EMK4 16 4371848-4383528 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 108.9;Peritubular cells: 57.3;Sertoli cells: 97.0;Smooth muscle cells: 96.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "U-2197: 126.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011246, HPA016992" Uncertain Approved Nucleoplasm,Nucleoli,Mitochondria "Secreted - unknown location" NA Yes 2400000000 Mitochondria "Nucleoplasm, Nucleoli" "HPA011246: AB_1858720, HPA016992: AB_2732418" "unprognostic (2.20e-1)" "unprognostic (2.75e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (6.24e-5)" "unprognostic (2.35e-3)" "unprognostic (8.91e-3)" "unprognostic (3.15e-3)" "unprognostic (5.92e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.81e-1)" "unprognostic (8.82e-3)" "unprognostic (4.23e-2)" "unprognostic (4.95e-3)" "unprognostic (5.27e-2)" 22.4 10.2 4.9 7.7 6.7 3.8 28.6 1.6 6.5 19.9 5.1 5.6 6.4 5.1 14.3 13.6 16.2 9.9 10.2 12.9 4.4 1.8 21.6 14.1 17.2 5.2 2.7 2.9 21.0 9.8 1.7 5.9 30.2 4.8 12.9 2.0 33.6 7.9 13.1 7.0 16.0 4.0 9.4 3.6 7.9 6.5 14.7 3.5 0.0 15.2 5.5 8.2 16.6 19.0 0.3 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.0 2.8 3.2 1.2 5.3 5.2 1.6 2.7 0.3 0.6 0.0 1.9 3.5 0.2 0.0 0.0 0.1 0.2 1.2 0.1 0.1 1.5 1.6 10.2 0.0 0.0 3.3 0.0 4.0 0.1 2.7 0.0 0.0 0.2 0.0 0.2 1.8 0.0 0.4 0.3 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.1 0.9 2.5 4.2 0.0 0.2 0.9 0.2 0.0 4.9 1.3 126.7 0.6 0.0 0.0 0.0 1.5 0.0 0.4 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.9 6.7 1.6 6.5 4.4 1.8 2.7 2.9 4.8 3.5 6.0 12.5 0.9 6.0 8.5 0.0 12.9 35.7 1.4 3.4 22.7 0.0 3.0 6.6 10.3 1.0 3.3 0.2 0.0 2.6 6.4 108.9 7.4 3.5 12.9 2.8 0.0 0.0 4.9 0.3 1.8 46.3 1.2 13.5 0.0 0.4 16.3 17.4 0.0 57.3 12.5 0.7 97.0 96.8 0.5 5.1 6.6 8.4 1.8 0.2 3.3 VWA5B1 FLJ32784 ENSG00000158816 "Von Willebrand factor A domain containing 5B1" Q5TIE3 1 20290919-20354894 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.6;epididymis: 6.4;testis: 6.9" "Group enriched" "Detected in some" 12 "Early spermatids: 7.7;Late spermatids: 6.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 5 "pons and medulla: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "SCLC-21H: 5.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA027496, HPA028405, HPA064829" Enhanced Approved "Plasma membrane,Mitochondria,Cytosol" "Secreted in male reproductive system" NA NA Mitochondria "Plasma membrane, Cytosol" "HPA027496: AB_10599853, HPA028405: AB_10600992, HPA064829: AB_2685363" "unprognostic (2.34e-1)" "unprognostic (2.91e-1)" "unprognostic (7.78e-2)" "unprognostic (1.16e-2)" "unprognostic (4.73e-2)" "unprognostic (1.21e-2)" "unprognostic (1.09e-1)" "unprognostic (1.86e-2)" "unprognostic (4.39e-2)" "unprognostic (1.73e-1)" "unprognostic (5.41e-4)" "unprognostic (7.43e-4)" "unprognostic (1.82e-2)" "unprognostic (3.33e-2)" "unprognostic (1.03e-1)" 0.0 1.2 0.7 0.2 3.3 0.0 0.0 0.0 0.5 0.0 0.0 6.1 0.0 0.0 0.0 6.4 0.1 0.7 0.5 0.1 2.8 3.3 2.0 0.0 0.1 0.2 0.2 0.4 0.0 0.1 2.2 5.6 0.2 17.6 0.2 0.0 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 6.9 0.5 0.0 0.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.5 2.8 3.3 0.2 0.4 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 WDR26 "FLJ21016, GID7" ENSG00000162923 "WD repeat domain 26" Q9H7D7 1 224385143-224437033 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.9" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 178.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028538, HPA028539, HPA061094" Enhanced Enhanced Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Cytosol" Mitochondria "HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427" "unprognostic (4.09e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (1.31e-2)" "unprognostic (6.67e-2)" "unprognostic (2.27e-1)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (8.42e-2)" "unprognostic (6.32e-2)" "unprognostic (5.59e-2)" "unprognostic (4.18e-1)" "prognostic unfavorable (3.31e-6)" "unprognostic (8.40e-3)" "unprognostic (4.00e-1)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" 8.2 7.2 6.7 6.7 6.7 18.5 7.2 8.2 7.3 7.8 7.0 6.7 6.7 4.0 6.8 9.3 13.0 5.9 7.0 7.5 6.7 5.0 6.7 9.3 9.0 7.2 6.7 6.7 7.0 6.9 9.2 6.7 8.7 6.7 7.0 6.7 6.7 7.2 6.7 15.2 9.9 6.7 7.1 6.7 10.2 6.3 63.9 6.7 6.7 7.0 6.7 7.4 6.7 8.3 1.5 2.1 8.3 3.9 2.7 2.7 1.3 11.9 6.2 19.3 8.9 25.8 29.4 13.9 17.6 28.8 16.1 15.2 9.8 13.6 14.2 17.7 28.3 6.2 10.9 11.3 15.1 26.5 11.1 12.9 9.8 8.1 9.2 28.1 10.2 17.2 27.3 21.9 17.0 16.1 26.7 26.8 8.7 12.9 14.7 21.1 6.6 10.5 9.9 18.6 12.4 7.2 9.7 20.2 11.2 19.6 12.1 7.0 17.9 20.0 27.1 21.5 21.1 31.1 16.8 28.1 13.8 6.3 12.9 21.1 15.7 7.5 9.7 15.7 7.3 17.0 4.1 1.9 3.3 2.7 2.4 1.5 1.5 1.9 2.1 1.8 1.4 1.4 2.1 8.3 2.7 3.9 2.1 1.6 1.3 6.7 6.7 8.2 6.7 6.7 5.0 6.7 6.7 6.7 6.7 98.3 43.8 19.4 25.3 99.0 23.8 42.4 45.9 41.5 50.0 33.2 29.5 23.4 5.0 19.2 178.7 37.6 21.6 0.0 20.3 11.8 51.5 39.3 46.2 31.0 44.5 36.5 34.0 44.2 119.9 79.7 34.2 49.8 43.9 12.6 40.3 16.9 26.6 25.9 26.5 17.0 22.9 19.4 41.9 36.4 24.6 107.0 57.1 31.6 23.8 59.3 XAF1 "BIRC4BP, HSXIAPAF1, XIAPAF1" ENSG00000132530 "XIAP associated factor 1" Q6GPH4 17 6755447-6775647 "Predicted intracellular proteins" Apoptosis "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 56.6;Club cells: 50.0;granulocytes: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 33.1;BJ hTERT+ SV40 Large T+ RasG12V: 34.2;HHSteC: 15.2" HPA057302 Approved Supported "Nucleoplasm,Mitochondria,Rods & Rings" Yes NA Mitochondria "Nucleoplasm, Rods & Rings" "HPA057302: AB_2683405" "unprognostic (6.28e-2)" "unprognostic (1.71e-1)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (3.81e-1)" "unprognostic (1.11e-2)" "unprognostic (5.09e-3)" "unprognostic (4.89e-2)" "unprognostic (1.39e-1)" "unprognostic (8.08e-3)" "unprognostic (3.34e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.73e-7)" "unprognostic (2.33e-1)" "unprognostic (1.74e-2)" "unprognostic (2.31e-1)" "unprognostic (6.15e-3)" 32.8 7.5 12.2 27.0 13.2 17.5 14.4 4.3 14.0 12.8 10.5 8.9 11.4 15.3 15.6 22.4 11.8 12.0 20.1 13.1 10.7 7.9 19.1 37.9 25.1 15.8 11.0 9.6 34.6 2.7 2.2 8.6 15.2 16.4 13.2 10.1 9.9 26.4 9.0 9.1 10.7 14.4 14.7 10.8 35.0 14.0 5.4 11.0 17.3 10.5 9.2 11.3 12.0 13.4 4.3 7.7 13.1 11.6 7.7 8.5 5.3 2.0 0.1 0.2 0.5 2.8 6.3 0.2 2.5 10.4 33.1 34.2 0.2 3.0 0.5 0.8 3.8 11.9 1.2 0.0 0.5 3.8 4.5 0.1 0.7 0.3 0.4 15.2 0.4 3.1 2.9 0.0 4.4 0.1 0.1 2.7 9.6 0.2 10.8 1.0 0.1 2.2 8.8 0.2 0.1 0.8 4.3 0.1 0.2 0.0 1.9 0.2 0.2 1.2 0.2 5.5 0.2 0.3 12.1 0.3 0.4 0.3 0.9 0.2 1.6 0.5 0.2 0.9 7.2 0.8 13.1 8.8 4.2 7.5 11.6 5.7 3.3 5.9 5.2 7.7 4.3 4.0 4.1 10.6 7.7 10.7 0.8 8.5 5.3 12.2 13.2 4.3 14.0 10.7 7.9 11.0 9.6 16.4 11.0 56.6 31.7 5.4 5.3 4.6 0.2 1.6 12.7 36.1 50.0 0.0 0.0 0.1 0.0 1.1 3.1 24.8 8.1 23.3 1.7 3.5 8.7 2.7 46.3 13.6 15.0 0.0 1.7 28.8 16.4 0.6 33.6 22.5 5.0 3.6 8.4 1.0 6.2 0.0 25.8 0.2 0.3 19.4 3.9 0.3 0.6 2.4 0.3 13.8 6.6 5.4 XK "Kx, NA, NAC, X1k, XKR1" ENSG00000047597 "X-linked Kx blood group" P51811 X 37685756-37732130 "Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Blood group antigen" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.6" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 21.1;Erythroid cells: 23.3;Mucus-secreting cells: 12.1;Undifferentiated cells: 10.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 40 "basophil: 9.4;eosinophil: 6.8" "Lineage enriched" "Detected in single" 94 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "HEL: 25.2;HL-60: 13.0;K-562: 16.2;NB-4: 11.9;RPMI-8226: 11.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019036 Approved Approved Nucleoplasm,Vesicles,Mitochondria No No Mitochondria "Nucleoplasm, Vesicles" "HPA019036: AB_1846286" "unprognostic (2.37e-2)" "unprognostic (7.13e-3)" "unprognostic (5.03e-2)" "unprognostic (1.00e-2)" "unprognostic (7.97e-2)" "unprognostic (4.56e-1)" "unprognostic (3.59e-2)" "unprognostic (4.00e-2)" "unprognostic (4.77e-3)" "unprognostic (5.07e-2)" "unprognostic (6.63e-2)" "unprognostic (5.90e-2)" "unprognostic (4.44e-8)" "unprognostic (1.74e-1)" "unprognostic (4.75e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" 0.6 2.9 4.9 3.0 5.1 14.0 1.1 10.2 8.3 1.8 16.5 1.2 0.0 12.9 1.2 0.8 2.7 4.8 2.0 8.1 4.7 6.6 1.4 2.1 1.5 0.7 3.0 5.9 1.2 7.9 2.2 3.8 1.4 4.4 2.1 13.8 1.0 8.6 1.5 5.9 1.2 23.6 3.2 1.6 1.2 13.3 3.5 0.2 0.1 1.4 5.9 0.8 2.9 2.5 0.0 0.0 9.4 0.0 0.0 0.0 0.7 9.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 8.4 0.1 0.0 0.4 1.6 8.9 0.0 0.0 0.0 2.4 25.2 1.4 0.0 0.0 13.0 2.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.2 6.4 0.1 0.9 0.1 11.9 3.2 0.4 3.2 0.0 0.0 11.4 0.0 0.6 2.4 0.0 0.4 0.8 0.0 0.5 1.2 3.2 0.0 0.0 0.4 0.0 1.4 5.5 9.1 0.0 0.1 6.9 0.0 9.4 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 4.9 5.1 10.2 8.3 4.7 6.6 3.0 5.9 4.4 0.2 0.0 0.6 0.0 0.2 0.3 0.5 5.9 0.0 1.4 0.0 0.0 5.9 0.1 0.0 0.0 0.9 0.0 21.1 23.3 2.6 0.1 0.0 1.1 0.0 0.8 0.1 3.2 5.8 0.0 0.0 0.2 0.0 0.0 1.7 0.0 12.1 0.0 1.2 8.6 0.7 0.0 0.9 0.0 1.7 4.6 4.3 1.0 0.0 0.0 10.8 0.4 ZBED2 MGC10796 ENSG00000177494 "Zinc finger BED-type containing 2" Q9BTP6 3 111592900-111595443 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "lymphoid tissue: 21.0;thyroid gland: 74.5" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 41.7" "Cancer enriched" "Detected in many" 5 "thyroid cancer: 64.0" "Region enriched" "Detected in single" 6 "basal ganglia: 1.4" "Cell type enhanced" "Detected in many" "naive B-cell: 4.0" "Group enriched" "Detected in many" 6 "B-cells: 4.0;T-cells: 2.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0" "Not detected" "Not detected" HPA029786 Approved "Nuclear bodies,Mitochondria,Cytosol" No No "Mitochondria, Cytosol" "Nuclear bodies" "HPA029786: AB_10601028" "unprognostic (7.31e-3)" "unprognostic (1.67e-1)" "unprognostic (1.98e-3)" "unprognostic (1.66e-1)" "unprognostic (2.39e-3)" "unprognostic (3.49e-1)" "unprognostic (7.61e-2)" "unprognostic (1.47e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (8.83e-4)" "unprognostic (2.59e-1)" "unprognostic (1.47e-6)" "unprognostic (3.81e-2)" "unprognostic (4.34e-1)" "unprognostic (4.69e-2)" "unprognostic (3.29e-2)" 0.1 0.0 0.1 0.9 1.4 0.0 0.1 0.1 0.1 3.7 0.1 0.1 0.1 0.0 0.2 0.2 8.1 11.1 0.2 0.1 0.1 0.0 0.3 0.1 5.6 3.4 0.1 0.1 1.2 0.1 0.0 0.4 4.0 0.1 0.1 0.0 0.1 1.7 0.1 0.1 1.3 0.3 0.1 0.1 0.1 0.1 0.2 0.2 21.0 74.5 7.5 7.4 0.2 6.2 4.0 0.0 0.1 0.0 0.5 2.5 0.3 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.1 14.0 0.0 0.0 19.4 0.0 43.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.0 3.6 0.6 0.3 0.0 4.0 1.9 2.5 0.1 0.5 0.0 0.0 1.1 0.3 0.1 1.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 41.7 1.4 0.0 0.2 3.9 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.7 0.0 0.1 ZKSCAN1 "KOX18, PHZ-37, ZNF139, ZNF36, ZSCAN33" ENSG00000106261 "Zinc finger with KRAB and SCAN domains 1" P17029 7 100015572-100041689 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 212.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006672 Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitochondria" Yes No "Nuclear bodies" "Nucleoplasm, Mitochondria" "HPA006672: AB_1080707" "unprognostic (2.58e-1)" "unprognostic (1.59e-2)" "unprognostic (3.57e-2)" "unprognostic (4.62e-2)" "unprognostic (1.94e-1)" "unprognostic (2.24e-2)" "unprognostic (1.47e-2)" "unprognostic (4.76e-3)" "unprognostic (3.24e-2)" "unprognostic (1.86e-2)" "unprognostic (6.34e-3)" "unprognostic (8.59e-2)" "unprognostic (1.27e-3)" "unprognostic (7.75e-2)" "unprognostic (1.49e-1)" "unprognostic (1.70e-1)" "unprognostic (9.09e-3)" 11.7 19.5 16.1 12.1 23.9 8.1 23.6 15.0 23.9 16.8 21.2 38.9 16.3 18.1 16.2 18.3 19.8 23.0 25.1 10.8 18.8 15.2 14.2 47.6 11.7 12.2 26.1 27.3 20.6 26.7 18.3 14.3 11.1 27.6 24.3 24.3 14.7 25.0 19.4 11.9 32.5 16.5 14.3 23.6 13.5 33.0 16.4 23.1 17.3 12.5 11.4 12.1 14.4 17.5 6.1 7.3 13.3 10.0 11.7 7.5 4.5 9.2 6.8 18.1 19.8 18.7 22.8 6.8 10.4 12.7 6.2 6.3 4.1 8.8 10.5 13.3 11.6 11.0 7.7 10.4 9.0 12.0 10.1 6.4 8.5 8.3 10.6 10.6 16.1 10.2 15.3 14.4 8.4 28.3 17.0 13.7 12.5 19.5 9.2 12.3 12.3 15.3 9.6 7.3 17.4 8.6 9.1 9.2 9.4 10.5 14.6 21.1 25.2 16.2 21.3 18.3 10.8 10.8 10.8 20.6 13.7 13.4 15.9 10.5 10.7 18.5 10.9 9.3 11.6 17.9 13.3 4.7 5.0 6.8 4.0 6.7 5.1 5.4 6.7 7.3 6.1 7.5 5.3 5.3 11.7 10.0 5.2 4.3 4.5 16.1 23.9 15.0 23.9 18.8 15.2 26.1 27.3 27.6 23.1 23.8 39.4 30.6 38.6 13.4 91.6 37.3 142.7 161.9 56.9 43.6 141.4 32.1 13.3 46.0 35.7 43.9 59.0 0.0 38.3 12.7 32.9 84.1 33.6 124.6 17.1 84.2 212.3 35.6 28.8 14.6 47.5 27.1 38.8 27.9 82.8 74.9 41.8 84.2 50.2 23.0 68.3 19.4 22.2 28.9 14.6 18.7 55.2 18.7 98.9 47.9 ZNF445 "ZKSCAN15, ZNF168, ZSCAN47" ENSG00000185219 "Zinc finger protein 445" P59923 3 44431720-44477670 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 34.4;Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006678 Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA Nucleoplasm "Mitochondria, Cytosol" "HPA006678: AB_10603329" "unprognostic (7.72e-2)" "unprognostic (2.55e-1)" "unprognostic (1.12e-2)" "unprognostic (1.42e-1)" "unprognostic (7.14e-2)" "unprognostic (1.67e-2)" "unprognostic (1.79e-2)" "unprognostic (2.72e-2)" "unprognostic (1.60e-2)" "unprognostic (1.62e-1)" "unprognostic (1.03e-2)" "unprognostic (4.55e-2)" "unprognostic (3.11e-3)" "unprognostic (1.76e-1)" "unprognostic (2.48e-1)" "unprognostic (4.40e-3)" "unprognostic (1.05e-1)" 6.8 6.4 8.3 6.4 10.9 4.5 7.5 16.5 10.9 8.6 7.1 11.7 8.0 5.1 13.6 7.7 5.2 8.3 6.1 6.3 7.7 7.0 6.3 7.5 6.7 6.6 11.3 10.5 13.0 7.6 16.1 13.9 7.1 7.9 8.6 6.6 9.9 8.1 8.2 11.2 8.2 5.7 12.3 6.6 7.0 7.3 6.5 8.9 14.2 6.9 4.8 8.1 6.7 8.2 1.1 1.1 4.1 2.5 1.9 1.5 0.5 2.5 2.9 9.1 7.1 5.1 5.2 4.1 3.5 2.9 5.3 5.3 4.4 2.3 4.5 2.2 3.6 3.4 2.1 6.1 2.4 6.4 4.9 2.3 8.3 5.9 4.3 3.2 10.5 7.0 3.6 3.0 5.9 3.8 4.5 3.7 6.4 6.4 3.4 4.2 1.7 10.0 7.1 6.2 1.6 2.7 4.5 5.7 2.2 2.9 5.3 4.5 5.6 5.4 2.8 1.4 7.1 5.2 4.6 4.4 7.5 6.7 4.6 4.4 2.7 2.0 3.8 2.8 5.3 4.5 2.7 1.3 2.3 1.2 0.8 1.1 0.7 0.9 0.9 0.9 1.1 1.5 1.1 4.1 1.9 2.5 1.1 0.4 0.5 8.3 10.9 16.5 10.9 7.7 7.0 11.3 10.5 7.9 8.9 11.9 16.7 7.3 4.1 3.7 34.4 7.8 2.5 12.0 10.3 10.4 35.3 3.3 1.7 4.4 1.9 6.8 2.6 0.0 7.3 1.5 6.1 5.2 10.5 8.5 4.7 27.0 6.9 10.4 14.0 1.6 8.6 7.7 0.0 1.0 6.5 13.4 4.4 3.5 9.2 2.3 30.0 12.9 6.1 5.7 6.1 2.3 1.1 5.7 6.9 3.4 ZNF678 MGC42493 ENSG00000181450 "Zinc finger protein 678" Q5SXM1 1 227563543-227677443 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA028507 Uncertain Approved Nucleoli,Mitochondria,Cytosol Yes No "Mitochondria, Cytosol" Nucleoli "HPA028507: AB_10603567" "unprognostic (1.76e-2)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (4.42e-3)" "unprognostic (3.92e-2)" "unprognostic (4.64e-2)" "unprognostic (1.59e-2)" "unprognostic (2.19e-2)" "unprognostic (2.50e-1)" "unprognostic (1.64e-1)" "unprognostic (3.54e-6)" "unprognostic (1.39e-1)" "unprognostic (4.18e-1)" "unprognostic (1.10e-1)" "unprognostic (4.88e-4)" 9.0 7.6 8.2 6.6 16.2 7.1 8.8 19.4 10.8 9.3 7.2 6.7 7.1 5.4 9.2 6.2 6.1 7.7 7.4 7.4 8.9 6.3 6.4 5.3 7.8 9.8 12.7 8.2 9.9 12.6 7.2 19.4 9.7 8.9 10.6 10.8 4.6 7.6 6.3 6.2 5.2 6.6 7.5 14.2 9.5 7.6 8.7 15.5 12.0 12.7 5.1 9.1 8.2 9.4 6.6 3.2 7.1 1.1 2.2 3.2 1.5 2.0 3.2 11.9 13.5 1.5 3.4 7.2 2.7 2.7 4.1 4.4 2.6 2.6 8.3 7.2 1.2 2.2 4.0 7.0 1.8 6.8 3.5 13.4 3.9 2.5 1.6 2.7 6.6 10.6 3.0 3.4 2.5 5.3 3.1 3.9 9.3 9.9 13.1 4.5 1.7 9.1 2.3 10.4 3.0 5.4 7.1 7.7 3.2 3.0 6.5 5.1 9.9 4.1 4.9 2.0 6.1 6.8 8.4 2.5 5.1 4.9 4.6 5.6 4.2 9.6 9.1 2.1 1.2 5.3 7.1 1.1 1.3 2.5 0.3 3.0 6.6 2.5 1.4 2.1 4.5 2.2 3.2 0.2 2.2 0.7 3.2 2.7 1.5 8.2 16.2 19.4 10.8 8.9 6.3 12.7 8.2 8.9 15.5 3.0 5.3 4.7 3.6 2.1 11.6 3.6 5.1 5.3 4.5 3.5 3.9 1.8 1.7 3.3 0.6 4.7 1.5 0.0 4.4 2.1 3.4 5.6 3.5 1.6 1.4 1.6 9.2 3.7 3.7 0.2 6.9 2.2 0.0 1.8 3.9 4.2 2.9 4.5 2.5 1.1 6.7 0.0 2.1 7.2 10.0 0.5 1.1 7.5 2.6 3.4 ZNF787 ENSG00000142409 "Zinc finger protein 787" 19 56087366-56121280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 52.1;Cone photoreceptor cells: 104.1;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 43.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035140 Supported Approved Nucleoplasm,Nucleoli,Mitochondria NA NA Nucleoplasm "Nucleoli, Mitochondria" "HPA035140: AB_10602358" "unprognostic (1.97e-2)" "unprognostic (5.86e-2)" "unprognostic (8.77e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.24e-1)" "unprognostic (1.46e-2)" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (1.54e-1)" "unprognostic (4.83e-2)" "unprognostic (1.26e-1)" "unprognostic (1.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.96e-3)" 7.4 8.0 4.3 7.8 5.2 18.8 7.1 4.7 7.0 8.0 9.8 5.1 8.5 12.8 5.8 6.5 9.8 8.7 8.7 10.2 4.0 4.3 6.4 18.0 6.9 7.7 4.8 4.0 8.7 13.9 3.3 6.6 4.8 4.6 10.0 3.9 7.9 9.6 7.2 28.2 9.3 10.5 6.8 3.1 14.9 11.0 6.8 4.6 4.8 10.0 8.2 5.7 8.7 10.1 3.0 5.5 4.9 2.1 1.2 1.6 0.7 12.0 11.9 3.9 8.1 1.1 2.5 10.1 6.2 2.4 4.3 4.8 7.0 7.5 8.6 0.4 2.6 3.8 9.5 2.4 5.0 1.9 11.4 43.9 13.7 6.0 10.5 6.3 13.1 12.0 3.3 5.0 3.5 6.2 2.6 3.1 4.9 16.3 9.7 2.5 7.6 8.1 16.5 12.3 11.1 22.4 10.2 5.7 10.9 4.3 8.0 14.9 14.4 6.6 13.0 11.5 2.3 8.0 18.6 6.7 16.1 11.5 6.7 17.1 20.6 15.1 8.3 9.3 8.8 7.5 1.7 2.1 2.6 1.2 1.5 1.6 2.3 0.8 1.0 2.2 3.0 1.3 0.7 4.9 1.2 1.4 5.5 1.3 0.7 4.3 5.2 4.7 7.0 4.0 4.3 4.8 4.0 4.6 4.6 11.9 2.4 6.7 8.9 5.5 52.1 9.0 12.7 0.0 4.5 10.4 104.1 2.9 1.7 5.9 1.5 6.7 15.4 0.0 14.2 4.0 5.0 8.6 5.7 28.4 7.5 33.4 8.7 12.9 6.5 2.9 4.6 6.8 1.7 4.6 17.1 29.5 12.9 15.3 4.2 3.7 60.0 6.5 6.2 2.5 7.9 6.4 1.6 3.2 16.9 11.7